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Information-rich genomic data have transformed the study of genetic 
variants but have affected investigations of gene-environment interplay less, 
partly due to the multiple testing involved in genome-wide interaction 
studies. This thesis explores alternative uses of genome-wide techniques to 
investigate gene-environment interplay.  
Genetic associations with individual differences in response to an 
environment can be examined by performing genome-wide association 
studies in individuals with a shared exposure. Cognitive behavioural 
therapy is a controllable environment that can be studied prospectively. 
Genetic variants and RNA transcript expression were used to predict 
therapeutic outcome. No significant predictors were identified, suggesting 
that effects are likely to be small. 
Genome-wide association studies remain underpowered to detect small 
effects, despite increasingly large cohorts. Polygenic risk scores 
incorporating variants below traditional thresholds of statistical significance 
can capture true signal. These scores can act as a proxy for the effect of the 
genome in genome-by-environment interaction studies, and were used in 
this thesis to dissect the observed increase in body mass index in individuals 
with depression. Results suggest that this relationship is likely to result 
3 
 
primarily from causes other than the additive effects of common genetic 
variation.  
Polygenic risk scores were also used to assess the effects of social 
environmental and genetic influences on body mass index before and during 
adolescence, using a risk score primarily derived from adult participants. 
Positive associations between this risk score and adolescent body mass index 
phenotypes suggest a stable genetic influence on body mass. Social 
environmental influences on body mass had small effects, with weak 
evidence for an interaction between socioeconomic status and genetic risk 
influencing body mass. 
Statistical limitations on genomic analyses can be reduced by using 
alternative methods to complement genome-wide interaction studies. These 
approaches provide insight into the interactive effects of the genome and the 
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Chapter 1: Introduction 
1.1 Quantitative genetics, molecular genetics, and the relative roles of 
genetics and environment  
1.1.1. Quantitative genetics describes genetic and environmental influences 
on human behaviour as a complex trait 
The desire to understand the aetiology of behaviour has been a major 
theme within the field of genetics since its inception. A vital contribution to 
this endeavour was the creation of quantitative genetics, which seeks to 
understand the relative contributions of genetic and environmental 
influences to trait variance. The development of quantitative genetic theory 
reconciled the particulate genetic inheritance suggested by the work of 
Mendel with the more complex patterns of inheritance observed by 
biometricians such as Galton (Galton, 1869; Mendel, 1866). Quantitative 
genetics proposes that apparently complex traits result from the 
combinatorial effects of many factors, each of which obeys Mendelian laws 
of inheritance. These factors combine to generate a distribution of liability 
that underlies variation in complex traits (Fisher, 1918; Plomin, DeFries, 
Knopik, et al, 2012; Sarkar & Pfeifer, 2006; Wright, 1921). Observed within-
family similarities in complex traits can be explained by the combination of 
multiple genetic variants with additive effects in the presence of additional 
factors (Fisher, 1918). Such non-genetic factors are usually referred to as 
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environmental influences, although there is also a contribution from non-
additive genetic effects and from the random stochastic error that inaccurate 
measurement and observation necessarily incur. As such, the word 
“environment” can refer both to this "inferred component" and to specific 
effects stemming from the environment to which individuals are exposed 
("measured environments"). This latter concept is predominantly used 
within this thesis – where the intended meaning is not obvious from context, 
it is explicitly stated.  
The quantitative genetic model assumes the underlying influences on 
complex traits sum to a continuous distribution of liability, regardless of the 
presentation of the trait. In the case of discrete phenotypes (such as mental 
illnesses), a liability-threshold model can explain the apparent dichotomy, 
with the disorder manifesting above a certain amount of risk (the threshold; 
Falconer, 1965). This threshold could be defined by multiple factors, both 
genetic and environmental. If liability is modelled as a normal distribution, 
its variance can be partitioned among constituent factors (Figure 1; Plomin, 
DeFries, Knopik, et al, 2012).  At the simplest level, two main components 
can be defined: the genetic component (also referred to as broad-sense 
heritability) and the environmental component. Again, it is important to note 
that environment in this context is defined negatively as all of the variance in 
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the phenotype not explained by genetic factors, rather than the summed 










Related individuals shared genetic variants, and the degree of sharing 
(relatedness) can be determined from genetic theory. Relatedness is 
important to quantitative genetic methods because it allows the genetic and 
environmental components of variance to be inferred from the observed 
phenotypic variance. An individual is expected to share half of their genome 
with each of their parents, and with any full siblings, due to the independent 











Figure 1: Liability-threshold model for a discrete trait, showing  
the normal distribution of risk and the threshold, to the right of 
which the trait presents. Imagined contributions of genetic (below) 




Mendel, 1866). Identical twins, however, develop from a single zygote, and 
as such share all of their genome (ignoring rare early mutational events).  
This sharing is crucial to the design of one of the most prominent 
quantitative genetic methods, the classical twin study (reviewed in 
Boomsma, Busjahn & Peltonen, 2002). The correlation between the 
phenotypes of pairs of identical twins (which can be observed empirically) is 
the sum of genetic and shared environmental components (that is, factors 
that make the twins more alike). If any pairs have discordant phenotypes, 
the influencing factor must stem from the environmental component 
(because their genetic component is shared). Non-identical twins share only 
half of their genome (on average), so the genetic contribution to the 
correlation between pairs of non-identical twins is expected to be 
proportionally lower. From these observations and theories, the 
environmental and genetic components of variance can be inferred (Neale & 
Cardon, 1992; Plomin, DeFries, Knopik, et al, 2012).  
1.1.2 Molecular genetics enables the dissection of the heritable component 
Although quantitative genetic approaches can demonstrate that 
genetic effects influence behavioural traits, they cannot be used to determine 
which exact areas of the genome contribute. That is the preserve of molecular 
genetic methods. Initially, such methods relied either on the linkage of broad 
regions of the genome with outcomes of interest (linkage studies) or on 
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targeted examination of the effects of specific mutations (association studies). 
However, both of these approaches have considerable limitations. Linkage 
studies use variable number tandem repeats (repeated sequences of a few 
nucleotides), which are limited in number across the genome, resulting in 
low resolution and restricting linkage of traits to sections of chromosomes 
only, rather than to specific nucleotides (Botstein, White, Skolnick, et al, 
1980). Association studies can examine the genome at a much finer scale by 
assessing the effects of single nucleotide polymorphisms (SNPs). Initially, 
however, they were limited by the number of SNPs identified and by the 
technological capacity to assay them. As a result, early association studies 
focussed on candidate genes. However, this approach relies on potentially 
erroneous assumptions about which genes are relevant to a given trait, and 
such studies often only assess a few variants out of the many that may 
influence the action of the gene (Dick, Agrawal, Keller, et al, 2015; Munafo, 
2006). In the absence of likely effect size estimates, the cohorts examined 
were usually too small (in the context of effect size estimates from later 
genomic studies; Dick, Agrawal, Keller, et al, 2015). As a result, many of the 
findings from candidate gene studies have failed to replicate in more recent, 
genomic studies, and reported effect sizes have been over-estimated, a 
phenomenon known as winner's curse (Chabris, Hebert, Benjamin, et al, 
2012; Dunn, Brown, Dai, et al, 2015; Hirschhorn, Lohmueller, Byrne, et al, 
2002; Ioannidis, 2005; Ioannidis, 2014; Zollner & Pritchard, 2007). 
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The use of molecular genetics in the study of behaviour was altered 
considerably by the technological and statistical innovation that occurred 
during the Human Genome Project and following its completion (Lander, 
Linton, Birren, et al, 2001; McCarthy, Das, Kretzschmar, et al, 2016; Venter, 
Adams, Myers, et al, 2001). The consequent development of microarray-
based genome-wide genotyping and a more sophisticated knowledge of the 
multiple testing load made genome-wide association studies (GWAS) 
possible (Klein, Zeiss, Chew, et al, 2005; Wellcome Trust Case Control, 2007). 
GWAS combine the agnosticism of linkage studies with the precision of 
single-variant association studies. Large sample sizes are required to identify 
associated loci; consequently, psychiatric genomics has been driven almost 
from the outset by large-scale collaborations (Sullivan, 2010).  
1.1.3 The "four laws of behavior genetics" describe the relative importance of 
genetic and environmental components 
The accumulated evidence from quantitative and molecular studies in 
human behavioural genetics was pithily summarised as the three "laws of 
behavior genetics", with a fourth law recently added. These laws are:  
 Behaviour is heritable (Turkheimer, 2000; Turkheimer & 
Gottesman, 1991) 




 Non-shared environments contribute considerably to 
phenotypic variance (Turkheimer, 2000).  
 Variance in behavioural traits is associated with many genetic 
variants with very small individual effects (Chabris, Lee, 
Cesarini, et al, 2015). 
The success of behavioural genomics inspired the suggestion of the 
fourth law; although many behavioural traits await genomic study, the 
evidence from those studied to date argues that polygenicity is expected. The 
polygenic model (incorporating variation across the allele frequency 
spectrum) explains findings to date better than competing models, such as a 
high excess of common or of rare mutations (Gratten, Wray, Keller, et al, 
2014; Sullivan, Daly & O'Donovan, 2012; Visscher, Goddard, Derks, et al, 
2012; Yang, Visscher & Wray, 2010). Unlike the more seriously proposed 
fourth law, the original laws were deliberately simplistic and designed to 
highlight the probabilistic nature of genetic results, and the inherent biases 
of the methods used (Turkheimer, 2000). Nevertheless, the laws are an 
accurate summary of the field. Meta-analysis of twin studies conducted 
between 1958 and 2012 report an average effect of shared environmental 
component of 17% across all mental and behavioural disorders (819 traits, 
1599455 twin pairs), compared to an average heritability of 47% and 
therefore an average effect of the non-shared environmental component of 
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36% (Polderman, Benyamin, de Leeuw, et al, 2015). The effect of non-shared 
environment appears to be substantial. However, this component contains 
stochastic error, and as such its importance could reflect the imperfection of 
the model (Plomin, 1994; Plomin & Daniels, 2010; Turkheimer, 2000; 
Turkheimer & Waldron, 2000).  
1.2 Genetic and environmental influences on the disorders of interest  
Psychiatric genomics has begun to yield valuable results, despite the 
initial disappointment that resulted from the unexpectedly small effect sizes 
of individual variants associated with psychiatric phenotypes. Schizophrenia 
has been the pioneer disorder, with the most recent large international meta-
analysis reporting associations at 108 genetic loci (Schizophrenia Working 
Group of the Psychiatric Genomics, 2014). Theoretical estimations from this 
data suggest there are likely to be thousands of associated loci (although 
estimation is biassed by the assumed genetic architecture). The recent 
completion of large-scale genotyping projects is expected to boost 
considerably the power to detect these loci (Aas, Blokland, Chawner, et al, 




1.2.1. Studying the genetics of major depressive disorder is constrained by 
heterogeneity 
Genomics has been slower to produce results in other psychiatric 
disorders, particularly those with lower heritability. The archetypal example 
of this is depression; the heritability of depression as estimated from twin 
studies is approximately 40%, around half that estimated in schizophrenia 
(Polderman, Benyamin, de Leeuw, et al, 2015). Estimates differ by the 
classification of depression – "depressive episode" has a reported heritability 
around 30%, compared to an estimate of 45% for the chronic "recurrent 
depressive disorder" (Polderman, Benyamin, de Leeuw, et al, 2015). 
Furthermore, the average correlation between dizygotic twin pairs for 
recurrent depressive disorder was less than half that between monozygotic 
twin pairs, indicating the potential for non-additive genetic effects 
(Polderman, Benyamin, de Leeuw, et al, 2015). 
Until recently, genomics had been largely unsuccessful in depression. 
Despite a comparable cohort size to the successful efforts in schizophrenia 
(roughly nine thousand cases and nine thousand controls), the initial PGC 
mega-analysis of depression did not identify any variants at genome-wide 
levels of significance (Major Depressive Disorder Working Group of the 
Psychiatric, Ripke, Wray, et al, 2013; Schizophrenia Psychiatric Genome-
Wide Association Study, 2011). Although genomic studies have been 
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relatively unsuccessful in identifying genetic variants associated with 
depression, there have been hundreds of variants suggested by hypothesis-
driven "candidate gene" analyses (Lopez-Leon, Janssens, Gonzalez-Zuloeta 
Ladd, et al, 2008). Variants have been implicated near genes associated with 
neurotransmission, both transporters (such as SLC6A3/DAT and 
SLC6A4/5HTT) and receptors (including the dopamine receptors DRD2 and 
DRD4), as well as with signal transduction (like the G-protein GNB3), risk 
processes (including MTHFR, involved in folate metabolism), and comorbid 
disorders (such as APOE in Alzheimer's disease; Lopez-Leon, Janssens, 
Gonzalez-Zuloeta Ladd, et al, 2008). However, very few such variants are 
supported by evidence from GWAS (Dunn, Brown, Dai, et al, 2015).     
The success of genomics in depression has been limited by both the 
lower heritability and the phenotypic heterogeneity of the disorder. 
Although ostensibly a single disorder, depression is frequently split into 
subtypes according to the recurrence of the disorder or the symptoms with 
which individuals present. Recurrence is conflated with severity, duration 
and impairment – recurrent depression is usually more severe, longer lasting 
and causes a greater reduction in quality of life, including a higher 
occurrence of suicide attempts (Kessler, Zhao, Blazer, et al, 1997; Merikangas, 
Wicki & Angst, 1994). Depression can present with features including low 
mood, irritation, loss of pleasure (anhedonia), weight change, disrupted 
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sleep and activity, fatigue, guilt, loss of concentration and suicidality 
(Association, 2013). A diagnosis of depression requires as a minimum 
unusual and impairing low mood or anhedonia, as well as at least four out of 
the other seven features described above (Association, 2013). As such, a 
diagnosis of depression can result from 105 different combinations of 
symptoms. Furthermore, certain of these features, particularly weight and 
appetite, have no inherent direction in diagnosis. Depression featuring 
reductions in these areas is termed "typical" because such reductions are 
conceptually more similar to other depressive symptoms like loss of pleasure 
and low mood. Conversely, a vegetative state featuring weight gain and 
reduced activity is characteristic of atypical depression (Davidson, Miller, 
Turnbull, et al, 1982). Latent class factor analysis can distinguish separate 
classes within depression that can be labelled as typical and atypical, and 
which vary in severity (Kendler, Eaves, Walters, et al, 1996; Sullivan, Kessler 
& Kendler, 2014). The relationship between these classes and the clinically 
described subtypes is unclear, however, and such analyses usually also 
identify intermediate classes that show a mixture of depressive features. 
Subtypes may be arbitrary groupings of a continuous spectrum, effectively 
the result of defining multiple thresholds on the underlying liability 
distribution (Kessler, Zhao, Blazer, et al, 1997; Merikangas, Wicki & Angst, 
1994). As such, depression demonstrates clinical heterogeneity, and is 
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composed of grouped sets of features that are distinguishable within studied 
cohorts of individuals with depression.  
A further potential source of heterogeneity in meta-analyses of genetic 
studies of depression is the influence of measured environmental factors. 
Predominant among such factors are stressful life events, a broad range of 
influences that can include the death of loved ones, difficulties in social 
relationships, injury or illness, and historical or present neglect or abuse 
(Holmes and Rahe, 1967; Brown & Harris, 1978). The occurrence of such 
events has been consistently and robustly observed at a greater rate in 
individuals with depression compared to population controls (Mazure, 1998; 
Nanni, Uher & Danese, 2012). As such events tend to occur prior to the onset 
of depression, they are frequently hypothesised to have a causal role. This 
hypothesis has been tested by contrasting independent events (that is, events 
out of the individual's control) and dependent events, which the individual 
influences to some extent (Kendler, Karkowski & Prescott, 1999). Individuals 
with depression had experienced more independent stressful life events than 
population controls, suggesting a causal effect. However, the relationship 
was noticeably stronger when considering dependent events, suggesting that 
there is also a non-causal component, such as could be produced by a gene-
environment correlation in which individuals genetically predisposed to 
depression are more likely to generate dependent stressful life events, even 
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prior to depression (Kendler, Karkowski & Prescott, 1999). Such 
environmental factors may influence not just the onset and course of disease, 
but the effectiveness of treatment. For example, a meta-analysis of published 
studies suggests childhood maltreatment is associated with poorer response 
to pharmacotherapy (with or without psychotherapy) in depression (Nanni, 
Uher & Danese, 2012). 
Beyond stressful life events, there is considerable evidence that the 
social environment (that is, an individual's interactions with others) many 
influence depression, particularly in childhood. Studies of expressed 
emotion (the hostility or warmth towards an individual from others, usually 
family members), although initially most closely associated with 
schizophrenia, have been extended to study depression (Hooley, Orley & 
Teasdale, 1986; Vaughn & Leff, 1976). Such studies generally conclude that 
individuals with depression were more likely to relapse after experiencing a 
hostile, critical social environment (Wearden, Tarrier, Barrowclough et al, 
2000; Hooley, 2007). An association with relapse does not imply an 
association with the aetiology of the disorder. The evidence supporting a 
causal role for critical expressed emotion in depression is mixed. A 
prospective study of a child cohort found children in high-criticism families 
were more likely to develop depressive symptoms than those in low-
criticism families, suggesting expressed emotion may be a risk factor for the 
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development, as well as the maintenance, of depression (Burkhouse, Uhrlass, 
Stone et al, 2012). Similarly, high rates of maternal criticism have been 
reported in cohorts of children with or at risk for depression (Silk, Ziegler, 
Whalen et al, 2009; Tompson, Pierre, Dingman Boger et al, 2010). However, 
other longitudinal studies have highlighted the potential for reciprocal 
effects. Associations have been identified (albeit inconsistently) between past 
critical parenting and later childhood depression, and between earlier 
depression and increased harsh parenting, with the latter effects arguably 
the stronger (Hale, Keijsers, Klimstra et al, 2011, Nelemans, Hale, Branje, et al, 
2014; but see null findings from Frye & Garber, 2005). It should also be noted 
that this relationship is confounded with shared genetics between parent and 
offspring (Lau & Eley, 2008). There therefore appears to be a complex 
relationship between critical social relationships and depression.  
The influence of the parent-child relationship is an important 
component of the general effect of the social environment and of expressed 
emotion. Parenting is a multi-faceted and complex phenomenon that can be 
conceptualised in a number of different ways. For example, one aspect of 
parental strategy is the level of control within the parent-child relationship, 
which in turn has sub-dimensions encompassing withdrawal of the parent 
from the child, hostility towards the child, and warmth in parent-child 
interactions (McLeod, Weisz & Wood, 2007). This complexity has spawned a 
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broad literature on the effects of parenting on juvenile depression, but this 
literature is difficult to reconcile to identify consistent findings, partly as a 
result of the wide array of parenting constructs. Nonetheless, multiple meta-
analyses have suggested an effect of hostile parenting associated with 
increased rates of depression in young people (McLeod, Weisz & Wood, 
2007; Yap, Pilkington, Ryan et al, 2014).  
Variability in the definition of depression, and the influence of 
environmental factors like stressful life events, can create heterogeneity that 
reduces the power of meta-analyses of genetic studies. Examining the genetic 
correlations between independent GWA studies of schizophrenia results in 
very high correlations ≈ 0.9; despite clinical concerns about heterogeneity in 
the presentation of schizophrenia, there appears to be at least genetic 
consistency between studies (Cross-Disorder Group of the Psychiatric 
Genomics, 2013; Gratten, Wray, Keller, et al, 2014). However, performing the 
same analysis in the PGC depression cohorts yields much lower correlations 
≈ 0.55, reflecting phenotypic heterogeneity (Cross-Disorder Group of the 
Psychiatric Genomics, 2013; Gratten, Wray, Keller, et al, 2014).  
Recently, however, depression genomics has begun to produce 
results. The most recent PGC mega-analysis (with a considerable increase in 
the number of individuals studied) has identified a number of associated 
variants (although the final details were still unpublished at the submission 
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of this thesis; Lewis, 2015). Other significant associations have been 
identified by taking alternative approaches to increasing power. A GWAS in 
a population cohort of ~300,000 European individuals identified 15 loci at 
genome-wide significance in meta-analysis with existing data, 
demonstrating the power of large cohorts (Hyde, Nagle, Tian, et al, 2016). 
Actively reducing heterogeneity has also yielded success in studying 
depression, which demonstrates that increasing phenotype specificity can 
yield better power even if the cohort size is reduced (Traylor, Markus & 
Lewis, 2015). For example, selecting cases with an age-of-onset later than 27 
years identified a variant on chromosome 3 which reached genome-wide 
significance (Power, Tansey, Buttenschon, et al, 2016). Restricting the 
depression case group to women with severe melancholic depression in a 
Chinese sample yielded two variants at genome-wide significance 
(Consortium, 2015a). Contrasting approaches to increasing power 
(interrogating larger cohorts and directly addressing heterogeneity) are 
yielding insights into the specific genetic variants underlying variance in 
depression.  
1.2.2. The genetics of anxiety disorders may mirror those of depression 
As well as high heterogeneity, depression also exhibits high 
comorbidity with other psychiatric disorders, particularly anxiety (Kessler, 
Berglund, Demler, et al, 2003). The two disorders are frequently studied 
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together as internalising disorders (in contrast with the externalising 
disorders: attention-deficit hyperactivity disorder, conduct disorder and 
oppositional-defiant disorder), and the DSM-5 has a specific diagnosis of 
anxious depression (Association, 2013). Furthermore, there is evidence of 
high genetic overlap between depression and generalised anxiety disorder, 
suggesting that the different presentation of these disorders may result 
primarily from environmental influences (that is, those not attributable to the 
additive effect of genetics; Kendler, 1996; Kendler, Gardner, Gatz, et al, 2007; 
Kendler, Neale, Kessler, et al, 1992b). 
Anxiety also mirrors the heterogeneity seen in depression. Unlike 
depression, pathological anxiety is typically separated into distinct disorders: 
generalised anxiety disorder, panic disorder, agoraphobia, social anxiety 
disorder and specific phobias, as well as a childhood-specific disorder, 
selective mutism. Traditionally, obsessive-compulsive disorder and post-
traumatic stress disorder were included within the anxiety disorders. 
However, the distinct characteristics of these disorders resulted in their 
separation from the anxiety disorders (and from each other) in DSM-5 
(Association, 2013). Given the relative recency of this decision, many studies 
of anxiety disorders have included OCD and PTSD. A further disorder, 
separation anxiety disorder, was moved into the anxiety disorders from the 
childhood-onset disorders during the creation of DSM-5, an 
27 
 
acknowledgement of evidence that this disorder occurs (and has its onset) in 
adults as well as children (Association, 2013; Shear, Jin, Ruscio, et al, 2006; 
Silove, Alonso, Bromet, et al, 2015).  
The diagnostic boundaries between the anxiety disorders are 
particularly blurred in childhood, where affected individuals are frequently 
comorbid for several anxiety disorders, and transition between disorders is 
common (Rapee, Schniering & Hudson, 2009). Phobias, social anxiety 
disorder, and separation anxiety disorder typically have their onset in 
childhood, while generalised anxiety disorder, panic disorder and 
agoraphobia show an average age of onset in adolescence or early adulthood 
(Kessler, Angermeyer, Anthony, et al, 2007; Kessler, Berglund, Demler, et al, 
2005; Shear, Jin, Ruscio, et al, 2006). Not all juvenile anxiety disorders persist 
into adulthood but, because childhood represents a crucial developmental 
period, they are a risk factor for physical and psychiatric illnesses in later life, 
including adult anxiety disorder and major depressive disorder (Bardone, 
Moffitt, Caspi, et al, 1998; Gregory, Caspi, Moffitt, et al, 2007; Lewinsohn, 
Holm-Denoma, Small, et al, 2008). However, a caveat applies, namely that 
juvenile anxiety disorders are highly comorbid both within the anxiety 
disorders and with other disorders (such as major depressive disorder, 
conduct disorder and attention-deficit hyperactivity disorder) and as such 
associations between childhood anxiety and later adverse outcomes may be 
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confounded (Angold, Costello & Erkanli, 1999; Costello, Egger & Angold, 
2005). 
Heritability estimates for the anxiety disorders as a group and for the 
disorders individually are typically 30-40%, again mirroring depression 
(Hettema, Neale & Kendler, 2001; Kendler, Myers, Prescott, et al, 2001; 
Kendler, Neale, Kessler, et al, 1992a; Polderman, Benyamin, de Leeuw, et al, 
2015; Scaini, Belotti & Ogliari, 2014; Shimada-Sugimoto, Otowa & Hettema, 
2015; Tambs, Czajkowsky, Roysamb, et al, 2009; Van Houtem, Laine, 
Boomsma, et al, 2013). Attempts to identify specific genetic loci that 
contribute to this heritability have followed a familiar pattern, with 
equivocal candidate gene studies gradually giving way to better-powered 
genomic studies. The majority of well-powered studies have focussed on 
panic disorder; a recent meta-analysis identified 107 genes investigated in 
candidate gene studies (and GWAS), of which 23 variants in 20 genes had 
been studied regularly enough to justify meta-analysis (Howe, Buttenschon, 
Bani-Fatemi, et al, 2016; McGrath, Weill, Robinson, et al, 2012; Shimada-
Sugimoto, Otowa & Hettema, 2015). Of these, variants in the COMT (rs4680) 
and TMEM132D (rs7309727/rs11060369) genes were significantly associated 
with panic disorder (although only in European participants) after 
controlling for multiple testing (Howe, Buttenschon, Bani-Fatemi, et al, 2016). 
For the majority of associations from the candidate literature, replication has 
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either not been attempted or has failed (Howe, Buttenschon, Bani-Fatemi, et 
al, 2016; Shimada-Sugimoto, Otowa & Hettema, 2015). This conclusion 
extends to the broader anxiety genetics literature – many studies have been 
published, but their results are contradictory, and no robust associations can 
be discerned (McGrath, Weill, Robinson, et al, 2012).  
Furthermore, as with depression and schizophrenia, findings from the 
candidate gene literature have failed to replicate in the emerging GWAS 
literature. A caveat to this is that anxiety genomics is still in its infancy. A 
GWAS of phobia in 11000 individuals did not identify any associations at 
genome-wide significance (Walter, Glymour, Koenen, et al, 2013). In contrast, 
a series of studies of panic disorder in European samples have implicated the 
aforementioned rs7309727 variant in TMEM132D (p=1.05x10-8, OR= 1.45 (95% 
CI: 1.20–1.72); Erhardt, Akula, Schumacher, et al, 2012; Erhardt, Czibere, 
Roeske, et al, 2011). Some additional support for this association comes from 
a family-based genome-wide linkage study of a broad anxiety phenotype in 
a Mexican-American cohort, which identified the 12q24.32-q24.33 region 
(which contains TMEM132D, amongst other candidates) at genome-wide 
significance (Hodgson, Almasy, Knowles, et al, 2016). Additional analyses of 
this variant in a Japanese cohort initially suggested no effect of this variant in 
Japanese samples (Erhardt, Akula, Schumacher, et al, 2012). However, recent 
analyses tentatively suggest that there may be a gene-by-gene interaction. 
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The HLA-DRB1*13:02 allele is significantly enriched in panic disorder cases 
compared to controls within this cohort (p = 2.50x10-4; Shimada-Sugimoto, 
Otowa, Miyagawa, et al, 2015). Examining only individuals without this 
allele identified a significant association between panic disorder and 
rs7309727 (p = 5.02x10-6; Shimada-Sugimoto, Otowa, Miyagawa, et al, 2016). 
Additional analyses in this Japanese sample have also implicated a variant in 
the TMEM16B gene (Otowa, Kawamura, Nishida, et al, 2012). However, the 
findings in Japanese cohorts to date stem from a single cohort, and as such 
require independent replication. The COMT variant discussed above has not 
reached genome-wide significance in GWAS of panic disorder to date. 
Recently, GWAS of anxiety disorders as a heterogeneous group have 
emerged, including a large meta-analysis with a cohort size approaching 
those of the early PGC studies, which used both a case-control and a 
quantitative factor score approach to defining the phenotype (Otowa, Hek, 
Lee, et al, 2016; Otowa, Maher, Aggen, et al, 2014). These approaches yielded 
separate loci at genome-wide significance in multi-gene loci on 
chromosomes 3 and 2 respectively (case-control: rs1709393, p = 1.65x10-8; 
factor score: rs1067327, p = 2.86x10-8), with nominal significance for each 
locus in the alternative analysis (Otowa, Hek, Lee, et al, 2016).  
Moderate heritability implies that a considerable portion of the 
variance in anxiety results from influences beyond the additive effect of 
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genetic variants. One potential source of such variance is the combined effect 
of specific environments. Perhaps unsurprisingly, many of the risk factors 
for depression also appear to be associated with anxiety. For example, a 
higher rate of stressful life events has been reported in individuals with 
anxiety disorders. The cumulative impact of multiple life events, particularly 
those related to threat, loss and poor health, are enriched in individuals 
suffering from panic disorder (Klauke, Deckert, Reif, et al, 2010). Associations 
with other specific life events, particularly childhood sexual abuse and 
violence, have been reported in specific phobia and social anxiety (Magee, 
1999). Prospective studies have suggested that children with anxiety 
disorders experience a greater number of negative life events in the twelve 
months prior to the onset of their disorder than do unaffected children 
(Goodyer, Wright and Altham, 1988). In childhood, difficulties in social 
relationships, particularly between the child and their parents, have been 
associated with a broad anxiety phenotype (Goodyer, Wright & Altham, 
1990; Van Der Bruggen, Stams & Bögels, 2008), as has experiencing multiple 
stressful life events and having poorer general health (Ford, Goodman & 
Meltzer, 2004; Phillips, Hammen Brennan et al, 2005). As such, stressful life 
events and the early-life social environment appear to contribute to anxiety 
as well as to depression.  
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The effect of the early environment on the development of anxiety has 
been of considerable interest to investigators, partly because several anxiety 
disorders have their onset in childhood (Kessler, Angermeyer, Anthony, et al, 
2007; Kessler, Berglund, Demler, et al, 2005). Again, parenting represents a 
particular area of interest. The influences of warmth and control show 
similar effects to those observed in depression, although the evidence for a 
negative influence of lack of warmth is less consistent, and the role of over-
control is more prominent (McLeod, Weisz & Wood, 2007; Murray, Creswell 
& Cooper, 2009). In addition, parents provide a model for children. In this 
way, parental displays of anxious behaviour or of anxious interpretations of 
ambiguous stimuli can lead to increased anxiety in children (although a 
child-to-parent effect could also contribute; Eley, McAdams, Rijsdijk et 
al¸2015; Moore, Whaley & Sigman, 2014; Muris, Steernmen, Merckelbach et 
al, 1996; Suveg, Zeman, Flannery-Schroeder et al 2005).   
1.2.3. Behavioural genetics may be informative in understanding the 
aetiology of body mass index  
Genomic studies in depression and anxiety are beginning to yield 
interesting findings, but progress has been limited, not least due to the 
subjective nature of the phenotypes. Genomics has had more rapid success in 
other complex traits and has begun to provide slightly unexpected insights. 
For example, body mass index (BMI) is superficially an anthropomorphic 
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trait but may have a behavioural component to its aetiology. Evidence from 
neuroendocrinological approaches suggests that BMI is closely linked to 
energy homoeostasis, regarding both the storage and use of energy in the 
body and the behavioural control of satiety and appetite (Llewellyn & 
Wardle, 2015; Lustig, 2001). These components are not mutually exclusive, 
and the importance of both has been supported by secondary genomic 
analyses of BMI (Locke, Kahali, Berndt, et al, 2015; Speliotes, Willer, Berndt, 
et al, 2010).  
Gene-based analyses suggest a separable behavioural component to 
BMI when compared to other weight-related phenotypes. Body fat 
distribution (measured independently of BMI) was associated with genetic 
variants proximal to genes involved in adiposity (Shungin, Winkler, 
Croteau-Chonka, et al, 2015). In contrast, variants associated with BMI were 
enriched for genes highly expressed in the hypothalamus and pituitary 
gland, and the hippocampus and limbic system (Locke, Kahali, Berndt, et al, 
2015; Shungin, Winkler, Croteau-Chonka, et al, 2015). These systems were 
previously implicated in the control of BMI by animal studies and clinical 
observations. For example, individuals with damaged hypothalami show 
increased appetite, and the appetitive hormone leptin binds to hypothalamic 
neurones to regulate metabolism via the melanocortic system (Anand & 
Brobeck, 1951; Farooqi, 2014; Schwartz, Woods, Porte, et al, 2000; Zhang, 
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Proenca, Maffei, et al, 1994). Disruptions to this system (in the form of rare 
gene-altering mutations) cause severe obesity in humans, although they do 
not explain the heritable component of BMI alone (Locke, Kahali, Berndt, et 
al, 2015; Montague, Farooqi, Whitehead, et al, 1997). Evidence from studies of 
both common and rare genetic variation thus supports an appetitive 
influence on BMI. 
Additional support comes from examining the genome as a whole. 
The heritability detectable from GWAS analysis can be partitioned into 
functional components by annotating genetic variants to tissue-specific 
epigenetic marks. Performing this analysis in BMI identified a significant 
enrichment of central nervous system cell types, reinforcing the role of 
neural processes in BMI (Finucane, Bulik-Sullivan, Gusev, et al, 2015; 
Speliotes, Willer, Berndt, et al, 2010).  
Finally, genetic correlations have been examined between BMI and 
multiple traits (Bulik-Sullivan, Finucane, Anttila, et al, 2015). When 
compared to psychiatric traits, BMI has a significant positive correlation with 
anorexia and schizophrenia, and a significant negative correlation with 
ADHD (Anttila, Bulik-Sullivan, Finucane, et al, 2016; Bulik-Sullivan, 
Finucane, Anttila, et al, 2015). The original paper describing the method of 
assessing genetic correlation reported only the anorexia correlation, while all 
three were reported in a second paper, which used a larger BMI cohort 
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(Anttila, Bulik-Sullivan, Finucane, et al, 2016; Bulik-Sullivan, Finucane, 
Anttila, et al, 2015). This latter study also tentatively suggests that BMI is 
correlated more strongly with traditional psychiatric phenotypes than with 
neurological disorders. However, the relationship between BMI and 
psychiatric traits is still emerging.  
BMI has attractive properties as a phenotype for genetic study, 
compared to psychiatric disorders. It is a continuous phenotype and can be 
calculated objectively (via measurements of height and weight that have 
external validity) in large numbers of individuals. Evidence from twin 
studies suggests that BMI has a heritability around 60% (Polderman, 
Benyamin, de Leeuw, et al, 2015). However, designs, assessing correlations 
between distant relatives suggest estimates from twin and family studies 
may be inflated due to unmodelled effects such as assortative mating, and 
that the heritability of BMI could be closer to 30-40% (Hemani, Yang, 
Vinkhuyzen, et al, 2013; Visscher, McEvoy & Yang, 2010; Yang, Bakshi, Zhu, 
et al, 2015; Zaitlen, Kraft, Patterson, et al, 2013). These arguments concern the 
fundamental design of quantitative genetic studies, and as such extend to all 
traits.  
Genomics has been successful in studying BMI, with the most recent 
meta-analysis identifying 97 significant loci (Locke, Kahali, Berndt, et al, 
2015). These loci capture ≈ 2.7% of the variance in BMI (≈ 4-10% of the genetic 
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component, depending on the estimate of heritability), which compares 
favourably to schizophrenia (108 loci, ≈ 3.4% variance and ≈ 5% heritability, 
respectively; (Locke, Kahali, Berndt, et al, 2015; Schizophrenia Working 
Group of the Psychiatric Genomics, 2014). The genetic architecture of BMI 
also seems to mirror that of schizophrenia in part, with a common genetic 
component comprising many variants of small effect, and a single locus of 
larger effect. In the case of schizophrenia this lies in the major 
histocompatibility complex (MHC) gene cluster, while the strongest 
association in BMI GWAS is found in the FTO gene (Frayling, Timpson, 
Weedon, et al, 2007; Locke, Kahali, Berndt, et al, 2015; Schizophrenia Working 
Group of the Psychiatric Genomics, 2014). Curiously, there is now robust 
evidence that neither of these prominent associations acts via the genes in 
which they lie. The variant lying in the MHC appears to affect the C4A and 
C4B complement components rather than the more well-known HLA genes, 
while that near FTO alters the expression of the IRX3 transcription factor 
(Sekar, Bialas, de Rivera, et al, 2016; Smemo, Tena, Kim, et al, 2014). 
Unlike depression and anxiety, in which stressful life events are the 
most robustly-associated environmental influences, BMI is influenced by a 
broad range of environments (likely due to the metabolic aspects of the 
phenotype). Central among these is an energy-positive (as opposed to 
energy-balanced) environment, characterised by lower energy use from a 
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sedentary lifestyle with less physical activity and a diet rich in fat and sugar 
(Bray, 2004). Accurate measurement of the impact of these influences is 
confounded by the complexity of both concept and measurement in diet and 
activity, and reciprocal effects between the energy-positive environment and 
higher BMI (Rennie & Wareham, 1998; Ruel, 2003; Wareham, van Sluijs & 
Ekelund, 2005). A systematic review of the evidence for an effect of inactivity 
suggests overweight individuals typically engage in less physical activity, 
but that this pattern is limited by the confounding and reverse causality 
described above (Wareham, van Sluijs & Ekelund, 2005). Robust population-
level evidence exists to support higher BMI in individuals following a meat-
rich (Spencer, Appleby, Davey, et al, 2003) or sugar-rich diet (Te Morenga, 
Mallard & Mann, 2013), although this is similarly limited by uncontrollable 
confounding.  
Beyond the energy-positive environment, there is a growing body of 
research suggesting that poorer sleep quality is associated with greater BMI 
independent of diet, with a number of hypotheses proposed to explain this 
association, including increased energy demands, alterations to the 
appetitive system, desynchrony of circadian rhythms, and comorbidity with 
psychological distress (Cespedes, Hu, Redline, et al¸2016; Chan, 2017; 
Chaput, 2014). The association between poor sleep quality and increased 
BMI is further supported by evidence of a genetic correlation of 0.15 between 
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BMI and insomnia symptoms from a recent sleep quality GWAS (Lane, 
Liang, Vlasac et al, 2017). While not as predominant as in depression and 
anxiety, an increased incidence of stressful life events has also been reported 
with increased BMI, independent of sleep quality and activity levels 
(Sampasa-Kanyinga & Chaput, 2017).  
1.3 Gene-environment interplay  
1.3.1. Genetic and environmental influences are not independent 
The accumulated evidence argues that both genetic and 
environmental factors have important influences on human behavioural 
traits. The inherent assumption is that their actions are independent, which 
may not be the case; a proportion of variance in behavioural traits could be 
attributable to the combined effects of genetics and environment. This 
relationship has been discussed for over a century, with much of the debate 
concerning the relative importance of different types of interplay, the 
appropriate way to model interactions, and the relevance of statistical 
interactions to functional effects (Garrod, 1902, as described in Hunter, 2005; 
Kendler & Gardner, 2010; Rutter, 2010).  
The interdependent effects of genetic and environmental factors are 
usually framed as gene-environment interactions and gene-environment 
correlations. Gene-environment interactions describe a case where the effect 
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of one set of factors differs depending on the other. For example, exposure to 
sunlight has a greater effect on skin cancer risk in those with lighter skin 
(Adami, Hunter & Trichopoulos, 2008; Hunter, 2005). Gene-environment 
correlations describe instances when specific pairings of genetic and 
environmental influences co-occur at a rate greater than that expected by 
chance (Plomin, DeFries & Loehlin, 1977). One such correlation affects 
musical achievement; the frequency of practising an instrument is a heritable 
phenotype that in turn affects achievement (Hambrick & Tucker-Drob, 2015). 
Note that the examples given above refer to the influence of specific 
environments, rather than the broader meaning generally used in 
quantitative genetics. However, gene-environment interplay can also be 
studied using a quantitative genetic approach and modelling the 
environmental influence as all influences not attributable to the additive 
effects of genetics.  
Gene-environment interplay can bias the results of genetic association 
studies (including GWAS) when not modelled explicitly (Cooley, Clark & 
Folsom, 2014; Marigorta & Gibson, 2014). To give an extreme example, a 
genetic locus in the CHRNA5-A3-B4 gene cluster is robustly associated with 
an increased number of cigarettes per day in smokers (Ware, van den Bree & 
Munafo, 2011). The effect of this genetic variant is conditional entirely on 
whether the individual smokes (Hirschhorn, Lohmueller, Byrne, et al, 2002). 
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Such an association is impossible to discover in non-smokers and is a perfect 
gene-environment correlation (which is confounding). Non-independence 
between the effects of genetic variants and the environment can result in 
incorrect interpretations of evidence. For example, the CHRNA5-A3-B4 locus 
is associated with lung cancer. The locus might be pleiotropic, having effects 
on both phenotypes. If this were true, there could also be a gene-
environment interaction, with smokers having an increased risk of lung 
cancer if they carry this variant (Dudbridge & Fletcher, 2014). However, the 
weight of evidence favours confounding as the explanation, suggesting that 
the association results from the inclusion (intentional or otherwise) of 
smokers in lung cancer GWAS (Dudbridge & Fletcher, 2014; Gage, Davey 
Smith, Ware, et al, 2016; Hallden, Sjogren, Hedblad, et al, 2016; VanderWeele, 
Asomaning, Tchetgen Tchetgen, et al, 2012).  
Classically, the effects of gene-environment interactions have been 
modelled in a diathesis-stress framework, in which bearing certain genetic 
variants (the diathesis) places an individual at risk of negative outcomes 
when exposed to negative environments or stress (Bleuler, 1963; Meehl, 1962; 
Rosenthal, 1963). This idea has been criticised as only accounting for the 
negative role of genes (Belsky & Pluess, 2009). Instead, a differential 
susceptibility hypothesis is posited, extending the diathesis-stress model to 
acknowledge the potential for a genetic predisposition to positive responses 
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in positive environments, a concept termed vantage sensitivity (Pluess & 
Belsky, 2013). Rather than vulnerability genes, leading to negative outcomes 
in negative environments, the differential susceptibility hypothesis suggests 
the existence of sensitivity genes, which increase responsivity to the 
environment in general (Figure 2; Bakermans-Kranenburg & van IJzendoorn, 
2015). As such, individuals with a high load of sensitivity genes would be 
vulnerable to negative outcomes in negative environments, but would also 
benefit in positive environments. This hypothesis has found some support in 
human and animal studies (Bakermans-Kranenburg & van IJzendoorn, 2015; 
Kastner, Richter, Lesch, et al, 2015).  
 
Figure 2: Alternative theories of gene effect in gene-environment 
interactions.  




Gene-environment interactions have been a topic of interest within 
human behavioural genetics for decades, and a moderately-sized literature 
on the effects of individual variants in a variety of environments has been 
produced (Dick, Agrawal, Keller, et al, 2015; Duncan & Keller, 2011). 
However, the majority of these have made use of the candidate gene 
approach and show the same lack of power and inflated effect size estimates 
that limits genetic associations studies using this method (Munafo, 2015). 
The limitations on power are even greater in gene-environment studies, as 
the incorporation of an environmental exposure (with an inherent 
assumption of relevance) increases the level of multiple testing (Dick, 
Agrawal, Keller, et al, 2015; Duncan & Keller, 2011; Munafo, 2015).   
Arguably the most robust candidate gene-environment interaction in 
psychiatric genetics is also the most controversial. The serotonin transporter 
promoter polymorphism (5HTTLPR) was initially implicated in the 
differential effect of life stress on depression in a longitudinal population 
cohort. Carriers of one or two copies of the short allele (which is associated 
with reduced transporter activity) were more likely to exhibit a variety of 
depression-related phenotypes following stressful life events than were 
carriers of two long alleles (Caspi, Sugden, Moffitt, et al, 2003; Heils, Teufel, 
Petri, et al, 1996). Since this first study, over 81 studies have attempted to 
replicate the finding, with mixed success (Sharpley, Palanisamy, Glyde, et al, 
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2014). The robustness of this interaction has become controversial, with some 
meta-analyses suggesting no effect and others confirming the original 
finding, with disagreement over the correct criteria for including studies in 
each meta-analysis (Duncan & Keller, 2011; Karg, Burmeister, Shedden, et al, 
2011; Munafo, Durrant, Lewis, et al, 2009; Risch, Herrell, Lehner, et al, 2009; 
Sharpley, Palanisamy, Glyde, et al, 2014; Uher & McGuffin, 2010). The most 
recent meta-analysis reported a significant increase in depressive outcomes 
in S allele carriers exposed to stress (p=9x10-7), robust to the nature and 
measurement of the stressor and the design of the study (Sharpley, 
Palanisamy, Glyde, et al, 2014). A number of criticisms of this evidence have 
previously been advanced. These include the potential risk of publication 
bias and undisclosed multiple testing, the observation that larger studies 
were more likely to be negative, and heterogeneity of study design and 
analysis (Munafo, Durrant, Lewis, et al, 2009; Munafò, Zammit & Flint, 2014; 
Risch, Herrell, Lehner, et al, 2009). The most recent meta-analysis addresses 
these concerns in part (Sharpley, Palanisamy, Glyde, et al, 2014). It seems 
unlikely that the observed result could be explained by publication bias: the 
data showed a fail-safe ratio of 45 non-published negative studies for every 
study included (Sharpley, Palanisamy, Glyde, et al, 2014). Negative studies in 
the meta-analysis had a significantly larger sample size than positive studies, 
and studies using self-report data to assess depression and stress (rather than 
an interview or objective measures) were more likely to be negative; these 
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factors are inter-related, as has been previously noted (Sharpley, Palanisamy, 
Glyde, et al, 2014; Uher & McGuffin, 2010). Nonetheless, there are several 
potential confounders (such as inter-study heterogeneity) that remain 
difficult to control (Sharpley, Palanisamy, Glyde, et al, 2014). Furthermore, 
reliance on a single meta-analysis is inadvisable, because differences in 
approach can translate to differences in outcome, as is apparent from the 
example of the 5HTTLPR (Taylor & Munafo, 2016). The validity of 5HTTLPR 
meta-analyses was recently tested using p-curve analysis (which investigates 
the distribution of p-values in studies reporting positive findings; Karg, 
Burmeister, Shedden, et al, 2011; Simonsohn, Nelson & Simmons, 2014; 
Taylor & Munafo, 2016). This alternative method provided weak evidence 
for an effect of the 5HTTLPR, which was very dependent on the lowest 
reported p-values. Given these results, the remaining doubt, and current 
understanding of the nature of genetic influences in psychiatry, the effect of 
the 5HTTLPR is still not fully resolved. The conclusion made by one 
commentary on the subject is probably the most reasonable: after addressing 
the confounding from various methodological artefacts, there appears to be a 
real, but probably small, effect of the 5HTTLPR (McGuffin, Alsabban & 




1.3.2. Limitations on genome-wide analysis of gene-environment interplay 
Using a genomic approach could allow gene-environment interactions 
to be studied with the hypothesis-neutral philosophy that has yielded 
success in exploring main effects on behaviour. However, this presents some 
problems in practice. Unlike the case for genetic traits, it is difficult to see 
how an agnostic approach could be taken in selecting environmental 
exposures, as there is no obvious finite amount of possible factors. Including 
multiple environmental influences in genome-wide interaction analyses 
increases the number of tests considerably. Assuming that a million 
independent signals result from genetic variation, every environmental 
factor tested adds a million new tests (Dudbridge & Gusnanto, 2008; The 
International HapMap, 2005). A two-step approach, whereby variants with 
main effects are identified and then tested for gene-environment interactions 
could reduce this burden (Ege & Strachan, 2013). However, the relative 
paucity of robustly identified main effects in behavioural phenotypes has 
limited the application of this process to date, and applying this method 
makes an inherent assumption that variants that interact with environmental 
influences will also show a main effect, which is contentious (Domingue & 
Boardman, 2016). 
A genome-wide study of gene-environment interaction would not 
necessarily require all possible environments to be examined. It might be of 
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interest to assess the effects of genome-wide genetic variation on a specific 
environmental exposure. The choice of exposure would be hypothesis-
driven, violating the agnostic approach of genome-wide studies in general. 
Therefore, proposing candidate environments requires an empirically robust 
association between the environmental and the trait under study (whether 
directly or via a gene-environment interaction; Dick, Agrawal, Keller, et al, 
2015). In general, candidate environments fulfil this requirement better than 
candidate genetic variants. For example, there is robust evidence that 
childhood maltreatment is associated with later life depression (Nanni, Uher 
& Danese, 2012).  
1.4 Alternative methods for leveraging genomic data to study gene-
environment interplay 
While genome-wide interaction studies (GWIS or GEWIS) are possible 
to perform (and have the potential to yield valuable results), they 
demonstrate some limitations. As such, it might be more informative to 
study these effects using alternative study designs, and leveraging the data-
rich output from GWAS (Boardman, Domingue, Blalock, et al, 2014; Thomas, 
2010). Although some of the caveats will remain, others can be reduced or 
removed with the analytical design. Within this thesis, two approaches are 
explored, making use of genomic and phenotypic data at varying depths. 
Specifically, a GWAS is conducted within a controllable environment 
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(cognitive behavioural therapy for anxiety disorders), to attempt to identify 
genetic variants predisposing to sensitivity to the environment (Chapter 3; 
Coleman, Lester, Keers, et al, 2016). This paradigm is then extended to using 
gene expression data, which represents a natural integration of genetic and 
environmental influences (Chapter 4; Coleman, Lester, Roberts, et al, 2016). 
Secondly, polygenic risk scores are used as proxies for the genetic 
component of variance in depression and BMI to dissect the correlation 
between these traits into genetic and environmental components (Chapter 5). 
Finally, more detailed measures of the social environment are used to 
explore genome-environment interactions predicting BMI in adolescence 
directly, using polygenic risk scores to reduce the multiple testing burden 
(and so increase power; Chapter 6). 
1.4.1. GWAS in a controllable environment: the genetics of response to 
cognitive behavioural therapy 
One of the major issues concerning gene-environment interactions is 
the difficulty in controlling the environment. It is not uncommon for critics 
of gene-environment studies (and of behavioural genetics in general) to 
compare investigations in humans to the more interpretable "common-
garden" methods of studying animal behaviour (Gottlieb, 2003; Turkheimer, 
2000). However, controllable environments exist (Eley, 2014). Studying the 
effects of genetics within a cohort who have all received a given exposure 
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can be informative about the genetic basis of differential response. This 
approach has been used with success in GWAS of trauma-exposed 
individuals to identify variants associated with the development of post-
traumatic stress disorder (Ashley-Koch, Garrett, Gibson, et al, 2015; Guffanti, 
Galea, Yan, et al, 2013; Logue, Baldwin, Guffanti, et al, 2013; Nievergelt, 
Maihofer, Mustapic, et al, 2015; Solovieff, Roberts, Ratanatharathorn, et al, 
2014; Stein, Chen, Ursano, et al, 2016; Sumner, Pietrzak, Aiello, et al, 2014; 
Wolf, Rasmusson, Mitchell, et al, 2014; Xie, Kranzler, Yang, et al, 2013). 
However, trauma is not a controllable exposure, which introduces 
heterogeneity into the approach. 
Cognitive behavioural therapy (CBT) represents a positive 
environmental exposure that is more predictable and controllable than the 
majority of non-experimental environmental exposures studied. CBT is a 
psychological treatment in which the recipient (in a controlled, supportive 
atmosphere) identifies negative cognitive processes and behaviours 
underlying distressing outcomes and learns techniques to mitigate against 
these negative schema and relieve distress (Beck, 2005; Hofmann, 
Asmundson & Beck, 2013). Furthermore, it is possible to design prospective 
studies of response because CBT is provided in predictable sessions. The last 
decade has seen an increase in the use of cognitive behavioural therapy as a 
treatment for internalising disorders. For example, the UK's Improving 
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Access to Psychological Treatment program aims to offer CBT to at least 15% 
of those suffering from anxiety or depression in the community (Baldwin, 
Anderson, Nutt, et al, 2014; Bandelow, Lichte, Rudolf, et al, 2014; Bandelow, 
Lichte, Rudolf, et al, 2015; Clark, 2011; NCCMH, 2011). The increasing use of 
CBT has resulted in part from evidence that the technique is effective and 
demonstrates cost-efficacy. Meta-analyses of randomised control trials of 
CBT for anxiety in children have shown a significantly greater response 
immediately post-treatment compared to untreated waitlist controls 
(remission of disorder: odds ratio (OR) = 7.85, reduction in anxiety 
symptoms: standardised mean difference (SMD) = -0.98; James, James, 
Cowdrey, et al, 2013). Analyses of the adult literature show similar results 
comparing CBT to placebo (remission of disorder: OR = 4.06, reduction in 
anxiety symptoms: SMD = -0.73; sign of SMD reversed for comparison with 
child data; Hofmann & Smits, 2008). Estimates of efficacy are usually greater 
when considering completing participants only versus including all 
participants in intention-to-treat analyses. For example, the intention-to-treat 
results from the adult literature for disorder remission (OR = 1.84) and 
reduction in anxiety symptoms (SMD = -0.33) are smaller, although still 
significant (Hofmann & Smits, 2008).  
Treating individuals with anxiety using CBT is effective compared to 
no treatment at all. Nevertheless, remission rates are rarely if ever 100%. CBT 
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treatment for childhood anxiety shows an average remission rate of 56% 
post-treatment, with very weak evidence suggesting a small increase with 
time after treatment (James, James, Cowdrey, et al, 2013). Similar remission 
rates have been reported in a meta-analysis of CBT for adults, 49.5% post-
treatment rising to 53.6% at follow-up (Loerinc, Meuret, Twohig, et al, 2015). 
Remission rates are greater than those reported for placebo, waitlist or 
treatment as usual conditions, which range from 14-28% (Hofmann, Asnaani, 
Vonk, et al, 2012).  
Analysable variance in response and remission following CBT exists 
between individuals, and a number of predictors of response have been 
posited (Haby, Donnelly, Corry, et al, 2006; Hudson, Keers, Roberts, et al, 
2015; Mausbach, Moore, Roesch, et al, 2010; Olatunji, Cisler & Tolin, 2010). 
Meta-regression across 33 studies of CBT for depression, generalised anxiety 
disorder, and panic disorder assessed the effect of disorder, disorder 
severity, treatment type, treatment intensity, and therapist characteristics, as 
well as factors related to the conduct of the trial (Haby, Donnelly, Corry, et 
al, 2006). Of these potential covariates, only higher disorder severity was a 
significant predictor of (poorer) response. However, this study did not 
investigate some potential predictors suggested elsewhere. Engagement with 
therapy, in the form of homework compliance, was a significant predictor of 
outcome across disorders and within the anxiety disorders in a separate 
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meta-analysis (Mausbach, Moore, Roesch, et al, 2010). In another study, 
psychiatric comorbidity did not show an effect on treatment outcome at 
post-treatment or follow-up for anxiety disorders in general, but a negative 
correlation between comorbidity and treatment outcome was reported in 
mixed anxiety disorder specifically (Olatunji, Cisler & Tolin, 2010). These 
findings contrast with results from the cohort studied in Chapter 3, in which 
comorbid mood and externalising disorders predicted poorer outcome at 
post-treatment and at follow-up (Hudson, Keers, Roberts, et al, 2015). In 
addition, individuals with social anxiety disorder had a significantly poorer 
response than those with generalised anxiety disorder, as did participants 
whose illness was more initially more severe (Hudson, Keers, Roberts, et al, 
2015). However, these latter results came from a mega-analysis of children 
receiving cognitive behavioural therapy for a range of anxiety disorders, 
incorporating studies from eleven sites across the globe. The strength of 
evidence for different predictors of CBT response differs between adults and 
children, and so differences between this study and others are unsurprising 
(Rapee, Schniering & Hudson, 2009). The potential for confounding by 
uncontrolled factors (such as the effect of the therapist) also cannot be 
excluded (Hudson, Keers, Roberts, et al, 2015). This last point extends to the 
literature in general – the many influencing factors and inherent 
heterogeneity in studying CBT limits the ability of meta-analysis and mega-
analysis to detect predictors (Taylor, Abramowitz & McKay, 2012). 
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Nevertheless, the evidence suggests that a number of factors, particularly 
initial disorder severity and engagement with treatment, may predict 
differential response to CBT in anxiety disorders.  
Given the uncertainty of phenotype-level predictors of treatment 
response, and the frequent time-specificity of such influences, examining 
genetic variation has value in understanding CBT response, as well as in 
broader behavioural genetic theory. Unlike environmental factors, the DNA 
code is fixed from birth, and as such does not alter with experience or time, 
suggesting genetic variants might predict response more generally and with 
greater stability than environmental alternatives.  
The genetic study of response to CBT for internalising disorders has 
focussed on individual variants (the candidate gene approach), a field 
termed "therapygenetics" in one of the first such papers (Eley, Hudson, 
Creswell, et al, 2012). To date, variation near 19 genes has been investigated 
in studies of CBT or related psychotherapies for internalising disorders 
(Lester & Eley, 2013; Lueken, Zierhut, Hahn, et al, 2016). The most promising 
association, and the one most publications have explored, is the 5HTTLPR. 
Even for this variant, findings have been equivocal, with studies identifying 
improved response, poorer response, or no effect of the S allele or SS 
genotype (Andersson, Ruck, Lavebratt, et al, 2013; Bockting, Mocking, Lok, et 
al, 2013; Bryant, Felmingham, Falconer, et al, 2010; Cicchetti, Toth & Handley, 
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2015; Eley, Hudson, Creswell, et al, 2012; Felmingham, Dobson-Stone, 
Schofield, et al, 2013; Furmark, Carlbring, Hammer, et al, 2010; Hedman, 
Andersson, Ljotsson, et al, 2012; Kohen, Cain, Buzaitis, et al, 2011; Lester, 
Roberts, Keers, et al, 2016; Lonsdorf, Ruck, Bergstrom, et al, 2010; Sakolsky, 
2011; Wang, Harrer, Tuerk, et al, 2009). In part, this may be attributable to a 
failure to control for the nearby rs25531 variant (which also reduces the effect 
of the long allele, making it functionally similar to the short allele; 
Nakamura, Ueno, Sano, et al, 2000). This is compounded by inconsistent use 
of a genotypic model (SS vs LS vs LL), a recessive model (SS vs others) or an 
allelic model (S vs L). The study of the 5HTTLPR, and the therapygenetics 
literature in general, is limited by its reliance on the candidate gene method 
and the associated tendency to explore a few variants in a limited set of 
genes, using a small cohort (Chabris, Hebert, Benjamin, et al, 2012; Ioannidis, 
2005; Munafo, 2006). As such, the veracity of reported associations is unclear. 
The relative paucity of studies and the high heterogeneity in the design and 
nature thereof makes meta-analysis of findings difficult (which would, in 
turn, allow assessment of potential publication bias; Munafo, Clark & Flint, 
2004).  
The therapygenetics literature reflects the limitations of the candidate 
gene method. Given the robust associations identified by GWAS in the 
aetiology of behavioural traits, moving the therapygenetics field into 
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genomics has two objectives. Firstly, it provides a test of the exposure-only 
GWAS paradigm, which is valuable for assessing the effects of genetic 
variants on differential response to the environment. It should also have the 
practical benefit of improving the reliability of therapygenetic discoveries. 
Accordingly, Chapter 3 presents the first GWAS of CBT response study, 
using a cohort of 980 children recruited from sites across the world 
(Coleman, Lester, Keers, et al, 2016; Hudson, Keers, Roberts, et al, 2015). 
1.4.2. Gene expression could be informative in exposed-only genome-wide 
studies 
Genetic variants are attractive as possible predictors of CBT response, 
and genome-wide genotype data have applications beyond individual-
variant association studies, such as polygenic risk scoring and the calculation 
of genetic correlations with other traits. Nonetheless, genetic effects are often 
difficult to interpret (Ward & Kellis, 2012). One of the most interesting 
findings from genomic studies is that the majority of significant variants lie 
in non-coding areas of the genome, suggesting some causal variants may 
exert their effects through altering the regulation of transcription or 
translation, the processes by which the DNA code determines the production 
of RNA and proteins (Hindorff, Sethupathy, Junkins, et al, 2009; Maurano, 
Humbert, Rynes, et al, 2012). However, it is not straightforward to identify 
the causal variant tagged by an association, nor to infer its functional effect. 
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As such, discovering a significant variant does not necessarily mean 
understanding why it is significant (Westra, Peters, Esko, et al, 2013). 
 Given the apparently regulatory role of many implicated genetic 
variants, it could be valuable to investigate differential RNA levels resulting 
from alterations in DNA transcription. Analysing the expression of genes 
shifts focus from the effects of a single variant (usually with only a minor 
influence on a highly polygenic trait) to those of many variants. Transcripts 
with significant differences in expression should be expected to explain more 
phenotypic variance than individual variants, and represent a potential 
biological marker of the combined effect of genetic and environmental 
influences (Emilsson, Thorleifsson, Zhang, et al, 2008; Rockman & Kruglyak, 
2006). Reported raw correlations between RNA expression levels and protein 
abundance are modest (ranging between 0.3-0.6 in a study of more than 6000 
proteins across 12 tissues; Wilhelm, Schlegl, Hahne et al, 2014). This may 
represent an effect of the rate of action of the translational machinery, 
differing between tissues and between specific gene products (Wilhelm, 
Schlegl, Hahne et al, 2014).  Although the abundance of RNA transcripts and 
proteins differs between tissues, the gene-specific ratio of RNA to protein is 
consistent (Wilhelm, Schlegl, Hahne et al, 2014). Protein abundances 
predicted from RNA expression weighted by this ratio correlate strongly 
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with observed protein levels (r > 0.8; Edfors, Danielsson, Hallström, et al, 
2016; Wilhelm, Schlegl, Hahne et al, 2014). 
However, the analysis of RNA transcripts is limited by spatial and 
temporal restrictions to their effects. Changes in transcription are subject to a 
"hit-and-run" effect, whereby relevant changes are only detectable at the time 
they are occurring and in specific tissues (Stanworth, Roberts, Sharpe, et al, 
1995). This latter issue (termed the tissue of interest problem) is a major 
limitation in investigating transcriptional and epigenetic biomarkers for 
behavioural traits (Davies, Volta, Pidsley, et al, 2012; Heijmans & Mill, 2012; 
Roth, Hevezi, Lee, et al, 2006; Sullivan, Fan & Perou, 2006). Brain tissue 
would be the ideal substrate in investigations of behaviour, as it is the most 
likely site for relevant biological variation. As extracting brain tissue from 
living subjects has obvious technical and ethical impediments, proxy tissues 
must be used. On the other hand, while tissue specificity may limit the 
insight that behavioural studies of gene expression can have into brain 
biology, this may not affect the study of response to cognitive behavioural 
therapy to a great degree. Robust associations between peripheral gene 
expression and response to therapy would have predictive value, even if 
they offered limited biological insight. 
Variation in gene expression can be studied within the context of CBT 
response to provide a stronger indicator of the combined effects of genetic 
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and environmental variation. Only one study (from the cohort studied in 
Chapter 4) has examined gene expression in the context of CBT response for 
anxiety disorders. A genome-wide examination of change in expression 
across exposure treatment for panic disorder and specific phobia showed no 
association of treatment response with individual gene expression nor with 
co-expressed clusters (Roberts, Wong, Keers, et al, Under Review). Other 
studies have focussed on treatment response in PTSD and depression. An 
association between increased expression of FKBP5 and response to CBT in 
PTSD has been reported in two independent candidate studies, albeit in 
small samples (Levy-Gigi, Szabo, Kelemen, et al, 2013; Yehuda, Daskalakis, 
Desarnaud, et al, 2013). Combined scores from a biomarker panel (previously 
associated with depression) were assessed in individuals with depression 
before and after CBT (Keri, Szabo & Kelemen, 2014a; Le-Niculescu, Kurian, 
Yehyawi, et al, 2009). After CBT, scores in cases were significantly greater, 
although still significantly lower than those in controls. Change in score was 
associated with a change in depressive severity on the Hamilton Depression 
questionnaire (Keri, Szabo & Kelemen, 2014a). The same group also assessed 
the effects of pro-inflammatory markers (Tol-like receptor genes and NF-κβ) 
on CBT for depression (Keri, Szabo & Kelemen, 2014b). A decrease in TLR4 
and NF-κβ expression (but not TLR2 expression) was observed in treated 
individuals compared to controls, along with a dose-response effect, with 
greater reduction in pro-inflammatory markers associated with better 
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response to CBT. Gene expression analyses in CBT response are in their 
infancy and show early promise, but initial findings have come from 
candidate studies, and replication in larger, hypothesis-neutral studies is 
required. 
Studying RNA transcripts and DNA variation individually has 
benefits and limitations for predicting differential response to CBT. Variation 
in DNA is effectively unchanging between tissues and does not alter with 
time, providing a source of predictors that can be validly assessed at any 
point before or after treatment. In comparison, the expression of RNA 
transcripts is spatially and temporally restricted and as such must be 
assessed prior to treatment, with careful consideration of which tissue to 
assess. However, statistical associations between a phenotypic outcome and 
DNA variation are often difficult to translate into specific causal variants and 
functional effects. In comparison, RNA transcript levels can be used to 
predict protein levels, which has clearer biological relevance for 
understanding the aetiology, and potentially modulation, of treatment 
response.   
Combining these analyses can increase power and yield a greater 
understanding of the role of both sources of variation (Ritchie, Holzinger, Li, 
et al, 2015). If significant variants from a GWAS are also associated with gene 
expression, this suggests a potential function (and a route for further 
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investigation). Conversely, understanding which genetic variants alter the 
expression of a significant transcript may offer insights into the differential 
control of transcription.  
RNA transcripts provide an indicator of the integration of genetic and 
environmental influences. As such, gene expression analyses within the 
context of CBT response could provide insight into the combined effects of 
genes and a controllable positive environment. Integrating genetic variation 
into this model in the context of expression quantitative trait locus analyses 
could provide further genomic context. In Chapter 4, a cohort of adults 
undergoing CBT for anxiety disorders, who provided DNA and RNA 
samples from whole blood, were investigated to assess the combined role of 
genetic variants and RNA transcripts (Chapter 4; Coleman, Lester, Roberts, 
et al, 2016).  
1.4.3. Polygenic risk scores as a proxy for the genetic contribution to variance 
 Genomic studies provide a data-rich output, which can be used to 
perform additional analyses beyond the initial association study. A popular 
example of this higher-order approach is polygenic risk scoring (PRS), in 
which genetic variants within the study of interest (the target) are weighted 
by their association with a second phenotype, usually obtained from a 
separate association study (the base; Dudbridge, 2013; Euesden, Lewis & 
O'Reilly, 2015; International Schizophrenia, Purcell, Wray, et al, 2009; Wray, 
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Lee, Mehta, et al, 2014). The PRS strategy has two primary applications: it can 
be used within-trait to validate a phenotype, or across traits to compare the 
relationship between two phenotypes. It is this second use exemplified 
within this thesis. 
1.4.4. Dissecting the genetic component of phenotypic correlation using 
polygenic risk scores 
As discussed above, a major limiting factor in depression genomics to 
date has been the phenotypic heterogeneity of the disorder. Appetite 
dysregulation and altered weight are features of major depressive disorder, 
and the direction of this dysregulation has been proposed to generate a 
typical-atypical spectrum (Davidson, Miller, Turnbull, et al, 1982; Sullivan, 
Kessler & Kendler, 2014). The precise relationship between depression and 
BMI is unclear. Studies suggest a bidirectional, longitudinal pattern whereby 
high BMI predicts later, persistent depression and depression predicts later 
obesity, although the strength of the relationship depends on the precise 
measurement of depression and obesity (Gibson-Smith, Bot, Paans, et al, 
2016; Luppino, de Wit, Bouvy, et al, 2010). Reported effect sizes are relatively 
small (largest OR = 1.58 for depression predicting obesity), which is 
concordant with inconsistencies seen between individual studies (Faith, 
Matz & Jorge, 2002; Luppino, de Wit, Bouvy, et al, 2010). Meta-analysis of 
these individual studies suggests there is a significant interaction, such that 
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individuals with depression typically have higher BMI, although there is 
also evidence for a U-shaped relationship (de Wit, Luppino, van Straten, et 
al, 2010; de Wit, van Straten, van Herten, et al, 2009; Luppino, de Wit, Bouvy, 
et al, 2010). 
The phenotypic relationship between BMI and depression is complex, 
and the causal direction is unclear. Genetic variation is a potential source of 
shared aetiology. Twins studies of the relationship have suggested a small 
genetic correlation exists, estimated around 12% (Afari, Noonan, Goldberg, 
et al, 2010; Jokela, Berg, Silventoinen, et al, 2016; Schur, Godfrey, Dansie, et al, 
2013). A series of studies have examined the potential genetic correlation 
between BMI and depression, largely focussing on genetic variants 
associated with BMI (Hung, Breen, Czamara, et al, 2015; Hung, Rivera, 
Craddock, et al, 2014; Jokela, Elovainio, Keltikangas-Jarvinen, et al, 2012; 
Rivera, Cohen-Woods, Kapur, et al, 2012; Samaan, Anand, Zhang, et al, 2013; 
Samaan, Lee, Gerstein, et al, 2015). Although approaches have explored a 
variety of variants both individually and in concert, they have provided only 
tentative evidence that genetic variants associated with BMI are associated 
with depression, primarily focussing on variants around the FTO and TAL1 
genes (Samaan, Anand, Zhang, et al, 2013; Samaan, Lee, Gerstein, et al, 2015). 
Variants in the FTO gene and a polygenic risk score of 32 BMI-associated 
variants have both shown increased association with BMI in depression 
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cases over controls, suggesting the depression status may interact with 
genetic risk to increase BMI (Hung, Breen, Czamara, et al, 2015; Rivera, 
Cohen-Woods, Kapur, et al, 2012).   
Using polygenic risk scores as a proxy for the genetic component of 
each trait allows the assessment of the role of genetics and of environment 
(that is, influences beyond the additive effect of genetics) independently and 
together. If there were a shared aetiology between the two disorders, one 
would expect significant cross-disorder prediction using polygenic risk 
analyses, as well as within-trait genetic correlations. The absence of such a 
genetic relationship would argue instead for a more prominent role of other 
factors. These could be shared environmental effects, for instance an 
environmental insult that increased BMI as well as causing depression, or 
this could reflect the causal effect of one disorder on the other (such as 
higher BMI causing depression). Alternatively, there could still be a genetic 
relationship, but one that involved unmodelled factors like rare variants not 
captured by the common variants comprising the risk score. Identifying an 
interaction (for example between the polygenic risk for BMI and depression 
status, affecting BMI) might suggest a shared genetic sensitivity to the 
environment underlying the phenotypic correlation. 
The role of genetics in this context was recently assessed in two 
independent studies. In the first, the association between polygenic risk 
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scores and depression was assessed in a cohort of depressed individuals 
stratified into typical and atypical conditions (Milaneschi, Lamers, Peyrot, et 
al, 2016). While case status in individuals with typical depression was only 
associated with polygenic risk scores from psychiatric disorders, polygenic 
risk scores from metabolic traits (including BMI) were associated with 
atypical depression (Milaneschi, Lamers, Peyrot, et al, 2016). The second 
publication, from the Generation Scotland study, explored the relationship 
between depression and BMI (in the context of neuroticism and general 
health) using polygenic risk scores from the 2010 GIANT BMI and the PGC 
major depressive disorder analyses (Clarke, Hall, Fernandez-Pujals, et al, 
2015). Polygenic risk scores predicted within trait but did not predict across 
trait. A significant interaction was identified between BMI polygenic risk and 
depression status predicting BMI, and stratified analyses demonstrated an 
increased effect of polygenic risk for BMI predicting BMI within depression 
cases.  
To add to this growing literature, I sought to perform similar analyses 
in the UK Biobank cohort, which provides a large sample independent of the 
previously studied cohorts. More powerful polygenic risk scores have also 
become available following the publication of these previous studies (Locke, 
Kahali, Berndt, et al, 2015). Accordingly, Chapter 6 presents an analysis of the 
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association between BMI and depression, including their respective 
polygenic risk scores in the model as well as their interaction terms. 
1.4.5. Polygenic risk-environment interactions 
Using polygenic risk scores as proxies for the genetic contribution to 
variance in a trait provides insight into the environmental contributions, but 
only inasmuch as the variance not accounted for by the genetic component is 
assumed to be environmental. If a well-defined environmental influence is 
available in a genomic dataset, however, it is possible to explore direct 
polygenic risk-by-environment interactions. Polygenic interaction studies are 
becoming increasing popular, and have been applied to test the interaction of 
genetic risk and stressful life events on the development of depression 
(Mullins, Power, Fisher, et al, 2016; Musliner, Seifuddin, Judy, et al, 2015; 
Peyrot, Milaneschi, Abdellaoui, et al, 2014; Vrshek-Schallhorn, Stroud, 
Mineka, et al, 2015). An interaction between PRS and childhood trauma has 
been reported, but failed to replicate in an independent cohort, potentially 
reflecting differences in study design (Mullins, Power, Fisher, et al, 2016; 
Peyrot, Milaneschi, Abdellaoui, et al, 2014). In behavioural genetics more 
generally, this approach has provided evidence that lifetime trauma 
exposure interacts with genetic risk for externalising behaviours such that 
highly traumatised individuals at high genetic risk show poorer working 
memory than others with low genetic risk (Sadeh, Wolf, Logue, et al, 2015). A 
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pair of studies on externalising behaviour and problematic alcohol use in 
adolescents suggests that peer deviance and low parental monitoring 
exacerbate genetic risk for both phenotypes (Salvatore, Aliev, Bucholz, et al, 
2015; Salvatore, Aliev, Edwards, et al, 2014). Further investigations report 
that polygenic risk for alcohol dependence is associated with reduced verbal 
ability in individuals from socially deprived areas; that early adoption of 
heavy smoking in adolescence mediates the effect of genetic risk on smoking 
problems in adulthood; and that traumatic events and low neighbourhood 
social cohesion are associated with more cigarette smoking in individuals 
with high genetic risk (Belsky, Moffitt, Baker, et al, 2013; Clarke, Smith, 
Gelernter, et al, 2016; Meyers, Cerda, Galea, et al, 2013).  
Although the use of this approach is growing and providing 
interesting insights, the limitations and assumptions of measuring and 
analysing a candidate environment in gene-environment interaction 
previously referenced still apply (Dick, Agrawal, Keller, et al, 2015). 
Obtaining a high-quality environmental measure in a cohort of sufficient size 
to perform genome-wide analysis requires a considerable investment. BMI is 
a useful phenotype in which to explore polygenic risk-environment 
interactions, as the relative ease of defining the phenotype allows greater 
investment in defining environmental measures. This ease of definition has 
also contributed to large GWAS analyses, enabling the generation of 
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powerful polygenic risk scores (Felix, Bradfield, Monnereau, et al, 2016; 
Locke, Kahali, Berndt, et al, 2015). Furthermore, many potential candidate 
environments might influence BMI. Previous studies have examined the 
effect on BMI of genetic risk interacting with education (no interaction); 
intake of sugary drinks (greater effect of genetic risk with more frequent 
intake); diet (greater effect of genetic risk in diets higher in saturated fat and 
fried food); and physical activity (smaller effect of genetic risk in more active, 
and less sedentary, individuals, although negative findings have also been 
reported; Ahmad, Rukh, Varga, et al, 2013; Casas-Agustench, Arnett, Smith, 
et al, 2014; Johnson, Ong, Elks, et al, 2014; Li, Zhao, Luan, et al, 2010; Liu, 
Walter, Marden, et al, 2015; Qi, Chu, Kang, et al, 2014; Qi, Chu, Kang, et al, 
2012; Qi, Li, Chomistek, et al, 2012; Reddon, Gerstein, Engert, et al, 2016). 
Exploring such interactions may be easier in children and adolescents, 
where environmental influences tend to be more restricted and controlled 
(due to the reduced autonomy of childhood). One example of such an 
environment is parenting style, which can influence child BMI via multiple 
pathways. Direct influences include parental control of child energy intake 
(through the regulation of eating behaviours) and energy use (such as by 
providing opportunities for exercise; Davison & Birch, 2001; Rhee, 2008). 
Parental style can also affect child BMI through more indirect means, 
including influencing child energy-related and self-regulatory behaviours 
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(Rhee, 2008; Rhee, Lumeng, Appugliese, et al, 2006). There is evidence that 
authoritative parenting (characterised by warmth and clear discipline) is 
associated with positive child energy behaviours (increased physical activity, 
healthier diet and lower BMI; Shloim, Edelson, Martin, et al, 2015). A recent 
study in the Twins Early Development Study (TEDS) cohort demonstrated 
an association between juvenile emotional difficulties and the interaction 
between colder, more punitive parenting style and a genetic risk score 
proposed to capture sensitivity to the environment (Keers, Coleman, Lester 
et al, 2016). As such, parental style can be considered an environment that 
has genetically-sensitive effects on behavioural phenotypes. The cohort and 
measure used in this study are also used in Chapter 6. Building on this 
sensitivity effect, the evidence suggesting parental style affects psychiatric 
phenotypes such as depression and anxiety in childhood, and the proposed 
role for parenting style in influencing childhood BMI, Chapter 6 investigates 
whether the effects of parental style on childhood BMI are influenced by the 
genetic influences. 
However, parenting style is only one aspect of the more general 
influence of the social environment on juvenile BMI, and so there may be 
benefits to using a broader measure, such as parental SES, to capture this 
general effect. Previous studies, using a lifetime measure of socioeconomic 
status have suggested a greater effect of genetic risk and so higher BMI in 
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individuals with lower socioeconomic status (Liu & Guo, 2015). This is also 
reflected in epidemiological studies, including those in adolescents and 
young adults. Studies tend to report lower SES in late childhood associated 
with higher BMI, and the persistence and potentially the strengthening of 
this effect into adulthood (Braddon, Rodgers, Wadsworth, et al, 1986; Hardy, 
Wadsworth & Kuh, 2000; Monteiro, Moura, Conde, et al, 2004; Parsons, 
Power, Logan, et al, 1999; Shrewsbury & Wardle, 2008; Sobal & Stunkard, 
1989; Sundquist & Johansson, 1998; Wang, Kim, Gonzalez, et al, 2007). 
However, the magnitude and direction of effects varies across 
epidemiological studies, most likely due to differences in related factors such 
as ethnicity, age and gender, and due to variability in the definition of SES. 
There are also apparent cohort effects, with null results more common in 
cohorts ascertained less recently, and the opposite direction of effect (that is, 
higher BMI associated with higher SES) more commonly seen in developing 
compared with developed countries (Blane, Hart, Smith, et al, 1996; Laitinen, 
Power & Jarvelin, 2001; Lauderdale & Rathouz, 2000; Monteiro, Moura, 
Conde, et al, 2004; Parsons, Power & Manor, 2001; Power & Moynihan, 1987; 
Shrewsbury & Wardle, 2008; Sobal & Stunkard, 1989). Nonetheless, in 
contemporary juvenile cohorts from developed countries, lower SES appears 
to be usually associated with higher BMI, and Chapter 6 seeks (as a 
secondary analysis) to investigate whether this relationship differs with the 
genetic predisposition to BMI. 
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Given that the social environment and genetics may both influence 
BMI through behavioural processes, it may be informative to investigate this 
genome-environment interaction. Therefore, adding to the growing 
polygenic risk-environment interactions literature in BMI, Chapter 6 
examines the effect of the interaction of specific (parental style) and general 
effects of the social environment (parental SES) with genetic risk to predict 
BMI in late childhood and adolescence.  
1.5 Summary and Aims 
 There is convincing evidence that both genetic variation and 
environmental factors affect behavioural traits, including psychiatric 
disorders and their treatment. It seems very unlikely that such influences act 
in isolation, but progress in understanding how such factors interact has 
been slow, in part due to concerns over the low power provided by genome-
wide interactional studies. The chapters of this thesis explore alternative 
ways to use the data-rich output of genomic studies to investigate such 
effects, with the aim of adding to genetic theory and beginning to inform the 
pragmatic goal of improved decision-making in mental health.   
Chapter 3 describes a genome-wide association study of response to 
treatment with cognitive behavioural therapy. This aims to identify any 
common variants present in the genome that can be captured using a low-
coverage microarray, and which have a large effect (considered in an 
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additive model) on response to a shared environmental exposure. There are 
also three secondary aims of the study: to replicate positive associations from 
the candidate gene therapygenetic literature (some of which were reported 
with large effect sizes); to quantify the common additive genetic influence on 
CBT response via GCTA-GREML; and to establish whether polygenic risk 
scores generated from schizophrenia (the most powerful psychiatric 
polygenic risk scores available), depression (the psychiatric disorder with 
genomic data most closely associated with CBT response in patients with 
anxiety), and anti-depressant response (the phenotype with genomic data 
most similar to CBT response) were associated with response to CBT. 
Chapter 4 extends the paradigm used in Chapter 3 to include 
individual differences in RNA expression, which result from the integration 
of genetic and environmental influences. Specifically, it examines the 
association of genetic variants and RNA expression levels (individually and 
together) with response to CBT. The principal aims of the study are to 
identify whether the level of expression of any RNA transcript is associated 
with CBT response; whether data- and literature-defined groups of 
transcripts are associated with CBT response; and to identify genetic variants 
that interact with CBT response to predict RNA expression. The ability of 
polygenic risk scores derived from Chapter 3 to predict response to CBT in 
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this cohort is tested as a secondary aim. Similarly, the association of PRS 
derived from one treatment group to predict response in the other is tested. 
In the first two results chapters, genetic variants are assayed genome-
wide, but primarily modelled as individual influences on response to an 
environmental exposure. The latter two results chapters examine polygenic 
risk scores as proxies for the overall effect of genetic variation genome-wide 
(although this is limited to common effects modelled additively). Chapter 5 
uses polygenic risk scores to control for the genetic component of the 
phenotypic relationship between BMI and depression. If controlling for this 
component attenuates the association between BMI and depression, this 
implies that the relationship is principally genetic, and does not involve a 
substantial contribution from non-genetic influences ("environmental" 
influences, although including non-additive genetic effects and effects from 
rare variants).  Specifically, this chapter aimed to investigate whether 
modelling the genetic influences on BMI and depression as optimised 
polygenic risk scores from the largest publically-available GWAS of these 
traits attenuated the association between BMI and depression observed in 
the absence of modelled genetic effects. Furthermore, this analysis also 
aimed to identify interactions between increased genetic risk for BMI and 
depression status associated with variance in BMI, and similar interactions 
associated with depression status. Secondary aims test whether the common-
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variant heritability of BMI differs between depression cases and controls, 
and whether a genetic correlation exists between BMI and depression.  
Finally, Chapter 6 seeks to assess directly the interaction between the 
genome-wide effect of common variants (modelled as a polygenic risk score) 
and a specific environment, parental warmth and punitive discipline, on pre-
adolescent BMI, and on the change in BMI across adolescence. The main aim 
of the study is to identify whether the child's genetic predisposition to higher 
BMI is differentially associated with the BMI phenotypes of interest 
dependent on parental style. A secondary aim was to establish whether these 
effects differed according to the sex of the child. In the course of these 
analyses, it became clear that investigating socio-economic status as a 
broader measure of the social environment is valuable. Accordingly, 
secondary analyses are performed using parental socio-economic status at 
the birth of the child in the place of parenting, with the same aims. 
This thesis seeks to exemplify that genome-wide genotype data can be 
used to examine the relationship between genetic and environmental 
influences on traits of psychiatric interest, in ways other than performing a 
genome-wide gene-environment interactional study. Specifically it examines 
genetic predictors of differential response to an environmental exposure 
(Chapter 3), the association of RNA expression on response to an 
environmental exposure (with and without genetic variation; Chapter 4), the 
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importance of the genetic component (compared to the environmental 
component) in the relationship between depression and BMI (Chapter 5) and 
assesses the interaction between genetic effects combined across the genome 
and a specific environment on BMI phenotypes in childhood (Chapter 6).      
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Chapter 2: Methodology 
2.1 Genome-wide genetics 
2.1.1. Linkage disequilibrium underlies genomic studies 
The phenomenon of linkage disequilibrium is essential to the design 
and understanding of genome-wide studies. During the process of cell 
division, chromosome pairs align at the cell equator and are then pulled to 
opposite ends of the dividing cell (Remak, 1862; Weismann, Poulton, 
Schönland, et al, 1891). This separation can cause part of each chromosome to 
break off the main body and reanneal to the sister chromosome, a process 
called recombination (Holliday, 1964). Over multiple generations, repeated 
recombination events occur, resulting in a chromosome made up of stretches 
of DNA that originated on different chromosomes, known as haplotype 
blocks, linkage regions or regions of high linkage disequilibrium (Daly, 
Rioux, Schaffner, et al, 2001). Breakages are not equally likely along the 
length of the chromosome, resulting in recombination hotspots (Myers & 
Stahl, 1994; Sun, Treco, Schultes, et al, 1989). Consequently, the size of these 
linkage regions varies. Variants in linkage disequilibrium violate Mendel's 
law of independent assortment; sections of the genome in the same region 
are more likely to be inherited together than expected given their frequencies 
in the population (Bateson, Saunders & Punnett, 1906; Geiringer, 1944; 
Morgan, 1917). The identities of variants in linkage disequilibrium are highly 
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correlated, such that the identity of one variant can be used to predict 
another. This enables the genetic mapping of genomes and the dissection of 
heritability.  
2.1.2. Whole genome sequencing enabled the development of microarrays 
The Human Genome Project, and the genome-wide sequence data 
that resulted from it, was fundamental to the development of microarray-
based genome-wide genetic studies for two broad reasons (Gabriel, 
Schaffner, Nguyen, et al, 2002; Lander, Linton, Birren, et al, 2001; Myers, 
Bottolo, Freeman, et al, 2005; Venter, Adams, Myers, et al, 2001). Firstly, it 
identified thousands of SNPs and their surrounding sequence, enabling the 
design of SNP-detecting probes that could be chemically bonded to a 
microarray to assay genetic variation genome-wide (Gunderson, Steemers, 
Lee, et al, 2005; Sapolsky, Hsie, Berno, et al, 1999; Steemers, Chang, Lee, et al, 
2006). Furthermore, whole-genome sequence data provided an improved 
reference for mapping linkage disequilibrium across the genome. 
Consequently, the identity of millions of SNPs not present on microarrays 
can now be imputed (estimated with a quantifiable degree of confidence) 
from the known identities of assayed SNPs with which they are in linkage 
disequilibrium. A better understanding of the architecture of variation in the 
genome enabled the estimation of an appropriate threshold to control for the 
multiple testing inherent in genome-wide studies (Dudbridge & Gusnanto, 
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2008; Myers, Bottolo, Freeman, et al, 2005). The conventional genome-wide 
significance threshold of p=5x10-8 was derived from this theoretical work, 
and has been established through its use by the large collaborations that 
have come to dominate the field (Collins & Sullivan, 2013; Fadista, Manning, 
Florez, et al, 2016; Psychiatric, Cichon, Craddock, et al, 2009; Sullivan, 2010).  
2.1.3. Microarray-based genome-wide association studies 
Whole-genome sequencing directly genotypes many more variants 
than sparse, proxy-reliant microarray-based genotyping. However, it is 
currently prohibitively expensive for the assessment of the tens of thousands 
of individuals required for the study of common complex behavioural traits 
(Corvin, Craddock & Sullivan, 2010; Spencer, Su, Donnelly, et al, 2009). 
Microarray-based genotyping, followed by imputation to a sequenced 
reference panel, can accurately estimate the identities of millions of genetic 
variants across the genome comparatively cheaply (Marchini & Howie, 2010; 
Spencer, Su, Donnelly, et al, 2009). For this reason, microarray-based GWAS 
has driven the rapid development of the field of psychiatric and behavioural 
genetics in the last decade (Smoller, 2014). It is central to the work presented 
in this thesis, both directly in the generation of new genomic data in 
Chapters 3 and 4, and indirectly in the use of existing data in Chapters 5  
and 6.  
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Assaying many variants also provides large amounts of data that can 
be used to control for confounds such as between sample relatedness, quality 
of genotyping, and sample contamination. These data also allow studies to 
progress beyond individual association tests and integrate external 
information from other genomic datasets to examine associations between 
the phenotype and higher-order genetic variation. In this way, the genome-
wide approach can assess the role of genetic variation ranging from 
individual variants to studying the effect of the entire genome (Visscher, 
Brown, McCarthy, et al, 2012; Wray, Goddard & Visscher, 2007). 
Generating high-quality data from the output of microarray-based 
genotyping requires a careful process of both automated and manual 
inspection of variants (recalling), as well as several quality control steps 
(Anderson, Pettersson, Clarke, et al, 2010; Teo, 2008; Weale, 2010). These 
processes are described in the Appendix to this chapter (Appendix I), 
published as Coleman, Euesden, Patel, et al (2016). Specifically, this paper 
describes and justifies a process of excluding variants and individuals 
according to thresholds related to minor allele frequency (or count); missing 
variant calls; deviations from the expected pattern of Hardy-Weinberg 
equilibrium; sample relatedness; incorrect assignment of gender; 
heterozygosity of variants; and population stratification. It then describes the 
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process of imputing thousands (or millions) of variants, and describes 
secondary quality control and basic association analyses. 
2.1.4. Measuring inter-individual relatedness using genomic data 
The studies within this thesis use more advanced techniques than 
those described in Appendix I, which is a guide to the essential steps to 
perform a GWAS, not an exhaustive review of the field (which has also 
advanced considerably since the submission of that protocol). Appendix I 
describes the strategy for controlling for population stratification using 
principal components from genotyped variants (having removed variants in 
linkage disequilibrium; Menozzi, Piazza & Cavalli-Sforza, 1978; Price, 
Patterson, Plenge, et al, 2006). Although principal component analysis is an 
effective means by which to control for population stratification, a finer-scale 
method has since been developed based on genomic-relatedness matrices 
(GRMs; Kang, Sul, Service, et al, 2010; Yang, Benyamin, McEvoy, et al, 2010; 
Yang, Lee, Goddard, et al, 2011; Yang, Zaitlen, Goddard, et al, 2014). In this 
approach, individuals are scored at each SNP according to how different the 
number of reference alleles they carry is from the average in the cohort, 
weighted by the heterozygosity of the variant (Yang, Lee, Goddard, et al, 
2011). These scores are summed across all variants to give an overall score 
per individual, which can then be compared to assess how similar any two 
individuals are within the cohort. In this way, GRMs provide an alternative 
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and more sensitive method of identifying sample relatedness and population 
stratification than does principal component analysis (Kang, Sul, Service, et 
al, 2010; Yang, Benyamin, McEvoy, et al, 2010; Yang, Lee, Goddard, et al, 
2011). However, principal component analysis captures additional variance, 
resulting from confounding effects independent of sample relatedness such 
as genotyping batch effects. As such, some studies now recommend 
including fixed effects from principal components as well as the random 
effect of the GRM in mixed association models, or conducting more 
sophisticated integration of the two approaches (Yang, Zaitlen, Goddard, et 
al, 2014; Zhang & Pan, 2015).  
The relatedness coefficient from the GRM can be entered into mixed 
linear models as a random effect to perform association analyses (MLMA; 
Yang, Zaitlen, Goddard, et al, 2014). In MLMA, the association of each 
variant with the phenotype of interest is examined in the context of the gross 
genetic similarity between individuals (Kang, Sul, Service, et al, 2010; Yang, 
Zaitlen, Goddard, et al, 2014). As a further refinement to this approach, 
regions of the genome close to the variant of interest can be excluded from 
the calculation of the GRM, increasing power (Listgarten, Lippert, Kadie, et 
al, 2012; Yang, Zaitlen, Goddard, et al, 2014). The specific example of this 
general approach used in this thesis is the leave-one-chromosome-out 
approach, in which GRMs are calculated from the whole genome excluding 
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the chromosome bearing the variant of interest (Yang, Lee, Goddard, et al, 
2011).  
Despite the recent success of genomic studies, variants identified at 
genome-wide significance generally explain only a small proportion of 
heritability (Manolio, Collins, Cox, et al, 2009). However, this “missing 
heritability” problem can be explored by using GRMs. By providing a 
measure of the small degrees of relatedness between population samples 
(compared to the higher relatedness of family members), GRMs allow 
estimation of the genetic component of variance via a process referred to as 
genomic relatedness matrix-based restricted estimation of maximum 
likelihood or GREML (Yang, Lee, Goddard, et al, 2011). The effects of all 
SNPs are entered into a mixed linear model as random effects weighted by 
the GRM, and the components of variance estimated by an iterative 
algorithm designed to maximise the likelihood of the estimate (Yang, Lee, 
Goddard, et al, 2011). The ability to estimate variance in this manner frees 
heritability estimation from requiring related samples (Visscher, Yang & 
Goddard, 2010). However, the resulting estimates are limited to the 
proportion of variance able to be captured by variants on microarrays 
(Visscher, Yang & Goddard, 2010). Additionally, the original method relies 
on several assumptions concerning the allele frequency distribution of causal 
variants and the effect of linkage disequilibrium. Violations of these 
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assumptions will bias the results of GREML studies. Improvements have 
been made to address these biases, by using multiple GRMs stratified by 
allele frequency and average linkage disequilibrium (Yang, Bakshi, Zhu, et al, 
2015).  
2.1.5. Secondary analyses using summary statistics (LD score regression)  
Although GRM-based methods have been extremely influential and 
valuable to the field, they require individual-level genotype data to produce. 
While this is feasible for local datasets (such as those generated in Chapters 3 
and 4), this becomes more burdensome for combining multiple studies, 
where data sharing may be limited by logistical or ethical concerns, or by the 
computational burden of analysing large amounts of genotype data 
(Finucane, Bulik-Sullivan, Gusev, et al, 2015; Loh, Bhatia, Gusev, et al, 2015). 
These difficulties motivated the development of methods that use summary 
statistics from association studies.  
One particularly prominent method that has emerged in the last few 
years is LD score regression (Bulik-Sullivan, Finucane, Anttila, et al, 2015; 
Bulik-Sullivan, Loh, Finucane, et al, 2015; Finucane, Bulik-Sullivan, Gusev, et 
al, 2015; Loh, Bhatia, Gusev, et al, 2015; Loh, Tucker, Bulik-Sullivan, et al, 
2015; Yang, Bakshi, Zhu, et al, 2015). Variants in linkage disequilibrium with 
causal variants show increased effect sizes in association studies (Pritchard & 
Przeworski, 2001; Sham, Cherny, Purcell, et al, 2000; Yang, Weedon, Purcell, 
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et al, 2011). In regions where many variants are in high linkage 
disequilibrium, the chances of one of those variants being causal (and so 
increasing the effect size of all other variants) is greater than in areas of 
sparse linkage disequilibrium. There is, therefore, a positive correlation 
between the average linkage disequilibrium of a variant (its LD score) and its 
effect size. The p-values obtained from a GWAS are expected to follow a 
uniform null distribution, and deviation from this expectation is known as 
genomic inflation. Inflation can result from the combined effect of true 
signals and from confounding processes such as population stratification or 
batch effects. These confounding effects are uncorrelated with linkage 
disequilibrium, and so, by regressing the effect sizes of variants on their LD 
score, it is possible to differentiate the polygenic effect of true signal (as 
captured by the LD score) from inflation due to confounds. This separation is 
the principle purpose of LD score regression, but it has a variety of other 
applications, including estimating heritability from genome-wide data (or 
from specific regions of the genome) and assessing genetic correlations 
between traits (Bulik-Sullivan, Finucane, Anttila, et al, 2015; Bulik-Sullivan, 
Loh, Finucane, et al, 2015; Loh, Bhatia, Gusev, et al, 2015). 
LD score regression is a valuable approach and represents one 
method in an expanding arsenal of summary statistic-based methods. 
However, although such methods require less complex data to use than 
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genotype-reliant methods, they show reduced power (Bulik-Sullivan, Loh, 
Finucane, et al, 2015). As such, the most appropriate approach is determined 
both by data availability and by the intended analysis. In cases where 
genotypic data is available, using both methods (for example, to estimate 
heritability) can be valuable as a means of technical validation.  
2.1.6. Polygenic risk scoring 
The work in this thesis (particularly the latter two chapters) makes 
regular use of one particular secondary analysis from GWAS data. Polygenic 
risk scoring (PRS) combines both the genotype-level and summary statistic-
based approaches discussed above (although versions of the technique using 
summary statistics only have been developed; Johnson, 2013; Palla & 
Dudbridge, 2015).  
Even with the large sample sizes available to international consortia, 
genomic studies of behavioural phenotypes remain underpowered to detect 
all associated variants (International Schizophrenia, Purcell, Wray, et al, 2009; 
Palla & Dudbridge, 2015; Wray, Lee, Mehta, et al, 2014). Each variant within 
a study theoretically falls into one of four groups: true positives (variants 
capturing real effects that are called as significant), false positives (variants of 
no effect called as significant by chance), true negatives (variants of no effect 
that are not significantly associated with the phenotype), and false negatives 
(variants of real effect that miss significance within the study). The 
84 
 
conventional threshold of genome-wide significance (p=5x10-8) aims to 
reduce the number of false positives, at the expense of increasing false 
negatives. As such, there may be valuable information beneath the 
significance threshold (false negatives). Incrementally increasing this 
threshold may gradually capture more signal, but at the expense of 
increasing statistical noise (true negatives becoming false positives; Figure 3). 
 
Figure 3: Imagined distribution of true positives (red) in GWAS results, 
showing the potential signal accessible beneath the  




To create a polygenic risk score, variants from an existing GWAS (the 
base) are grouped by the p-value, and each effect allele is weighted by its 
effect size (Wray, Lee, Mehta, et al, 2014). Within the dataset of interest (the 
target), the weighted alleles are summed to give a total genetic risk score per 
individual. This score is then regressed on the target phenotype to assess the 
relationship between genetic risk for the base phenotype (determined by the 
p-values and effect sizes used in generating the score) and the target 
phenotype. Typically, this process is performed multiple times, with 
increasingly relaxed thresholds for including variants in the score (Wray, 
Lee, Mehta, et al, 2014). Within this thesis, polygenic risk scores were 
generated on genotyped data (or hard-called imputed data), using mean 
imputation for missing genotypes, and calculating the score as the mean 
average of each per-allele score (Chang, Chow, Tellier et al, 2015; Purcell, 
Neale, Todd-Brown et al, 2007). 
As discussed in the introduction, PRS has two uses, within-trait and 
cross-trait. As an example, if the target were a case-control study of 
schizophrenia, results from the most recent PGC schizophrenia mega-
analysis could be used as the base. The genetic risk would be expected to 
predict schizophrenia case status in the target dataset; were this not the case, 
it might then raise questions about the genetics (or diagnosis) of 
schizophrenia within the target cohort. The same logic applies when 
86 
 
investigating across traits, but in this instance, the results may be more 
informative about pleiotropy and shared genetic aetiology between the base 
and target phenotypes.  
Examining the pattern of association between different risk scores and 
the phenotype can be informative about the target sample and about the 
base. Assuming the association study used as the base were well-powered, 
different traits would show different patterns. For a truly Mendelian trait, 
where a single variant captures all of the heritability (pi0 → 1 in Figure 4), 
risk scores constructed at the lowest significance thresholds would explain 
all of the genetic variance, and this would gradually decline as the threshold 
was increased and the signal was lost in the accumulating noise. At the 
opposite extreme, a highly polygenic trait underlain by many variants of 
small effect (pi0 → 0 in Figure 4) would show a different risk profile, one in 
which the proportion of variance explained gradually increased with more 
variants until an unknown tipping point was reached. At this point, the 
noise added by raising the threshold would negate the increase in signal 
(Figure 4; Dudbridge, 2013). As the power of the base study increases, the 
likelihood that any false negative becomes a true positive increases, and as 
such, the PRS profile of the polygenic trait is expected to become more like 
that of the Mendelian trait (Dudbridge, 2013; International Schizophrenia, 













The pattern of multiple risk scores can, therefore, be informative. In 
other instances, it is useful to define the optimal risk score (that is, the one 
that describes the most variance in the target). If a limited set of risk scores 
are assessed, it is likely that the optimal score will be missed, or that a 
misleading pattern is described. For this reason, high-resolution scoring 
approaches were developed, which extend the basic PRS method to examine 
thousands of scores, and apply a suitable correction for multiple testing 
(Euesden, Lewis & O'Reilly, 2015). In Chapters 3 and 4, risk scores are used 
Figure 4: Expected p-values (y-axis) of multiple risk scores including variants 
with p-values between 0-p1 (x-axis), assuming different proportions of 
variants with no effect on the phenotype (pi0) and moderate (but not full) 
power to detect true positives. Reproduced from (Dudbridge, 2013). 
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as proxies of the genetic component of variance, and as such it is valuable to 
identify the optimal risk score using high-resolution approaches.      
2.2 Interaction modelling with linear and logistic regression 
 The second half of this thesis relies on modelling interactions between 
polygenic risk scores (as proxies for the effect of the genome) and measures 
of the environment (both inferred components and measured environments). 
Although the linear and logistic regression methods that underlie this 
approach are robust, commonplace statistical approaches, there are some 
considerations that must be made in performing such studies.  
A statistical interaction is best defined (in this case) as a deviation 
from an additive function of genetic and environmental effects, on a given 
scale (Plomin, DeFries & Loehlin, 1977; Thomas, 2004). This does not 
translate directly into a specific mathematical operation. For example, many 
studies model interactions as multiplicative effects, where the effects are 
modelled on the logarithmic scale, and so the combined risk of both 
influences is expected to be the product of the risk from each influence alone. 
This is an analytical choice, rather than an inherent part of studying gene-
environment interplay (Kendler & Gardner, 2010; Yang & Khoury, 1997). 
Particularly in the field of public health, modelling gene-environment 
interactions as additive (where significant interactions deviate from the sum 
of the risks from each influence) can be informative (Li & Chambless, 2007).  
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The appropriate way to model a given interaction is not always 
obvious. One solution would be to model all interactions as multiplicative 
effects (Thomas, 2010). This would be akin to standard practices in main-
effects GWAS, where the multiplicative model of SNP effects has come to 
dominate. It would also have the benefit of reducing the multiple testing 
incurred by testing multiple models of interaction (Lewis & Knight, 2012; 
Zammit, Lewis, Dalman, et al, 2010). However, an inappropriate model may 
lead to false positive findings, or prevent the discovery of real effects 
(Rothman, Greenland & Walker, 1980). Furthermore, rejecting the null 
hypothesis in a study of gene-environment interaction only means that the 
interaction deviates from the modelled expectation – this may be entirely 
uninformative about the mechanism of any interaction that exists (Kendler & 
Gardner, 2010; Zammit, Lewis, Dalman, et al, 2010).  
Modelling gene-environment interactions is scale-dependent, and so 
relies on the construction of the genetic and environmental variables. For 
example, environmental variables can range in the length, type, and precise 
measure of the exposure (Dick, Agrawal, Keller, et al, 2015). Especially in 
studies of human behaviour, the environmental variable may not have an 
obvious scale; while weight has a clear interval scale (kg), the severity of 
depression is a complex phenomenon usually described with an arbitrary 
ordinal scale (Dick, Agrawal, Keller, et al, 2015; Falconer & Mackay, 1996; 
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Lynch & Walsh, 1998). The nature of the scale is extremely important – for 
example, a multiplicative interaction between gene and environment 
becomes additive if the environmental variable is log-transformed (which 
may be an arbitrary decision), potentially changing the interpretation 
entirely (Dick, Agrawal, Keller, et al, 2015). Such variability in the 
environmental exposure produces a source of heterogeneity that will at best 
reduce the power of large-scale meta-analysis, and may result in true 
interactive effects between specific environments and genetic variants being 
lost (Dick, Agrawal, Keller, et al, 2015). Finally, most (if not all) of the 
statistical concerns surrounding candidate gene-environment interactions 
also apply to genome-wide studies (Dick, Agrawal, Keller, et al, 2015).  
Gene-environment interaction studies have traditionally included 
covariates within their models but frequently have included these as main 
effects only (Keller, 2014; Yzerbyt, Muller & Judd, 2004). To control for the 
effects of these covariates on the interaction term, it is necessary to include 
gene x covariate and environment x covariate effects as well, with the 
resulting increase in terms in the model and degradation of evidence for the 
interaction term (Keller, 2014; Yzerbyt, Muller & Judd, 2004). Although this 
correction was proposed to address off-target gene-environment correlations 
in single-variant gene-by-environment interaction studies, the logic extends 
to genome-by-environment interaction studies as well.   
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Gene-by-environment interaction models assume that the genetic and 
environmental components are independent (Dudbridge & Fletcher, 2014). If 
this assumption is false, the results of the interaction may be biassed such 
that a spurious interaction could be generated or a true interaction obscured 
(Dudbridge & Fletcher, 2014; Jaffee & Price, 2007; Purcell, 2002). 
Accordingly, it is necessary to test for gene-environment correlations when 
exploring gene-environment interactions, and to interpret the results 
appropriately (Jaffee & Price, 2007).  
2.3 Gene expression analyses 
 Much as is the case for genomic studies, whole-genome expression 
studies have benefited from increased knowledge from the Human Genome 
Project and from technological advancement, particularly the development 
of DNA microarray technology (Kuhn, Baker, Chudin, et al, 2004; Schena, 
Shalon, Davis, et al, 1995). Genome-wide investigations require certain 
considerations regardless of the exact biology studied. Just as GWAS 
requires large sample sizes and consistency in the way that DNA is obtained, 
so does genome-wide gene expression analysis. Although the sample size 
requirement may be smaller (because there are fewer RNA transcripts 
compared to genetic variants), the requirement for consistency is arguably 
greater. There are two reasons for this. The tissue-specificity issue previously 
discussed constrains analyses to a single tissue or else requires adequate 
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control for cross-tissue analysis (Heijmans & Mill, 2012). Single-stranded 
RNA is also a less stable molecule than double-stranded DNA, and as such 
requires more immediate analysis following extraction, with a resultant 
increase in the potential for technical artefacts (batch effects; Leek, Scharpf, 
Bravo, et al, 2010; Scherer, 2009; Tsui, Ng & Lo, 2002).  
 Genome-wide expression analysis involves assessing associations 
between the phenotype of interest and synthesised DNA complementary to 
RNA transcripts. Typically, gene expression studies have focussed on a 
differential expression approach, assuming a dichotomous phenotype or 
different cell types for comparison (Ritchie, Phipson, Wu, et al, 2015). 
However, the analysis of continuous phenotypes is straightforward, and at 
the simplest level can be performed with correlation or regression analyses.  
In addition to analysing individual transcripts, network-based 
examinations of the combined effects of multiple genes can be performed 
(Butte & Kohane, 2000; Eisen, Spellman, Brown, et al, 1998; Zhang & 
Horvath, 2005). The gene sets studied can be drawn from the literature or 
through observing how the empirical data clusters (Butte & Kohane, 2000; 
Eisen, Spellman, Brown, et al, 1998; Subramanian, Tamayo, Mootha, et al, 
2005; Zhang & Horvath, 2005). Multiple sources of information can be used 
to construct and define sets of related genes, including genomic features 
(such as DNase hypersensitivity sites), co-expression of RNA transcripts, or 
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interactions of the resulting proteins. These approaches have the benefit of 
highlighting patterns of enrichment that are obscured by focussing on single 
transcripts, and which may be biologically relevant. Collapsing the results 
from many individual data points into fewer sets also reduces the number of 
tests it is necessary to perform on the data.  
The analysis presented in Chapter 4 uses two methods of network 
analysis to examine data-driven and literature-driven groupings 
respectively. Weighted Gene Network Co-Expression Analysis (WGCNA) is 
a suite of analysis methods built around a data-driven clustering algorithm 
that groups genes with similar expression into modules (although this 
method can cluster any data associated with a continuous metric; Langfelder 
& Horvath, 2008; Zhang & Horvath, 2005). This approach has become 
popular as a means of assessing inter-gene correlations because it relies 
heavily on networks, which are a familiar concept in biology and the 
mathematics of which can accurately describe observed biological patterns 
(Barabasi & Albert, 1999; Bergmann, Ihmels & Barkai, 2004; Jeong, Tombor, 
Albert, et al, 2000; Langfelder & Horvath, 2008; Tanaka, 2005; Zhang & 
Horvath, 2005).  
WGCNA is built around a weighted network in which expressed 
transcripts are the nodes. Transcripts are connected to each other by edges, 
with each edge weighted by a continuous value (the adjacency of the two 
94 
 
nodes). In the simplest instance, this adjacency is determined by the 
correlation between expression levels of the two transcripts, raised to a 
power that optimises scale-free topology while still retaining a high number 
of connections between nodes (Langfelder & Horvath, 2008; Zhang & 
Horvath, 2005). Once a network is constructed, co-expression modules can 
be defined by linking strongly-connected genes together in a hierarchical 
manner (Langfelder, Zhang & Horvath, 2008). Associations can then be 
determined between the modules and the phenotype, with clear reductions 
in multiple testing compared to transcript-level analyses. 
Modules provide a means of dimensional reduction in analysing 
expression data, and can also be biologically meaningful. Gene annotations 
from the literature (described in repositories such as Gene Ontology) can be 
used to identify enrichment for biological pathways in modules, as is 
implemented in WGCNA (Ashburner, Ball, Blake, et al, 2000; Langfelder & 
Horvath, 2008). Such analysis is not limited to modules, and many programs 
exist to conduct literature-driven clustering or pathway analysis at the level 
of individual transcripts. The method used in Chapter 4 is GOrilla (Eden, 
Navon, Steinfeld, et al, 2009). Unlike many methods for literature-based 
annotation, GOrilla can identify GO term enrichment in ranked lists of genes 
without requiring separate target and background sets (Eden, Navon, 
Steinfeld, et al, 2009). This is achieved by an algorithm that takes all listed 
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genes as the background set, defines all possible target sets with a stepwise 
inclusion of genes from the top of the list, and then identifies the target set 
that gives the strongest enrichment (Eden, Lipson, Yogev, et al, 2007). The p-
value for this enrichment is then corrected for the multiple thresholding the 
algorithm involves (Eden, Lipson, Yogev, et al, 2007; Eden, Navon, Steinfeld, 
et al, 2009). Accordingly, GOrilla identifies enrichment of GO terms at the top 
of a ranked list, which is valuable for identifying potential biological signals 
of interest in the absence of a clearly defined target set. However, because 
GOrilla uses rankings rather than any weighting (for example, by the effect 
size of the association to the phenotype), the results of the enrichment 
analysis require careful interpretation, taking into consideration how the 
ranking was performed. In addition, the ranking of genes could be 
performed agnostic to the direction of effect (such as ranking by ascending 
p-value) or with regard to the direction of effect (such as by ranking on 
Pearson's r; Hong, Zhang, Li et al, 2013). Different rankings may yield 
different results. The published analyses in Chapter 4 used p-value based 
ranking; additional analyses ranking on Pearson's r are included in 
Appendix III.              
Further insight into the importance of individual or group differences 
in expression in the context of a given phenotype can be gained by 
integrating genomic data into the analysis (which in turn provides new 
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information about the genomic data; Ritchie, Holzinger, Li, et al, 2015; Zhu, 
Zhang, Hu, et al, 2016). This can be achieved by context-dependent 
expression trait locus (eQTL) analysis. eQTL studies are effectively a special 
case of multivariate GWAS, using the expression of all RNA transcripts as 
the phenotypes (Jansen & Nap, 2001; Schadt, Monks, Drake, et al, 2003). 
Investigations can be restricted to associations between transcripts and 
variants local to the relevant coding region (cis-eQTLs), or can be truly 
genome-wide (incorporating trans-eQTLs). Performing such studies requires 
a considerable number of tests, especially in the case of genome-wide eQTL 
studies; however, efficient software for performing such interactions has 
been developed, such as the MatrixEQTL R package used in this thesis 
(Shabalin, 2012). 
Genotype-environment interactions are integral to biology, and eQTL 
associations tend to be of large effect and detectable in cohorts comprising 
only tens of individuals (Monks, Leonardson, Zhu, et al, 2004; Morley, 
Molony, Weber, et al, 2004). However, it is the relationship between eQTLs 
and phenotypes that is of most interest. Such relationships can be used to 
annotate significant findings from association analyses; identifying a 
significant SNP from GWAS as an eQTL might provide functional insight.  
It would be useful to perform a full interaction analysis, assessing 
whether genetic variation and differential gene expression together influence 
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a separate phenotype. However, this increases the number of tests 
performed. Every factor in a genome-wide interaction analysis incurs a 
million additional tests. Assuming twenty thousand transcripts are tested, 
billions of tests must be performed. For traits such as BMI, where 
measurement is straightforward and there are minimal ascertainment 
differences in participants, this level of multiple testing might be acceptable. 
In traits where sample sizes are limited and ascertainment is more complex 
(including most behavioural phenotypes), focussing on interactions between 
local SNPs and transcripts (or examining only cis-eQTLs and their associated 
transcript) can reduce the number of tests required (Consortium, 2015b). 
However, this comes at the expense of missing potential long-distance 
interactions. An alternative approach, limiting analyses only to SNPs already 
robustly associated with the disorder, has been successful in physical 
disorders but is limited by the current small numbers of associated SNPs in 
behavioural traits (Westra, Peters, Esko, et al, 2013).  
Alternatively, genotype-by-phenotype interactions could be used to 
predict gene expression. These effects identify eQTLs that are context-
dependent, and the effects tend to be considerably smaller and harder to 
detect than those of eQTLs in general. Selecting a subset of interactions to 
examine increases the power to detect significant interactions (although at 
the expense of missing true interactions that are not selected). Such selection 
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could be determined by location (favouring local cis- interactions over 
distant trans- interactions), or by the effects of individual components, such 
as including only those eQTLs where either the genotype or the transcript is 
associated with a main effect or including only known eQTLs (Hernandez, 


























Addendum: GRMs and principal components 
 The analyses in Chapter 3 used a random effect derived from a 
genomic relatedness matrix (GRM) to control for population stratification in 
the multi-ethnic sample. The rationale behind this was that the multiple 
ethnicities in the sample resulted in principal components (PCs) that 
primarily separated samples of African or East Asian ancestry from those of 
White Western European (WWE) ancestry (Figures DS2a and DS2b). 
Accordingly, the WWE samples (which represent 92% of the cohort) were 
poorly separated by PCs. One approach to addressing this would have been 
to remove samples that lay outside the WWE cluster on the PC plot (red box 
in Figure DS2b), and re-run PC analysis to obtain WWE-specific components 
for use in the final analysis. Controlling for gross genetic similarity between 
samples using the GRM offered a means to address better both fine-scale and 
broad-scale inter-sample relatedness (compared to PC-based control; Wang, 
Hu & Peng, 2013) whilst retaining sample size (and so statistical power).  
The use of GRMs to control for population stratification has become 
much more common since the analysis in Chapter 3 was performed, and the 
validity of using GRMs in the presence of population stratification has come 
under greater scrutiny.  Although GRM-based control is generally robust in 
the presence of population stratification, it fails in the presence of extreme 
differences in allele frequency between populations (Price, Zaitlen, Reich et 
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al, 2010). As such, this method may not appropriately control for population 
stratification in this instance. The robustness of GRM-based correction in the 
case of unbalanced population stratification (that is, the situation in Chapter 
3) has not been explicitly tested. As such, it may be the case that the results of 
Chapter 3 are limited by inadequate control for population stratification, and 
that outlier removal would have been a better strategy for analysis in this 
instance. Accordingly, I performed sensitivity analyses, limiting the cohort to 
WWE samples only. This yields results that are largely concordant with 
those reported - 5/7 loci have p<10-5 in pre to post-treatment analyses in the 
full cohort and limited to the WWE samples only, and 6/7 loci have p<10-5 in 
the analyses to follow-up. All loci reported in Tables 1 and 2 have p < 5x10-5 
in the WWE analysis. The conclusions of the analysis are not substantially 
biased due to the method used, although the precision of the associations 
differs when considering the WWE samples only. In the analysis limited to 
WWE samples, as in the analyses in the full sample, there are no variants of 
large effect, and there are a number of loci at a suggestive level of 
significance, although any true signal cannot be disentangled from 
associations due to chance. Loci with p<1x10-4 in the sensitivity analyses are 









































Chapter 5: The relationship between depression and body mass index in 
the UK Biobank, and the contribution of polygenic risk 
5.1 Introduction  
Depression and obesity are severe and growing public health 
concerns. Depressive disorders account for approximately 3% of the total 
global burden of disease and are the largest single contributor to years lived 
with disability (Whiteford, Degenhardt, Rehm, et al, 2013). While the global 
burden of disease has decreased in relative terms in the last twenty years, the 
burden of depressive disorders has increased (Murray, Vos, Lozano, et al, 
2012). The effect of high body mass index (BMI) shows a similar pattern, 
accounting (indirectly) for around 4% of the global burden of disease, and 
increasing substantially from 1990 to 2010 (Lim, Vos, Flaxman, et al, 2013; 
Ng, Fleming, Robinson, et al, 2014).  
Variation in BMI and depression are not independent. Although 
individual studies often show contradictory results, large-scale meta-
analyses have repeatedly shown a small positive correlation between 
depression and BMI (de Wit, Luppino, van Straten, et al, 2010; Luppino, de 
Wit, Bouvy, et al, 2010; Scott, Bruffaerts, Simon, et al, 2007; Simon, Von Korff, 
Saunders, et al, 2006). Furthermore, diagnostic criteria for depression include 
BMI-related processes such as weight change, dysregulated appetite, and 
unusual sleep and activity patterns (Association, 2013). As these criteria have 
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no inherent directionality, both reductions (termed typical depression) and 
increases (atypical depression) in these aspects can be present in depression 
(Sullivan, Prescott & Kendler, 2002). As such, variation in BMI is not merely 
associated with depression, but can also be an inherent part of the diagnosis. 
However, the causal nature and direction of the relationship remains 
unclear, and many potential mediators or moderators have been suggested 
(Faith, Butryn, Wadden, et al, 2011; Faith, Matz & Jorge, 2002; Gibson-Smith, 
Bot, Paans, et al, 2016; Konttinen, Kiviruusu, Huurre, et al, 2014). 
Insights into the relationship between depression and BMI could be 
gained by analysing the genetic contribution to variance in each trait, and 
assessing to what extent these contributions are shared. Evidence from the 
twin literature suggests that BMI and depression may share a small genetic 
component, resulting in a genetic correlation around 12% (Afari, Noonan, 
Goldberg, et al, 2010; Jokela, Berg, Silventoinen, et al, 2016). Studies seeking 
to identify genetic variants have suggested a role for common (and 
potentially for rare) variants, but such findings await robust replication 
(Jokela, Elovainio, Keltikangas-Jarvinen, et al, 2012; Milaneschi, Lamers, Bot, 
et al, 2015; Samaan, Lee, Gerstein, et al, 2015).  
Molecular genetic studies of BMI and depression have differed in 
their rate of success to date. Studies of BMI have successfully detected high-
effect rare variants (such as perturbations in the leptin system) and identified 
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a considerable amount of the contribution of common genetic variants 
(Zhang, Proenca, Maffei, et al, 1994). Much of this latter success has been 
driven by meta-analyses from the GIANT consortium, the most recent of 
which identified 97 associated genetic loci and a genome-wide heritability 
estimate from genome-wide genotype data of ~20%(Locke, Kahali, Berndt, et 
al, 2015). In contrast, the progress of genomics in studying depression has 
been slower despite considerable research effort (Major Depressive Disorder 
Working Group of the Psychiatric, Ripke, Wray, et al, 2013). However, 
genome-wide significant loci are emerging. A detailed study of severe 
depression in Han Chinese participants yielded 2 variants at genome-wide 
significance (Cai, Bigdeli, Kretzschmar, et al, 2015). An investigation of self-
reported data from users of the 23&Me consumer genotyping service 
(limited to those with European-ancestry) identified 15 loci in meta-analysis 
with previous studies from the Psychiatric Genomics Consortium (PGC; 
Hyde, Nagle, Tian, et al, 2016). The next iteration of the PGC depression 
genomic mega-analysis is expected to yield further associations (Lewis, 
2015).  
Genomic data have uses beyond identifying genome-wide significant 
loci. Genomic studies are typically underpowered because individual genetic 
variants have small effects; as a result, loci with real effects will be enriched 
at p-value thresholds below conventional significance. Although these 
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cannot be specifically identified, the predictive power of such loci can be 
leveraged through building polygenic risk scores, which use the results of 
established genome-wide association studies (such as those mentioned 
above) to weight variants in a target cohort, and thus enable the calculation 
of genetic risk for a disorder in a novel cohort (Dudbridge, 2013; Euesden, 
Lewis & O'Reilly, 2015; International Schizophrenia, Purcell, Wray, et al, 
2009). Such risk scores can also be used to examine the relationship between 
disorders. A similar approach has been carried out previously in the 
Generation Scotland cohort, in which variance in BMI was predicted using 
genetic risk scores for depression and for BMI (Clarke, Hall, Fernandez-
Pujals, et al, 2015). The study found no effect of genetic risk of depression on 
BMI (nor of genetic risk for BMI on depression) but did find a significant 
interaction between (unweighted) BMI polygenic profile scores and 
depressive disorder predicting BMI, with a greater effect of BMI genetic risk 
in the case group compared to controls. 
Recently, there has been increased interest in BMI as a behavioural 
phenotype. Most antipsychotic and some anti-depressant drugs alter BMI, 
potentially implying shared biological pathways, and a combined role of 
metabolic and psychiatric influences has been proposed in a variety of 
psychiatric disorders (Fava, 2000; Khansari & Sperlagh, 2012; Yao & Reddy, 
2005). One of the most intriguing pieces of evidence has emerged from the 
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field of complex genetics. The common additive component of the genetic 
contribution to variance in a trait (sometimes referred to as “chip” 
heritability) can be partitioned into cell-type-specific components according 
to the annotation of genetic variants to cell-type-specific histone 
modifications (Finucane, Bulik-Sullivan, Gusev, et al, 2015). When this 
procedure was performed on the results from a large meta-analysis of BMI 
genomic studies, significant enrichment was found for central nervous 
system cell types (in comparison to enrichment of adrenal and pancreatic cell 
types with  variance in fasting glucose levels; Finucane, Bulik-Sullivan, 
Gusev, et al, 2015; Speliotes, Willer, Berndt, et al, 2010). This reinforces the 
potential for a shared behavioural genetic component between BMI and 
psychological or psychiatric phenotypes.      
Within this study, we investigated the relationship between BMI and 
depression using polygenic risk scores in a large population cohort, the UK 
Biobank (Sudlow, Gallacher, Allen, et al, 2015). The results of this study add 
to recent analyses to provide additional insight into this complex 
relationship and address the relevance of genetic factors within that 
relationship (Clarke, Hall, Fernandez-Pujals, et al, 2015; Milaneschi, Lamers, 




5.2 Materials and methods 
5.2.1 Cohort Description 
The UK Biobank is a prospectively sampled population cohort of 
approximately 500,000 adult individuals (aged between 40-69) from the UK, 
with data collected on an extensive range of health-related phenotypes 
(Sudlow, Gallacher, Allen, et al, 2015). Data were made available from the 
baseline assessment of the full cohort, as well as a targeted re-assessment of a 
subset of individuals. Health data were gathered via an extensive 
touchscreen questionnaire, with specific details on prescription medications 
and health conditions obtained during interviews with a nurse. Additional 
information was available from electronic health records detailing inpatient 
hospital episodes data. Full details on the collection of the UK Biobank 
cohort can be found on the project website (http://www.ukbiobank.ac.uk/).  
5.2.2 Phenotype definitions 
Data on BMI and covariates were available from UK Biobank. 
Individuals reporting regular use of antipsychotic or mood stabilising 
medications, reporting cancer of any kind or reporting an eating disorder (all 
of which may alter BMI) were excluded from analysis. Raw BMI scores were 
transformed with a natural logarithm to increase normality. 
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Depression was defined as any reported primary diagnosis of 
depression from inpatient hospital episodes data (ICD 10 subchapters F32 
and F33) or meeting criteria from a previous publication on the UK Biobank 
cohort (Smith, Nicholl, Cullen, et al, 2013). These latter criteria required 
participants to report (as part of their general assessment) a previous visit to 
a GP or psychiatrist for stress, anxiety or depression, and at least one period 
of depression or anhedonia lasting at least two weeks. Depression cases were 
excluded if they self-reported (or had a hospitalisation primarily for) bipolar 
disorder, psychosis, multiple personality disorder, autism or intellectual 
disability. Depression controls were defined as individuals who did not meet 
the criteria for case status, did not report depression, anxiety or the excluded 
conditions outlined above, and did not report taking medication with an 
antidepressant or anxiolytic indication. Individuals who did not provide 
sufficient data to establish depression case status were excluded from 
analysis.  
5.2.3. Genotyping and imputation 
Genome-wide genotyping of the cohort was performed by Affymetrix 
using two customised microarrays, the UK BiLEVE and UKB Axiom arrays, 
which have very similar content and assay over 800,000 variants. Details of 





web.pdf. Genotype data were imputed to a combined reference panel of the 
UK10K and 1000 Genomes Phase 3. Imputation analyses were performed as 
part of the UK Biobank project using IMPUTE3 software; full details of this 
procedure are available at 
http://biobank.ctsu.ox.ac.uk/showcase/docs/impute_ukb_v1.pdf. 
5.2.4. Genotype quality control 
Preliminary quality control was performed by Affymetrix during and 
after genotyping, and centrally by the UK Biobank team before and 
following imputation, and is described in the previously noted references. 
Further quality control specific to this study was performed using PLINK2 
and QCTOOL (Chang, Chow, Tellier, et al, 2015; 
http://www.well.ox.ac.uk/~gav/qctool). The cohort was limited to depression 
cases and controls who self-identified as British and were of White Western 
European ancestry (as inferred from principal components analysis by UK 
Biobank). No participants were substantially related in this subset of the 
cohort (all pairwise  KING relatedness coefficient < 0.044, equivalent to a 
greater separation than third-degree relatives). Participants were retained in 
the analysis if they had > 98% of genotyped variants available and had 
genome-wide heterozygosity (as inferred from genotyped variants) within 
three standard deviations of the sample mean. Imputed variants were 
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retained for the analysis if they were common (minor allele frequency ≥ 0.01), 
imputed with high certainty (info ≥ 0.9) and did not deviate substantially 
from Hardy-Weinberg equilibrium (Hardy-Weinberg equilibrium test  
p ≥ 1x10-6). 
5.2.5. Generation of polygenic risk scores 
Polygenic risk scores (PRS) were derived for the analyses using the 
default settings of PRSice, which performs high-resolution scoring to identify 
the most predictive PRS (Euesden, Lewis & O'Reilly, 2015). The depression 
PRS was derived from the PGC1 mega-analysis of major depression, and the 
BMI PRS from the GIANT 2015 trans-ethnic analysis (Locke, Kahali, Berndt, 
et al, 2015; Major Depressive Disorder Working Group of the Psychiatric, 
Ripke, Wray, et al, 2013). Variants were retained for the analysis if present in 
the relevant base dataset and the UK Biobank dataset, which were merged 
and then clumped to address linkage disequilibrium. Scores were calculated 
at p-value thresholds extending from 0.0001 to 0.5, with intervals of 0.00005. 
Analyses were performed within- and across-trait. The most predictive PRS 
was identified by comparing the R2 of the model containing the PRS and 
genotyping batch, assessment centre, and the first eight principal 
components (to address potential confounding by technical artefacts and 
population stratification) with that not including the PRS. As fewer 
covariates were included, PRS were calculated on a slightly larger cohort 
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than was assessed in the main analysis. Variance explained for depression is 
reported by PRSice as Nagelkerke's pseudo-R2 (on the observed scale). This 
was back-converted to the Cox-Snell pseudo-R2, and then converted to the 
liability scale using the software package GEAR, assuming a population 
prevalence of 12% (Chen, 2014; Fernandex-Pujals, Adams, Thomson, et al, 
2015; Lee, Goddard, Wray, et al, 2012). Variance explained for log-BMI is on 
the liability scale. The multiple testing incurred by the PRSice method 
suggests an adjusted alpha threshold of 0.001 (derived by permutation) 
should be used for a single test (Euesden, Lewis & O'Reilly, 2015). To 
account for the four tests performed, the correlation matrix between the 
most-predictive PRS from each analysis was spectrally decomposed and the 
Nyholt-Šidák calculation of the effective number of independent tests was 
performed (Nyholt, 2004). 
5.2.6 Analyses 
Statistical analyses were performed in R. The most predictive within-
trait PRS were used as proxies for the genetic components of each trait. 
Depression case-control status was regressed on the depression PRS, on the 
BMI PRS, on log-BMI as a trait, and on the interaction between the three 
components, using a logistic model (to assess main effects and multiplicative 
interactions) and a linear model (to assess additive interactions; Mullins, 
Power, Fisher, et al, 2016; Rothman, Greenland & Lash, 2008). A linear model 
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was used to assess the effects of BMI PRS, depression PRS, depression case 
status and the interaction between the dependent variables on log-BMI. All 
analyses featured as covariates fixed effects of sex, age in years (at baseline 
assessment), Townsend Deprivation Index, the first eight principal 
components (as derived by UK Biobank from the genotype data), and 
unordered factors accounting for region of birth, assessment centre and 
genotyping batch. The Townsend Deprivation Index is a measure of 
neighbourhood deprivation, where a higher score on the index represents 
more unemployment, less vehicle or home ownership, and more home 
overcrowding (Townsend, Phillimore & Beattie, 1988). Region of birth was 
converted from Cartesian coordinates (as received from UK Biobank) into 
eight factors by k-means clustering using the pamk function from the fpc R 
package(Kaufman & Rousseeuw, 2009;  
https://cran.r-project.org/web/packages/fpc/fpc.pdf). Where the model 
included an interaction between the trait and either or both PRS, all 
covariate-by-trait and covariate-by-PRS interactions were included in the 
model (Keller, 2014). All continuous variables were normalised for analysis. 
Following the initial analysis of log-BMI, the cohort was stratified into 
depression cases and controls to assess differential effects of PRS on log-BMI 
within these groups. Significance for each test was set at 0.0125 (Bonferroni 
correction for four tests, assessing association with depression, with BMI and 
stratifying the tests with BMI into cases and controls). 
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In addition to the linear models as described above, genome-wide 
association analyses (GWAS) of depression and of log-BMI (in the whole 
cohort and stratified by depression status) were performed. GWAS was 
performed using the "frequentist" option in SNPTEST and probabilistic 
dosage estimates from the imputed genotypes (Marchini & Howie, 2010). 
The variables of interest (log-BMI and depression) were separately regressed 
on the covariates from the linear models, and the resulting residuals used as 
the phenotype for GWAS.  The results of GWAS were used to calculate 
genetic correlation and to estimate differences in heritability. Specifically, 
genetic correlations between the residuals for depression and for log-BMI, 
and between the residuals for log-BMI in depression cases and in controls, 
were calculated using LDScore, which also provides an estimate of 
heritability (Bulik-Sullivan, Loh, Finucane, et al, 2015). Analyses were 
performed without constraining the intercept of the LD score regression, and 
constraining the intercepts for heritability to 1 and genetic covariance to 
0.0625 (the correlation between the residuals for depression and for log-
BMI). Additional estimates of heritability were calculated from imputed 
genotypes (hard-called using the thresholds used in GWAS) using GCTA-
GREML (Lee, Yang, Goddard, et al, 2012; Yang, Lee, Goddard, et al, 2011). 
Estimates of log-BMI heritability were compared between depression cases 
and controls.  
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Sensitivity analyses were performed to assess the importance of 
antidepressant or anxiolytic use in the case group. Medications were 
classified as weight-increasing, weight-decreasing, weight-modulating (both 
increasing and decreasing) or weight-neutral (Supplementary Material). 
Additional analyses were performed by removing all cases reporting 
medication use, and by adding the different categories of medication as 
covariates in the model. 
Post-hoc power analyses were conducted in R using the pwr package. 
Cohen's f2 at 80% and 90% power, and power to detect observed effects of 
each variable of interest, was calculated for each analysis (Cohen, 1988; 
Selya, Rose, Dierker, et al, 2012). Cohen's f2 is a measure of effect size suitable 
for assessing the contribution of a single variable in a multiple regression 
(Cohen, 1992). 
The BMI PRS analyses presented in this paper mirror previous work 
performed in the Generation Scotland cohort (Clarke, Hall, Fernandez-
Pujals, et al, 2015). However, this previous analysis used an earlier meta-
analysis of BMI GWAS (Speliotes, Willer, Berndt, et al, 2010). As this GWAS 
did not list betas for each variant, the PRS produced is unweighted, differing 
from that used in this analysis. As such, there may be differences between 
the results of Clarke et al and this analysis that are attributable to the 
different PRS. To test this, the analyses in this study were repeated with the 
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older, unweighted PRS (all betas = 1), and the analyses in Generation 
Scotland were repeated using the new BMI PRS (Locke, Kahali, Berndt, et al, 
2015). Analyses in Generation Scotland were performed in 18850 individuals, 
of whom 2605 were defined as depression cases, with 16245 controls. Age, 
sex and 4 multi-dimensional scaling components were included as 
covariates. As in the UKBB cohort, the optimal PRS was identified using the 
default settings in PRSice (Euesden, Lewis & O'Reilly, 2015). 
5.3 Results 
5.3.1. Cohort characteristics 
The interim release of the genotyping data contained genotypes for 
152,734 individuals, from which 7,009 depression cases and 14,030 controls 
were available with full phenotypic data following quality control 
(Supplementary Figure 1). Imputed genotype data were available on 
8,747,914 variants following quality control. 
A higher proportion of depression cases than controls were female 
and cases tended to have higher BMI than controls. Cases were also younger 
and tended to live in more deprived areas (Table 1). All covariates were 
associated with at least one variable of interest: log(BMI), depression status 




5.3.2. Polygenic risk score analyses 
The Nyholt-Šidák method indicated that the within-trait and cross-
trait PRS analyses were largely independent (3.75 effective tests), resulting in 
an adjusted alpha threshold of p = 2.67x10-4 (Euesden, Lewis & O'Reilly, 2015; 
Nyholt, 2004). PRS were significantly associated within-trait, but not cross-
trait (Table 3). The optimal within-trait PRS (bold in Table 3) were taken 
forward for further analyses, including calculating correlations with 
covariates (Table 2). 
5.3.3. Effects on depression 
Depression and log-BMI had a small but significant positive 
correlation at the phenotype level (Table 2). In the linear and logistic 
analyses of depression, no interactions (neither the three-way interaction 
between depression status, depression PRS and BMI PRS, nor the two-way 
interactions alone or in combination) were significantly associated with 
outcome when modelled as multiplicative, nor when modelled as additive 
(Table 4). BMI PRS was not significantly associated with depression status, 





5.3.4. Effects on log-BMI 
In the analysis of log-BMI, no interactions were significantly 
associated with variance in log-BMI. Depression status and BMI PRS were 
significantly associated included together and separately (Table 5). The 
polygenic risk for depression was not significantly associated with log-BMI. 
Analyses stratified by depression case status show a nominally significant 
effect of depression PRS in controls, but this does not survive correction for 
multiple testing (Table 5).  
5.3.5. Stratified heritability and genetic correlations 
Heritability estimates for log-BMI did not differ substantially between 
depression cases (16.8%, 95% CIs: 3.56-30.1%) and controls (18.8%, 95% CIs: 
11.9-25.7%), and the genetic correlation between the two groups = 1 when 
intercepts were not constrained. Constraining the intercepts did not alter the 
results substantially (cases = 19.9%, 95% CIs: 10.8-29.0%; controls = 18.5%, 
95% CIs: 13.4-23.6). 
When the intercepts were not constrained, the genetic correlation 
between depression and log-BMI was not statistically significant (rg = 1.26%, 
95 CIs: -21.5% – 24.1%). Variance explained by common genetic variants in 
the cohort was estimated at 11.3% for depression (95 CIs: 6.03-16.5%; liability 
scale, assuming population prevalence of 12%), and at 18.4% for BMI (95 CIs: 
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13.4-23.4%; estimates from LDScore, similar estimates from GCTA not 
shown). Defining the intercepts had minimal effect on the estimation of 
heritability (depression = 13.1%, 95% CIs: 9.6-16.6%; log-BMI = 20.5%, 95% 
CIs: 16.8-24.2%), but altered the estimate of genetic correlation, although this 
did not pass statistical significance (rg = 10.7%, 95 CIs: -5.05% – 26.5%).  
5.3.6. Sensitivity analyses concerning antidepressant use 
Antidepressant or anxiolytic medication use was reported by 1368 
(19.5%) individuals with depression (some of whom were taking more than 
one drug). Analyses were performed excluding individuals using medication 
(Supplementary Tables 5, 6), and including the medication categories as 
covariates (Supplementary Tables 7). Controlling for medication use did not 
alter the conclusions from any analysis. 
5.3.7. Power 
The main analyses were powered to detect very small effects at 90% 
power (f2 = 0.000521), as were the analyses of BMI stratified by depression 
case status (f2= 0.00154 and 0.000764 in cases and controls respectively). 
Cohen suggested f2=0.02 should be considered "small" (Cohen, 1988). 
5.3.8. Replication of Clarke et al (2015) 
BMI analyses were repeated using the Speliotes GWAS as the base, 
and assuming all betas = 1 to create an unweighted risk score (Speliotes, 
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Willer, Berndt, et al, 2010). Overall, results did not differ from the main 
analysis: BMI PRS was associated with log-BMI and not with depression 
status, regardless of other additions to the null model, and no interactions 
were significant (Supplementary Tables 8 and 9). However, the interaction 
between BMI PRS and depression status predicting log-BMI was nominally 
significant with the same direction of effect as was observed in Clarke et al 
(2015). 
Additional analyses were performed in the Generation Scotland 
cohort using a weighted PRS derived from the most recent GIANT BMI 
GWAS meta-analysis (Supplementary Table 10; Locke, Kahali, Berndt, et al, 
2015). The BMI PRS was strongly associated with BMI in the cohort, but not 
with depression, and the depression PRS was associated with depression but 
not BMI. The interaction between BMI PRS and depression status remained 
significant, but had a diminished effect compared to that reported in Clarke 
et al (2015). 
5.4. Discussion 
A small but significant positive correlation was observed between 
BMI and depression status, such that individuals with depression have an 
increased BMI on average. Polygenic risk scores capture within-trait variance 
in the cohort, apparently independently of the phenotype-level relationship 
between BMI and depression. Genetic risk for increased BMI does not appear 
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to affect depression status, nor is there a significant interaction between PRS-
BMI and PRS-MDD to predict depression status or BMI. This argues that the 
mechanism of association between BMI and depression is not accounted 
substantially by the shared additive effect of common genetic variants. 
The results suggest that the association between depression and BMI 
does not result from a genetic relationship that would arise from a genetic 
correlation greater than 25% (that is, greater than the 95% confidence interval 
of the observed genetic correlation). This is concordant with the estimate of 
genetic correlation around 12% reported in the twin literature. More modest 
genetic correlations will be detectable when the full UK Biobank data are 
released.  A further caveat to this is that the genetic component studied 
herein results from an additive model of the effects of common variants 
captured by (or imputed from) genome-wide microarrays. As such, a 
relationship resulting from rare variation or non-additive scale (dominance) 
or interaction (epistatic) effects would not be captured in this study. 
Furthermore, although the PRS used in this study were generated from the 
largest relevant studies published to date, they still do not capture the full 
contribution of additive genetic effects. The absence of a sizable genetic 
component to the association between depression and BMI argues for 
increased study of non-genetic factors, including the effects of physical 
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illnesses that are correlated with both traits, as well as the environmental 
(including social) risks driving higher BMI in the context of depression.   
The effect of genomic risk on the relationship between BMI and 
depression has previously been examined in the Generation Scotland cohort, 
a similar (but largely independent) study to the UK Biobank (Clarke, Hall, 
Fernandez-Pujals, et al, 2015). The Generation Scotland study found no cross-
trait associations of PRS, in accordance with the results of this study, but 
differed in that a significant interaction between BMI polygenic profile scores 
and MDD predicting BMI was identified, with higher BMI PRS in the case 
group compared with the controls. Although the two cohorts are similar, the 
BMI PRS used in the Generation Scotland study was from a previous GIANT 
BMI meta-analysis compared to that used in this study, and the PRS 
produced was a summed risk score, not weighted by beta values (which 
were not available in the data release). Repeating the relevant analyses in the 
UK Biobank and in Generation Scotland (such that both PRS were used in 
both studies) suggests that the use of the unweighted PRS explains some, but 
not all of this disparity. No distinction was made for differing symptoms of 
depression in either this study or in Clarke et al (2015), and inter-study 
differences are likely to account for the rest of the inconsistency in results. In 
particular, depression associated with increased appetite and weight gain 
("atypical depression") might be more common in the Generation Scotland 
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cohort than in UK Biobank. If so, this could explain some of the observed 
difference between the cohorts. This is supported by a further investigation 
in an independent cohort, which dissected depression into typical and 
atypical subtypes (and more specifically low vs high appetite subtypes) and 
showed no effect of metabolic PRS (including BMI PRS) on depression status 
overall, but found an effect of BMI PRS when the atypical group was 
considered alone (Milaneschi, Lamers, Peyrot, et al, 2016).  
An important difference between the results of this analysis and those 
of Clarke et al was the use of weighted versus unweighted polygenic risk 
scores (Clarke, Hall, Fernandez-Pujals, et al, 2015). The most appropriate 
score depends on the power of the analysis. The accuracy of weighted risk 
scores can be limited if the base dataset is underpowered to detect the true 
effect sizes of variants associated with the phenotype, as is usually the case 
in psychiatric genetics. Underpowered GWAS are vulnerable to winner's 
curse (the overestimation of significant effect sizes when multiple tests are 
performed), which biases simple weighting by effect size (Vilhjálmsson, 
Yang, Finucane et al, 2015; Shi, Park, Duan, et al, 2016). More sophisticated 
weighting of variants could be performed, such as shrinking the reported 
effect size to a prior distribution reflecting the genetic architecture of the 
trait, but this may be inaccurate if the true genetic architecture differs from 
that modelled (Vilhjálmsson, Yang, Finucane et al, 2015). Assuming simple 
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weighting by effect size, unweighted scores are more robust to confounds 
like winner's curse (Dudbridge, 2013). However, as the power of the base 
dataset increases, the sampling error of the weighted score reduces to zero, 
unlike that of the unweighted score, and weighted scores become superior 
(Dudbridge, 2013). Additional complexity is added by the use of risk scores 
to perform cross-trait analyses. The weighting of the risk score is trained to 
the base phenotype, and reflects the observed distribution of effects. In 
comparison, an unweighted score would capture only which variants are 
associated, without imposing any effect size distribution on them. 
Accordingly, the precise hypothesis tested by cross-trait PRS differs if the 
score is weighted ("those at greater genetic risk of the base phenotype are 
more likely to exhibit the target phenotype") or unweighted ("the variants 
associated with the base phenotype are also associated with the target 
phenotype").  As such, the reported differences between results obtained 
with the Speliotes unweighted BMI risk score (Speliotes, Willer, Berndt, et al, 
2010) and the Locke weighted risk score (Locke, Kahali, Berndt, et al, 2015) 
reflect differences in the method used as well as the power of the base 
studies.  
This study represents an initial study on the pilot data of the UK 
Biobank, which will become an increasingly valuable resource as new data 
are added, especially when genetic data are available on the full cohort. 
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However, the breadth of the cohort results in some limitations, particularly 
in the diagnosis of depression. Although the definition of depression used 
herein has a high genetic correlation with the results of the PGC MDD meta-
analysis (0.738, 95 CIs: 0.404-1.07), suggesting external validity on a genetic 
level, the lack of a formal psychiatric diagnostic assessment makes it difficult 
to assess the clinical validity of depression as defined (Major Depressive 
Disorder Working Group of the Psychiatric, Ripke, Wray, et al, 2013). In 
addition, dissection into symptom groups was not possible, as mentioned 
above. Finally, although this represents a large cohort for study, the final 
sample size is still underpowered to detect a very small contribution to 
variance from the genetic factors (particularly in the case of depression), and 
so we cannot exclude such effects. However, future analyses in the full UK 
Biobank cohort could be informative about such effects, 
A small but significant positive correlation exists between BMI and 
depression, and this does not result from a substantial effect of shared 
common genetic variants. The effect of genetic risk for depression or for BMI 
does not appear to be influenced substantially by variance in the opposite 
trait, although this does not replicate previous findings; this disparity may 
result from unmeasured cohort-specific effects. Understanding the 
relationship between BMI and depression, and the effects of non-genetic 
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factors on these traits, may provide insight into two areas of growing 
concern for public health.    
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5.6.1. Table 1 






N 21039 10232 10807 - 7009 14030 - 
Female sex (N [%]) 10232 [48.6] - - - 4250 [60.6] 5982 [42.6] < 10-50 
Age (mean, SD) 56.9 [7.95] 56.4 [7.85] 57.4 [8.01] 2.26x10-22 55.9 [7.79] 57.4 [7.98] 7.92x10-39 
Townsend Index (mean, 
SD) 
-1.55 [2.78] -1.54 [2.75] -1.56 [2.80] 0.522 -1.19 [2.94] -1.73 [2.67] 1.31x10-37 
BMI (mean, SD) 27.5 [4.68] 27.0 [5.10] 27.9 [4.21] 3.65x10-40 27.9 [5.11] 27.3 [4.44] 8.99x10-17 
 
Table 1: Demographic variables in the full cohort, and split by gender and depression case status. Significant differences between 




5.6.2. Table 2 
Variable 
log(BMI) Depression BMI PRS Depression PRS 
r P r p r p r p 
log(BMI) - - 0.0539 4.88x10-15 0.240 < 10-50 0.0130 0.0598 
Depression 0.0539 4.89x10-15 - - 0.0103 0.137 0.0505 2.22x10-13 
BMI PRS 0.240 < 10-50 0.0103 0.137 - - 0.00172 0.803 
Depression PRS 0.0130 0.0598 0.0505 2.22x10-13 0.00172 0.803 - - 
Male gender 0.113 < 10-50 -0.170 < 10-50 0.0106 0.125 -0.00262 0.704 
Age (years) 0.0477 4.59x10-12 -0.0891 2.56x10-38 0.000138 0.984 -0.0201 0.00361 
Townsend Index 0.0871 < 10-50 0.0912 < 10-50 0.0317 4.39x10-6 0.0165 0.0167 
Centre * -0.0509 1.42x10-13 0.0365 1.18x10-7 -0.0182 0.00846 0.0468 1.14x10-11 
Birth Cluster * -0.0478 4.04x10-12 0.0207 0.00273 -0.0245 0.000379 -0.0601 2.51x10-18 
Batch * 0.0277 6.04x10-5 -0.0133 0.0542 0.0276 6.24x10-5 -0.0167 0.0155 
PC1 -0.0130 0.0595 0.000341 0.961 0.0263 0.000136 -0.0204 0.00301 
PC2 0.00109 0.874 0.00682 0.323 0.00835 0.226 0.0271 8.24x10-5 
PC3 -0.0000125 0.999 -0.00259 0.707 -0.000322 0.963 -0.00558 0.419 
PC4 0.0261 1.56x10-4 0.00398 0.564 0.00571 0.408 0.115 < 10-50 
PC5 -0.0264 1.30x10-4 -0.00281 0.684 -0.0111 0.109 -0.174 < 10-50 
PC6 -0.00604 0.381 -0.0129 0.0614 -0.00260 0.706 0.00881 0.201 
PC7 -0.00141 0.838 0.00604 0.381 -0.0112 0.106 -0.0179 0.00952 
PC8 0.00133 0.847 -0.00599 0.385 0.0310 7.09x10-6 0.0903 < 10-50 
Table 2: Pairwise univariate correlations between the variables under study. Correlations with p < 0.05 are marked in bold.  
For factors (marked with *), the most significant correlation is reported.  
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5.6.3. Table 3 
 
Table 3: Polygenic risk scoring results within and between traits. Within-trait 
analyses were significant (bold, p < 2.67x10-4), cross-trait analyses were non-
significant. Variance explained is reported on the liability scale where the 
phenotype was log-BMI. Where the phenotype is depression, pseudo-R2 
transformed to the liability scale is reported, with the untransformed 
Nagelkerke's pseudo-R2 in parentheses. 
  














Depression 0.1811 8.56x10-15 0.00310 (0.00343) 
PGC 
MDD 
log-BMI 0.0001 0.0349 0.000202 
GIANT log-BMI 0.04795 < 10-50 0.0559 
GIANT Depression 0.0055 8.67x10-4 0.000570 (0.000631) 
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5.6.4. Table 4 
Coefficient B SE p 
Null model See Supplementary Table 1 
… + depression PRS 0.112 0.0154 4.37x10-13 
… + BMI PRS 0.0161 0.0151 0.287 
… + log-BMI 0.144 0.0151 1.09x10-21 
… + depression PRS 







… + depression PRS x log-BMI 
(Multiplicative) 
-0.0287 0.0157 0.0680 
… + depression PRS x log-BMI 
(Additive) 
-0.00548 0.00332 0.0984 
… + BMI PRS  







… + BMI PRS x log-BMI 
(Multiplicative) 
0.00268 0.0150 0.858 
… + BMI PRS x log-BMI 
(Additive) 
-8.55 x10-4 0.00317 0.787 
… + depression PRS  







… + depression PRS x BMI PRS 
(Multiplicative) 
-0.0150 0.0158 0.343 
… + depression PRS x BMI PRS 
(Additive) 




 (Table 4 continued) 
 
Table 4: Effects of adding variables and interactions to the null model (effects 
shown in Supplementary Table 1) predicting variance in depression status. 
Significant (p < 0.0125) terms are in bold. Interactions include all main effects, 
covariates and covariate interaction terms (Keller, 2014). 
  
… + depression PRS  
… + BMI PRS  










… + depression PRS x BMI PRS 
(Multiplicative) 
… + depression PRS x log-BMI 
(Multiplicative) 











… + depression PRS x BMI PRS 
(Additive) 
…+ depression PRS x log-BMI 
(Additive) 











… + depression PRS x BMI PRS 
x log-BMI (Multiplicative) 
0.00795 0.0148 0.590 
… + depression PRS x BMI PRS 
x log-BMI (Additive) 
0.00142 0.00311 0.648 
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5.6.5. Table 5 
Coefficient B SE p 
Null model See Supplementary Table 2 
… + BMI PRS 0.233 0.00661 < 10-50 
… + depression PRS 0.00809 0.00691 0.242 
… + depression 0.144 0.0147 1.30x10-22 
… + BMI PRS  







… + BMI PRS x depression 0.0192 0.0143 0.182 
… + depression PRS 







… + depression PRS x depression -0.0278 0.0150 0.0642 
… + BMI PRS 







… + BMI PRS x depression PRS -4.24x10-4 0.00686 0.951 
… + BMI PRS 
… + depression PRS  










… + depression PRS x BMI PRS 
… + BMI PRS x depression 










… + depression PRS x BMI PRS x 
depression 




(Table 5 continued) 
 
Table 5: Effects of adding variables and interactions to the null model (effects 
shown in Supplementary Table 2) predicting variance in log-BMI, and 
stratified analyses of log-BMI within depression cases and controls. 
Significant (p < 0.0125) terms are in bold. Interactions include all main effects, 
covariates and covariate interaction terms. 
 
Cases 
Null model See Supplementary Table 3 
… + BMI PRS 0.238 0.0116 < 10-50 
… + depression PRS -0.0162 0.0120 0.178 
… + BMI PRS 







… + BMI PRS x depression 
PRS 
0.00217 0.0118 0.854 
Controls 
Null model See Supplementary Table 4 
… + BMI PRS 0.230 0.00807 < 10-50 
… + depression PRS 0.0171 0.00844 0.0432 
… + BMI PRS 







… + BMI PRS x depression 
PRS 
-0.00230 0.00853 0.788 
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Chapter 6: Interactions between social environment and polygenic risk 
scores for body mass index predicting variance in adolescent body mass 
index 
6.1. Introduction 
The prevalence of overweight and obesity is increasing in children 
and adolescents in developed countries, such that over 20% of individuals 
under the age of nineteen have a body mass index (BMI) > 25 (Ng, Fleming, 
Robinson, et al, 2014). High BMI in this period is associated with 
psychosocial discrimination, and with socioeconomic hardship and 
increased cardiometabolic morbidity in later life (Ebbeling, Pawlak & 
Ludwig, 2002; Gortmaker, Must, Perrin, et al, 1993; Hill & Silver, 1995; Reilly 
& Kelly, 2011; Wabitsch, 2000). Understanding the aetiology of juvenile BMI 
and of factors influencing change in BMI across adolescence could be 
informative in developing interventions, and alleviating current and future 
personal and economic costs (Lobstein, Jackson-Leach, Moodie, et al, 2015; 
Lustig, 2001). 
There is robust evidence that variation in BMI is influenced by genetic 
factors, both from studies of rare variants (such as perturbations in the leptin 
signalling pathway) and from large genome-wide association studies in 
adults and in children (Chua Jr, Chung, Wu-Peng, et al, 1996; Felix, Bradfield, 
Monnereau, et al, 2016; Llewellyn, Trzaskowski, Plomin, et al, 2013; Locke, 
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Kahali, Berndt, et al, 2015; Yang & Barouch, 2007). Evidence from both 
neuroendocrinological and statistical genetic approaches suggest brain 
expressed genes may underlie variation in BMI, potentially through 
controlling energy homoeostasis directly within the body as well as via 
behavioural processes such as eating and exercise (Finucane, Bulik-Sullivan, 
Gusev, et al, 2015; Lustig, 2001).  
The rapid increase in obesity in the last three decades argues for a role 
of environmental factors, potentially acting to mediate genetic 
predispositions (Ebbeling, Pawlak & Ludwig, 2002; Lustig, 2001). Parenting 
is one factor that can influence childhood BMI directly through diet and via 
learnt food-related behaviours in children, including dietary self-control and 
regulation of active and sedentary behaviours (Davison & Birch, 2001). 
However, excessive parental control over food intake behaviours can have a 
rebound effect when that control is relaxed, such that children over-indulge 
in previously restricted foodstuffs (Birch & Fisher, 1998; Fisher & Birch, 
1999). Much of the research on parenting style and BMI has focussed on the 
related concepts of parental control and involvement, with some evidence 
suggesting a controlled disciplinary style and positive parent-child 
interactions are associated with greater control over BMI levels in childhood 
(Hughes, Power, Orlet Fisher, et al, 2005; Shloim, Edelson, Martin et al, 2015; 
Sleddens, Gerards, Thijs, et al, 2011; Vollmer & Mobley, 2013). The presence 
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of this effect is relatively consistent across studies (although not all studies 
report a significant effect), but the approaches taken to assessing such effects, 
and the reported measures of effect, are varied and inconsistent (Shloim, 
Edelson, Martin et al, 2015; Volmer & Mobley, 2013). There are a broad range 
of measures used in the assessment of parental style (Vollmer & Mobley, 
2013), and a focus on specific relationships and populations (specifically 
maternal influences in White, Western, affluent populations; Gicevic, 
Aftosmes-Tobio, Manganello et al, 2016) that potentially limit the 
generalisability of findings in the field as a whole.  
 Parenting style represents one part of the wider influence of 
socioeconomic environment on child development (Davison & Birch, 2001). 
Broader measures, such as parental socioeconomic status (SES), may capture 
this more general influence. In the particular case of BMI, low SES has been 
associated with higher BMI, particularly in adolescents and young adults 
(Braddon, Rodgers, Wadsworth, et al, 1986; Hardy, Wadsworth & Kuh, 2000; 
Sundquist & Johansson, 1998; Wang, Kim, Gonzalez, et al, 2007). However, 
reported results vary according to gender, ethnicity and nationality, and 
there is a potential cohort effect, with null results more common in cohorts 
ascertained less recently (Blane, Hart, Smith, et al, 1996; Laitinen, Power & 
Jarvelin, 2001; Lauderdale & Rathouz, 2000; Parsons, Power & Manor, 2001; 
Power & Moynihan, 1987). 
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There is an observable difference in BMI pre-adolescence between 
females and males, due in part to the earlier onset of puberty in females, and 
there is an ongoing debate whether the genetic aetiology of pre-adolescent 
BMI is sex-specific (Nan, Guo, Warner, et al, 2012; Schousboe, Willemsen, 
Kyvik, et al, 2003). A combined analysis of twin studies examining BMI in 
pre-adolescence did not identify any difference in heritability between sexes, 
but lacked necessary data (such as opposite-sex dizygotic twin pairs) to 
make strong conclusions (Nan, Guo, Warner, et al, 2012). In contrast, a larger, 
multi-national study of young adult twin pairs found higher heritability for 
BMI in females, with results largely consistent across national studies 
(Schousboe, Willemsen, Kyvik, et al, 2003).   
Evidence that genetic and environmental influences contribute to the 
aetiology of BMI before adolescence have prompted a considerable number 
of studies exploring gene-by-environment interactions (Ahmad, Varga & 
Franks, 2013). Of these, the interaction between variation in the FTO gene 
and physical activity is the most robust, although the functional mechanism 
of this interaction remains an area of active research (Andreasen, Stender-
Petersen, Mogensen, et al, 2008; Franks, Pearson & Florez, 2013). Beyond this 
interaction, most studies have explored the effects of single variants in the 
context of many different environments (Ahmad, Varga & Franks, 2013). 
However, this approach has been limited due to small sample sizes (and 
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hence low power), inadequate sampling of variation at the genetic locus of 
interest, and a potentially incorrect hypothesis-driven approach (Dick, 
Agrawal, Keller, et al, 2015; Duncan & Keller, 2011). Recent studies have 
begun to address this criticism by using gene scores that include associated 
variants from genome-wide meta-analyses of BMI (Hung, Rivera, Craddock, 
et al, 2014; Qi, Chu, Kang, et al, 2012; Qi, Li, Chomistek, et al, 2012). This 
technique can be extended by using weighted polygenic risk scores, which 
use genome-wide genotypes to construct scores, weighting each variant 
(commonly by its effect size in genome-wide association study meta-
analyses; Purcell, Wray, Stone, et al, 2009).  
I investigated the independent and interactive effects of parental 
warmth and discipline and genetic influences on BMI pre-adolescence, and 
on the rate of change in BMI across adolescence, in a cohort of unrelated 
adolescents representative of the population of the United Kingdom (the 
Twins Early Development Study: TEDS; Haworth, Davis & Plomin, 2013; 
Krapohl, Rimfeld, Shakeshaft, et al, 2014; Llewellyn, Trzaskowski, Plomin, et 
al, 2014). The contribution of genetic factors to phenotypic variance was 
estimated using the most associated polygenic risk score from the largest 
genome-wide association study meta-analysis in BMI published to date 
(Locke, Kahali, Berndt, et al, 2015). During these analyses, it became apparent 
that SES contributes to the aetiology of BMI in a manner that overlaps with 
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the effect of parental warmth and punitive discipline. As such, secondary 
analyses were performed assessing the effect of SES in the place of parenting.  
6.2. Materials and methods 
6.2.1. Analysis sample 
Data on BMI at 11 years old, child perceptions of parental warmth and 
punitive discipline, covariates of interest (including parental socioeconomic 
status) and genome-wide genotype data was available for 3414 unrelated 
participants from TEDS. The sample was restricted to individuals self-
identifying as White Western European (Appendix V; Trzaskowski, Eley, 
Davis, et al, 2013).  
6.2.2. Genotype data  
Genome-wide genotyping data was obtained in two waves of 
genotyping, and imputed using minimac3 to the Haplotype Reference 
Consortium reference data (Appendix V; Fuchsberger, Abecasis & Hinds, 
2014; Howie, Fuchsberger, Stephens, et al, 2012; McCarthy, Das, 
Kretzschmar, et al, 2016; Trzaskowski, Eley, Davis, et al, 2013). Details on 
quality control and imputation are included in Appendix V. Following QC, 





6.2.3. Polygenic risk scoring 
Polygenic risk scores (PRS) were generated in the TEDS cohort using 
the results from the largest published meta-analysis of BMI genome-wide 
association studies (Locke, Kahali, Berndt, et al, 2015). The risk score 
capturing the most variance in BMI at 11 years old was obtained using the 
default settings in PRSice, which identifies the most predictive score by high-
resolution polygenic risk scoring (Euesden, Lewis & O'Reilly, 2015). Eight 
principal components were included in PRSice analyses to control for 
population stratification. A binary variable was also included to capture 
differences between genotyping waves.  
Alternative meta-analyses were considered for generating polygenic 
risk scores. These were the European subset of the same meta-analysis, and 
the meta-analysis of a smaller cohort of children (Felix, Bradfield, 
Monnereau, et al, 2016; Locke, Kahali, Berndt, et al, 2015). However, the 
cross-ethnic meta-analysis was selected as it was largest and expected to 
provide the most power. Sensitivity analyses were performed using the 
alternative sources, with no major differences observed (Appendix V).  
Much of the literature on the effect of gene-environment interactions 
on BMI has examined variation in the FTO gene, particularly the variants 
rs1558902 and rs9939609 (which have shown strong associations with BMI in 
different GWAS; Ahmad, Varga & Franks, 2013; Andreasen, Stender-
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Petersen, Mogensen, et al, 2008; Franks, Pearson & Florez, 2013; Frayling, 
Timpson, Weedon, et al, 2007; Locke, Kahali, Berndt, et al, 2015). To allow 
comparison with the literature, analyses were repeated with each variant in 
place of the PRS (Appendix V). 
6.2.4. Phenotype definition 
BMI was calculated from self-reported height and weight, and 
transformed using a natural logarithm to increase the normality of the 
distribution. Parenting was defined as the combined results from the child-
report sections of the shortened Parental Feelings Questionnaire (PFQ) and 
the Parental Strategies Questionnaire (PSQ), which measure parental 
warmth and quality of parental discipline respectively (Deater-Deckard, 
2000; Deater-Deckard, Dodge, Bates, et al, 1998). The PFQ consists of seven 
statements designed to assess the warmth of the parent-child relationship 
(for example, "I feel close to my Mum/Dad", answered very true / quite true / 
not true). Similarly, the PSQ contains four three-point scales assessing 
parental actions when the child misbehaved, such as "When I misbehave I 
am told off or shouted at", answered not true / quite true / very true). Both 
scales were scored such that higher scores reflected less parental warmth and 
more punitive discipline respectively. Total scores were standardised and 
summed to give an overall parenting style variable (Keers, Coleman, Lester, 
et al, 2016).   
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Covariates were included to control for the effects of age (in days) at 
assessment, sex, pubertal development and SES at birth, in addition to the 
covariates used in PRSice analyses. Pubertal development was assessed 
using the Petersen Pubertal Development Scale (PDS), which has five items 
assessing the progress of markers of puberty (Petersen, Crockett, Richards, et 
al, 1988). This includes three general questions (for example "would you say 
your growth-spurt has not yet begun / barely begun / definitely begun / completed") 
and two sex-specific questions (assessing breast development and 
menstruation in females, and hair growth and voice deepening in males). 
The overall score is a mean average of these five items.  
A composite measure of SES was derived at the birth of the 
participants based on measures of maternal and paternal qualifications and 
occupations, and maternal age at first childbirth, which were standardised 
and summed (Petrill, Pike, Tom, et al, 2004). Specifically, maternal and 
paternal qualifications at birth were scored from 1 (no qualifications) to 8 
(postgraduate qualifications), and occupations were scored from 1 
(unskilled) to 9 (managerial). Maternal age at first childbirth was encoded in 
years. Higher composite scores reflect higher SES. 
6.2.5. Statistical analysis 
Linear models were constructed in R to test the individual and 
interactive effects of parenting and genetic risk on BMI at 11. Continuous 
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variables and covariates (that is, all except sex and genotyping wave) were 
standardised to produce standardised betas. Pairwise correlations between 
variables and covariates were calculated to assess the impact of 
multicollinearity. When interactions between parenting and genetic risk 
were included in the linear model, all covariate-by-parenting and covariate-
by-genetic risk interactions were also included (Keller, 2014). 
A subset of the cohort (N = 1943) had BMI data at a later assessment 
(14 years old, 16 years old, or both). 154 individuals with BMI data at 16 had 
no age information recorded, so their age at 16 was imputed from age at 11 
in a twenty-fold multiple imputation use the mi package in R (Graham, 
Olchowski & Gilreath, 2007; Rubin, 2004; Su, Gelman, Hill, et al, 2011). BMI 
was regressed on time from initial assessment in random effects models 
(random intercepts and random slopes, one model for each random 
imputation) using the lme4 package in R (Bates, Mächler, Bolker, et al, 2014). 
The random coefficient associated with time for each individual was 
averaged across the twenty models. The average coefficient was then used as 
the phenotype in further linear models to determine the effects of genetic 
risk and parenting at 11 years old on change in BMI across adolescence, 
controlling for covariates as in the previous analysis. 
Stratified secondary analyses were performed to assess sex-specific 
effects on BMI at 11 years and on change in BMI across adolescence. Post-hoc 
164 
 
power calculations were performed using the pwr package in R to assess the 
strength of evidence provided by this study. Specifically, the minimum f2 
values that the analyses had 80% and 90% power to detect were calculated, 
and the power of the analysis to detect observed f2 values for social 
environmental variables and genetic risk were calculated (Cohen, 1988; 
Selya, Rose, Dierker, et al, 2012).  
During analysis with parental warmth and discipline, it became clear 
that SES competed with parenting to explain variance in BMI at 11. When 
SES was included as a covariate in the model, the proportion of variance 
explained by parenting was diminished compared to when SES was not 
included. Analyses were thus repeated with SES as the environmental 
variable of interest (and parenting as a covariate). In total, twelve analyses 
were performed, with three basic models (full model, female-only and male-
only) for two phenotypes (BMI at 11 and change in BMI across adolescence) 
with two environments of interest (parenting and SES). 
6.2.6. Ethics 
Parents provided informed consent for each part of the study before 






Demographic data on the full cohort and subsets are available in 
Table 1. The subset of the cohort in which change in BMI across adolescence 
was assessed was significantly older than the main cohort. Although both 
SES and pubertal development were higher in the subset, the difference was 
not significant after multiple testing (Welch two sample t-test, Bonferroni 
correction for 17 tests, p = 0.00294; Table 1a). Females were significantly more 
developed than males, reported less harsh and punitive parenting, and had 
higher BMI, although the difference in BMI was not significant in the subset 
with multiple BMI assessments (Table 1b).  
Correlations between variables included in the analyses are displayed 
in Supplementary Table 1 in Appendix V. Genotyping wave was strongly 
correlated with the first principal component (r = 0.71), and BMI at 11 was 
strongly correlated with change in BMI across adulthood (r = -0.51). 
Repeating the analyses without including genotyping wave as a covariate 
did not alter the conclusions of the study. BMI at 11 is also strongly 
correlated with the random intercepts used in the construction of the change 
phenotype (r ≈ 0.9). As such, BMI at 11 is an integral part of the change 
phenotype, and the inclusion of this covariate is required for the proper 
166 
 
interpretation of these analyses. No other strong correlations were observed 
(all r < 0.5).  
6.3.2. Polygenic risk scoring 
Polygenic risk analyses identified a score comprised of 2321 
independent variants with p≤0.0032 in the GIANT 2015 all ancestries GWAS, 
which predicted a significant proportion of variance in BMI at 11 years of 
age (p = 4.55x10-32, R2= 0.0425; Locke, Kahali, Berndt, et al, 2015). This is 
consistent with previous estimations of polygenic risk in the TEDS cohort at 
age 16 (Krapohl, Euesden, Zabaneh, et al, 2015). In cross-trait analyses, scores 
from the GIANT GWAS were not associated with parenting (best threshold = 
0.0845, NSNPS = 18336, p=0.0663, R2 = 9.89x10-4). Similar analyses with SES 
identified a significant association with the BMI polygenic score when it was 
optimised for SES (threshold = 0.0795, NSNPS = 17580, p=9.18x10-5,  
R2 = 0.00445), but not when it was optimised for BMI (threshold = 0.0032, 
NSNPS = 2321, p=0.154, R2 = 5.93x10-4). The score optimised for BMI is reported 
in all main analyses.  
6.3.3. BMI at 11 
Higher genetic risk was associated with higher BMI at 11 years old 
(Table 2). A nominally significant effect of colder and more punitive 
parenting associated with higher BMI was observed, but was not significant 
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after Bonferroni correction for twelve tests (p = 0.05/12 ≈ 0.00417). No 
interaction between risk and parenting was identified in the main analysis, 
or after stratifying by sex (Supplementary Table 2a). In secondary analyses 
with SES as the environment of interest, lower SES was associated with 
higher BMI. The effect of SES was largely independent of the effect of genetic 
risk; the inclusion of both variables in the model did not substantially alter 
the effect sizes observed when each variable was included alone. The 
interaction between SES and genetic risk was nominally significant, but did 
not survive correction for multiple testing. No sex-specific effects were 
observed (Supplementary Table 2b).  
6.3.4. Change in BMI during adolescence  
Higher genetic risk was associated with a greater increase in BMI 
(Table 3). Genetic risk was significantly associated with change in BMI in 
females but not in males (Supplementary Table 3a). However, the interaction 
between PRS and sex was not significant in the main analysis (p = 0.240). No 
interaction between genetic risk and parental warmth and discipline was 
observed. In secondary analyses with SES as the environment of interest, 
there was no significant main effect of SES. The interaction between genetic 
risk and SES was nominally significant when both sexes were analysed 
together and in females only (Supplementary Table 3b). However, neither 
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the interaction in the full analysis nor that in the female-only subset was 
significant after correction for multiple testing.  
6.3.5. Power 
Post-hoc power calculations suggested that the full sample was 
powered to detect small effects (80% power to detect Cohen's f2 = 0.00229 at 
age 11, f2 = 0.00410 for change in BMI), as were sex-stratified analyses (BMI at 
age 11: f2 = 0.00452 and f2 = 0.00475; change in BMI across adolescence: f2 = 
0.00806 and f2 = 0.00832 for females and males respectively).  
6.4. Discussion 
6.4.1. Summary of findings 
This study examined the relationship between genetic and social 
environmental effects (individually and in combination) and two BMI 
phenotypes: BMI prior to adolescence and the rate of change in BMI between 
11 and 16. Genetic effects associated with higher BMI in the largest cohort 
published to date (the 2015 GIANT consortium meta-analysis) were 
associated with higher BMI before adolescence, and with a greater increase 
in BMI across adolescence (Locke, Kahali, Berndt, et al, 2015). In contrast, 
child perceptions of parental warmth and discipline were not significantly 
associated with pre-adolescent BMI or with change in BMI across 
adolescence in this study. However, lower parental SES, as a more general 
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measure of childhood social environment, was associated with higher BMI 
pre-adolescence, but not with change in BMI. 
6.4.2. Limitations 
The measures used in this study are unlikely to capture the full 
component of variance they each represent. The PRS is limited to the effects 
of common variants on BMI in an additive model, and only to those regions 
of the genome that are captured adequately by both the GIANT BMI GWAS 
and the TEDS study genotyping (Appendix V; Locke, Kahali, Berndt, et al, 
2015). In addition, only a small proportion of the genetic component of 
variance in BMI was captured by the PRS in this study (7-14%, assuming a 
heritability of BMI of 30-60%; Polderman, Benyamin, de Leeuw, et al, 2015; 
Yang, Bakshi, Zhu, et al, 2015). Finally, these analyses used the optimal PRS 
(that is, the one explaining the most variance in BMI as a main effect). 
Multiple PRS, generated using a variety of p-value thresholds, could be used 
in PRS-by-environment interaction studies. Using the optimal PRS is an 
analytical choice akin to only examining variables with main effects in any 
interaction analysis.  
An alternative BMI PRS (specifically, one optimised to predict SES) 
was significantly associated with SES. This demonstrates both that SES can 
be predicted from genetic data, and that there is an overlap of the genetic 
influences on BMI and SES (Krapohl & Plomin, 2015). The analyses in this 
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study used the PRS optimised for BMI (which was not significantly 
associated with SES) as this best captures the overall influence of the genome 
on BMI. The modelled interaction term then examines how this genomic 
effect alters in the presence of the social environment. It would be possible to 
use the PRS optimised for SES instead. This would focus on the genetic 
overlap between the two traits; however, the interaction term would then 
examine how this shared genetic component altered in the presence of the 
environment with which it is associated. It is unclear what the implications 
of a significant interaction would be in this case.  
Height and weight were ascertained in this cohort via self-report from 
the participants, as part of a larger questionnaire booklet (Haworth, Davis & 
Plomin, 2013). Studies comparing self-reported to objectively-measured BMI 
report a general trend for height to be overestimated and weight to be 
underestimated, which consequently results in underestimates of BMI 
(Connor Gorber, Tremblay, Moher, et al, 2007). Discrepancies tend to be 
greater in females, and increase with weight and age (Connor Gorber, 
Tremblay, Moher, et al, 2007). Although this discrepancy has largely been 
observed in adults, there is also similar evidence reported in children 
(Goodman, Hinden & Khandelwal, 2000; Strauss, 1999). Therefore, although 
reported discrepancies tend to be small (the correlation with ascertained 
measures is approximately 0.8), the precision of the BMI calculation within 
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this study is likely to be impaired by the self-reported collection. Due to the 
breadth of phenotype collection in TEDS, it was not practical for all 
phenotypes to be collected via objective measurement, nor was a subsample 
measured to allow for correction of the bias. 
A central issue of gene-environment interaction studies is the 
definition of the environment (Dick, Agrawal, Keller, et al, 2015). Although 
the measures of parenting and SES used in this analysis have previously 
been used successfully to capture their respective constructs, they both differ 
from possible alternatives (Keers, Coleman, Lester, et al, 2016; Petrill, Pike, 
Tom, et al, 2004). Previous research on the effect of parenting style on BMI 
has examined parental control and involvement. The concepts of punitive 
parental discipline and parental warmth used in this analysis are similar. 
However, parental control reflects aspects of both constructive and punitive 
discipline, whereas the discipline measure used in this analysis focusses on 
punitive discipline alone. As such, the parenting style measure used in this 
analysis differs from that used elsewhere in the BMI literature. Furthermore, 
parenting behaviour is highly complex and multi-faceted, and the measure 
of parental style used herein can only approximate the overall effect of 
parenting. In part, the secondary analyses performed using SES as the 
environment of interest reflects the need to examine the broader effects of the 
social environment. However, this measure is also only one means of 
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capturing a complex construct, and different measures of the social 
environment could yield different results.  
Results from the study of change across adolescence need careful 
interpretation. The random intercepts used in the construction of the change 
phenotype are highly correlated with BMI at age 11 (r ≈ 0.9). As such, the 
inclusion of BMI at 11 as a covariate in the analysis of BMI change largely 
accounts for influences on pre-adolescent BMI. The non-significant 
association of social environment with this phenotype may thus reflect the 
continuation of effects from pre-adolescence, rather than an absence of effect 
during adolescence. 
6.4.3. Interpretation 
Genetic risk, modelled as a PRS derived from a cohort mostly 
comprising adult participants, captures a significant amount of variance both 
in BMI pre-adolescence and in change in BMI across adolescence. This 
suggests that the genetic effects on BMI are (at least partly) stable across the 
lifespan. This is consistent with findings from quantitative genetic studies, 
which suggest a sizable component of genetic influence on BMI remains 
from childhood into adulthood, and with high genetic correlations (rg = 0.73) 
reported in a meta-analysis of GWAS studies in children (Felix, Bradfield, 
Monnereau, et al, 2016; Llewellyn, Trzaskowski, Plomin, et al, 2014; 
Silventoinen & Kaprio, 2009). The TEDS cohort, as a longitudinal study, 
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could be of considerable value in testing this hypothesised stable component, 
as genetic associations with BMI would eventually be able to be tested in a 
within-subject, repeated measures design across the entire lifespan. Such 
analyses would also be able to consider a broad range of potential 
environments as covariates and confounds. In the shorter term, growing 
cohort sizes for adult and particularly for child GWAS of BMI will allow 
increased precision in the estimate of the genetic correlation. The 
development of statistical analysis techniques such as partitioned heritability 
could be extended to identify the precise regions of the genome common 
between children and adults (and, perhaps more interestingly, those that are 
distinct); such techniques could also be informative about the biology of 
these shared and distinct components (Finucane, Bulik-Sullivan, Gusev, et al, 
2015; Finucane, Reshef, Antitila, et al 2017).  
Stratified analyses did not suggest a sex-specific effect in this study. 
Although genetic risk was significantly associated with change in BMI across 
adolescence in females only, the absence of a significant genetic risk-by-sex 
interaction in the main analysis suggests this could result from measurement 
error alone. However, the demographic differences between females and 
males observed in the cohort argue that stratifying analyses by sex is 




The effect of parental warmth and discipline in this study was of 
nominal significance and did not pass correction for multiple testing. 
However, when SES is not included in the model, the effect is larger (and 
would have passed correction for multiple testing had secondary analyses 
with SES not been performed). The analyses presented have reasonable 
power. Cohen suggested f2 = 0.02 as a small effect, and all post hoc power 
calculations show all analyses within this paper had lower f2 than this 
(Cohen, 1992). As such, while we cannot exclude an effect of parental 
warmth and punitive discipline on BMI, these results suggest any such effect 
is likely to be very small.  
In contrast to the effect of parenting in this analysis, parental SES was 
associated with BMI at 11, suggesting an effect of the social environment 
from sources other than parenting style alone. Furthermore, the interaction 
between genetic influences and SES reached a nominal level of significance 
in the analysis of BMI change across adolescence, and it may be of interest to 
explore this interaction in a larger cohort. However, conclusions from the 
analysis using SES must be tempered by the fact that these are secondary 
analyses, related to the initial hypothesis (that BMI and parenting act 
together to influence BMI) but not explicitly specified.  
The components of variance captured by parenting and SES appear to 
overlap (as including one in the model diminishes the effect of the other). 
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The social environment is a complex construct that is likely to reflect and to 
be influenced by many factors in the wider environment. As such, further 
investigation to identify the precise component of the social environment 
that influences juvenile BMI would be of value.   
The increasing rate of obesity is a developing public health crisis, and 
BMI, although imperfect, is a useful proxy for overall metabolic health 
(Janssen, Katzmarzyk & Ross, 2004). An improved understanding of the 
factors affecting BMI in late childhood and adolescence could provide useful 
information in addressing this crisis. It is likely that the majority of obesity 
does not stem from single factor causes (such as mutations in the leptin 
system), but rather from the upper extreme of the normal population 
distribution of BMI (Grarup, Sandholt, Hansen, et al, 2014). TEDS is a 
population cohort, and is not enriched for juvenile obesity. However, 
studying this cohort can yield insight about the aetiology of BMI within the 
normal distribution, which may, in turn, be informative about the extremes 
of that distribution.  
The generalisability of genetic findings from a population cohort to 
the genetics of obesity relies on the assumption that the genetic factors that 
predispose individuals to extreme BMI influence variance across the BMI 
spectrum. Yet it may be that distinct genetic influences predispose to 
extremely low and extremely high BMI (Berndt, Gustafsson, Mägi et al, 
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2013). Other anthropometric traits show evidence for distinct contributions 
of (often rare or non-additive) genetic effects at the extremes. For example, 
extremely short individuals show less depletion of a polygenic risk score for 
height than would be expected from their position in the overall spectrum, 
indicating a stronger influence of rare or non-additive effects (genetic or 
otherwise) at this extreme (Chan, Holmen, Dauber et al, 2011). However, a 
reanalysis of the GIANT BMI GWAS, comparing genetic influences in the 
tails of the distribution with those in the distribution as a whole reported no 
systematic differences in the additive effects of common variants (although 
this does not preclude rare variant effects or effects acting in a non-additive 
manner; Berndt, Gustafsson, Mägi et al, 2013). This mirrors similar findings 
in young adults (Paternoster, Evans, Nohr, et al, 2011). Furthermore, the most 
recent genomic study of anorexia nervosa (which is characterised in part by 
extremely low BMI) identified negative genetic correlations with extremely 
high BMI (rg = -0.29) and with BMI in the normal range (rg = -0.25; Duncan, 
Yilmaz, Walters et al, 2016). Together, these data provide tentative evidence 
supporting a role for a shared, common, additive genetic effect across the 
range of BMI (although genetic correlations are not necessarily transitive; 
Weiner, Wigdor, Ripke et al, 2016).  
Common, additive genetic influences on BMI may differ between 
children, in whom BMI is affected both by growth and by weight changes, 
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and adults, whose height is stable. As such, using PRS derived from studies 
of BMI in adult participants may fail to capture important aspects of the 
common genetic influence on childhood BMI (the reported genetic 
correlation of 0.73 notwithstanding; Felix, Bradfield, Monnereau, et al, 2016). 
One possible solution to this is to use a combined polygenic risk score from 
multiple sources (Krapohl, Patel, Newhouse et al, Under Review). This could 
be performed in a hypothesis-driven manner, such as combining BMI and 
height scores in adults to better capture variation in children, or machine-
learning approaches could be taken to allow the most predictive score to be 
generated from a large initial set of polygenic risk scores (with appropriate 
model fitting). In both cases, it would be necessary to use statistical 
techniques robust to correlated variables (such as penalised regression), as it 
is possible that the PRS may be correlated.  
This study has shown a stable effect of genetic variants (from a meta-
analysis predominantly of adult genome-wide association studies of BMI) 
capturing variance in BMI in children entering adolescence, and also 
capturing variance in the trajectory of BMI growth across adolescence. SES is 
associated with BMI pre-adolescence, but parenting style has at most a small 
effect. The availability of powerful genome-wide meta-analyses and the 
decreasing cost of obtaining genome-wide genotype data have increased the 
potential for performing genome-by-environment interaction studies to 
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identify influential factors underlying important phenotypes in public 
health.  
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6.6.1. Table 1a 




N 3414 1943 - 
Female sex (%) 51.3 53.7 0.0881 
Age (mean, SD) 11.3 (0.695) 11.5 (0.616) 1.52x10
-27
 
SES at birth (mean, SD) 0.235 (0.961) 0.289 (0.958) 0.0474 
Pubertal development (mean, SD) 1.69 (0.554) 1.74 (0.567) 0.00310 
BMI (mean, SD) 17.8 (3.07) 17.9 (3.101) 0.188 
Parenting style (mean, SD) 0 (1.71) -0.0733 (1.70) 0.131 
Change in BMI (mean, SD) - 0.580 (0.0995) - 
 
Table 1a: Demographic data of the full cohort and subset in which change in 
BMI was studied. Age was significantly higher in the subset after multiple 
testing correction; SES and pubertal development were greater in the subset, 
but did not pass multiple testing correction (Welch two sample t-test, p = 













N 1750 1664 - 
Age (mean, SD) 11.3 (0.693) 11.2 (0.697) 0.550 
SES at birth (mean, SD)  0.232 (0.957) 0.238 (0.965) 0.862 
Pubertal development (mean, SD) 1.85 (0.589) 1.52 (0.457) 1.79x10
-72 
BMI (mean, SD) 17.9 (3.22) 17.6 (2.90) 0.00179
 
Parenting style (mean, SD) -0.152 (1.69) 0.160 (1.73) 9.87x10
-8 
Variable 
BMI Change Subset 
t-test p 
Females Males 
N 1043 900 - 
Age (mean, SD) 11.4 (0.633) 11.5 (0.584) 0.126 
SES at birth (mean, SD)  0.294 (0.947) 0.283 (0.970) 0.805 
Pubertal development (mean, SD) 1.90 (0.600) 1.56 (0.465) 1.06x10
-42
 
BMI (mean, SD) 18.0 (3.33) 17.8 (2.83) 0.206 
Parenting style (mean, SD) -0.234 (1.67) 0.113 (1.72) 7.53x10
-6 
Change in BMI (mean, SD) 0.581 (0.103) 0.580 (0.0951) 0.764 
 
Table 1b: Demographic data of the full cohort and subset in which change in 
BMI was studied, stratified by sex. Females were significantly more 
developed and reported less harsh and punitive parenting, and exhibited 
high BMI (the last of which only in the full cohort; Welch two sample t-tests, 




6.6.2. Table 2 
Coefficient B SE p Adjusted R2 
BMI at 11 years old, with parenting 
Null model Supplementary Table 2a 0.0667 
(Null model)  
+ Parental style 
0.0378 0.0167 0.0239 0.0678 
(Null model)  
+ BMI PRS 
0.210 0.0162 1.59x10-37 0.110 
(Null model)  
+ Parental style  








(Null model) + 
Parental style x 
BMI PRS  
0.00642 0.0172 0.709 0.113 
BMI at 11 years old, with SES 
Null model Supplementary Table 2b 0.0628 








Null model  
+ SES 








Null model + 
SES x BMI PRS 
-0.0336 0.0165 0.0413 0.112 
 
Table 2: Effects of adding variables and interactions to the null model 
predicting variance in BMI at 11 years old, with parental style (top) and SES 
(bottom) as the environments of interest. Significant (p<0.00417) terms are in 
bold. Interactions include all main effects, covariates and covariate 




6.6.3. Table 3 
Coefficient B SE p Adjusted R2 
BMI change, with parenting 
Null model Supplementary Table 3a 0.277 
(Null model) + 
Parental style 
-0.00848 0.0196 0.666 0.277 
(Null model)  
+ BMI PRS 
0.0902 0.0197 4.96x10-6 0.284 
(Null model) + 
Parental style  








(Null model) + 
Parental style 
x BMI PRS  
0.000551 0.0207 0.979 0.285 
BMI change, with SES 
Null model Supplementary Table 3b 0.277 
Null model  
+ SES 
0.0106 0.0196 0.591 0.277 
Null model  
+ BMI PRS 
0.0904 0.0197 4.70x10
-6 0.284 
Null model  
+ SES 








Null model + 
SES x BMI 
PRS 
-0.0494 0.0205 0.0159 0.289 
 
Table 3: Effects of adding variables and interactions to the null model 
(uppermost line) predicting variance in the linear trajectory of change in BMI 
between 11 and 16 years old, with parental style (top) and  SES (bottom) as 
the environment of interest. Significant (p<0.00417) terms are in bold. 
Interactions include all main effects, covariates and covariate interaction 




Chapter 7: Discussion 
7.1 Summary of the work 
  The work presented in this thesis seeks to demonstrate the value of 
information-rich genomic data in exploring questions about the interplay of 
genetic and environmental influences on behaviour. Within that overarching 
aim, it has explored two specific themes: employing exposed-only GWAS to 
identify biological predictors of response to CBT, and assessing genome-
environment relationships using polygenic risk scores. 
 The genetic study of response to CBT (therapygenetics) has relied 
almost entirely on the candidate gene method (Eley, Hudson, Creswell, et al, 
2012; Lester & Eley, 2013; Lueken, Zierhut, Hahn, et al, 2016). The GWAS 
described in Chapter 3 was the first in the field, and the genome-wide 
studies that follow in Chapter 4 extend these investigations to gene 
expression (along with a sister paper that investigated change in expression 
across the course of treatment; Roberts, Wong, Keers, et al, Under Review). 
Chapter 3 partially achieved its initial aim (to identify any large-effect 
common variants able to be captured using a low-coverage microarray). The 
analysis presented had sufficient power to examine large effects on response 
to CBT (4% of phenotypic variance), and the null results suggest such effects 
are unlikely to exist. However, the analysis was underpowered to detect all 
but the largest effects from common variants seen elsewhere in the 
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behavioural genetic literature. For example, the 97 loci significantly 
associated with BMI only explain 2.7% of the variance combined, and the 108 
loci significant loci in schizophrenia explain 3.4% of the variance (Locke, 
Kahali, Berndt, et al, 2015; Schizophrenia Working Group of the Psychiatric 
Genomics, 2014). Although the APOE locus accounts for approximately 5% 
of the phenotypic variance in late-onset Alzheimer's disease, this is an 
unusually large effect for a complex behavioural trait (Escott-Price, Shoai, 
Pither et al, 2017). If common variants of similar effect influence response to 
CBT, the analysis in Chapter 3 did not detect them, most likely due to a lack 
of power.  The results of Chapter 3 are concordant with a polygenic model of 
behavioural phenotypes, comprising many variants of very small individual 
effect (Chabris, Lee, Cesarini, et al, 2015; Visscher, Goddard, Derks, et al, 
2012). However, they are also concordant with the absence of a genetic 
component to CBT. The analysis did not achieve its secondary aim to 
quantify such a component, and polygenic risk scores derived from relevant 
psychiatric phenotypes were not associated with treatment outcome. 
Significant associations with individual SNPs had been previously reported 
in the candidate gene literature, some of which were tested in Chapter 3 as a 
secondary aim. The lack of effect shown by these variants calls into question 
the generalizability of these earlier findings (Lester & Eley, 2013).  
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Chapter 4 sought to increase power to detect significant predictors by 
combining two sources of information, genetic variants and measures of 
gene expression (Ritchie, Holzinger, Li, et al, 2015). Again, the analysis had 
sufficient power only to examine large effects on response to CBT, and the 
null results suggest such effects are unlikely to exist. The absence of a 
significant predictor in these results argues that no single genetic locus 
accounts for large amounts of variance in response to CBT, whether this 
quantified as the expression level of the related RNA transcript, or as a 
context-dependant eQTL. In addition, increasing power through 
dimensional reduction (specifically, grouping transcript expression levels by 
literature-driven and data-driven means) did not yield associations, and 
polygenic risk scoring between the results of Chapters 3 and 4 did not yield 
significant predictors. As such, Chapter 4 did not achieve its aims to identify 
correlates of treatment response, beyond casting doubt on the existence of 
loci of large effect.  
 Polygenic risk scores can be used as a proxy for the overall effect of 
common genetic variation on phenotypic variation (in an additive model; 
McGrath, Mortensen, Visscher, et al, 2013). This was the principal aim of 
Chapter 5, which sought to use risk scores to assess the genetic contribution 
to the complex relationship between BMI and depression, using a large 
population cohort. A significant correlation was observed, such that 
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individuals with depression had higher BMI on average, but polygenic risk 
scores were associated with BMI, and with depression, only in within-trait 
analyses. The correlation between the traits was not attenuated by 
concurrently modelling the genetic influences on either trait, neither through 
diminishing the main effects nor through the presence of a significant gene-
by-trait interaction. As such, the results of this analysis did not support the 
hypothesis that the relationship is affected by a shared common additive 
genetic component. The strength of this conclusion is limited by the small 
amounts of variance captured by the polygenic risk scores used, although 
similar estimates of the heritability of BMI in depression cases and controls 
provides further counter-evidence. The estimated genetic correlation 
between depression and BMI was also not significantly different from zero, 
yet this may be limited by the power of the study. Thus, the combined 
evidence from the study suggests that any shared common additive genetic 
component between BMI and depression is small. This suggests the 
increased BMI observed in depression cases results from another cause, of 
which many candidates exist, including shared physical comorbidities or a 
(potentially bidirectional) causal relationship, although the influence of gene-
environment correlation and rare or non-additive genetic effects cannot be 
excluded (Luppino, de Wit, Bouvy, et al, 2010).  
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The approach taken in Chapter 5 examines the relationship between 
broad measures of the overall influence of genetic and non-genetic factors. 
Polygenic scores may also be valuable in assessing the interaction of effects 
from candidate environments with those from the genome as a whole, and 
this concept was tested in Chapter 6, assessing the independent and 
combined impact of social environments and genomic risk on BMI in late 
childhood and across adolescence. Known genomic influences on BMI were 
associated with both pre-adolescent BMI and change in BMI across 
adolescence. These influences were identified from a study composed 
predominantly of adults; as such, this may suggest a stable genetic 
component to variance in BMI, although this was not tested explicitly within 
Chapter 6. The initial aim of the investigation was focussed on parental style, 
which showed only a small effect on BMI pre-adolescence (such that the 
effect was not significant after correction for multiple testing), and did not 
affect change in BMI across adolescence, nor did this effect differ 
significantly dependent on the polygenic risk score for BMI. However, the 
inclusion of measures of parental socioeconomic status in the model 
diminished the effect of parenting style. A more punitive parenting style was 
significantly correlated with lower socioeconomic status in the cohort, and as 
such the components of variance captured by these measures are not 
independent of one another, and may reflect a more general effect of the 
social environment. Repeating the analyses with socioeconomic status (as a 
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secondary analysis) identified an effect on BMI pre-adolescence. The effect of 
interactions between genomic risk and socioeconomic status on pre-
adolescent BMI and change in BMI across adolescence were of nominal 
significance, although not sufficiently strong to pass correction for multiple 
testing. Together, these argue for a general effect of social environment on 
BMI in adolescence (which may involve parental style in part, but must have 
contributions from other sources), which is smaller than the combined effect 
of the genome, and which differ only minimally in the context of the 
polygenic risk score for BMI.  Stratifying the analyses by gender, as a 
secondary aim, did not yield qualitatively different results. 
7.2 Limitations and points of debate 
 The effects of individual genetic variants on behaviour are very small, 
and (at least at the moment) the summed effects of those variants only 
explain part of the estimated heritability (Dudbridge, 2013; Wray, Yang, 
Hayes, et al, 2013). Similarly, individual environmental influences, while 
larger in effect than those of individual SNPs, are often smaller than the 
overall effect of the genome (although this is confounded by differences in 
the measurement of genetic and environmental effects; Dick, Agrawal, 
Keller, et al, 2015). The power required to estimate small effects is 
considerable, and they are vulnerable to confounding (Dudbridge, 2013). The 
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studies within this thesis attempt to address these concerns, but are each 
impaired by them to some extent. 
 Genetic research into CBT suffers considerably from a lack of 
participants (Lester & Eley, 2013; Lueken, Zierhut, Hahn, et al, 2016). 
Although the studies described in Chapters 3 and 4 are drawn from the 
largest cohorts of their type to date, they are not an exception to this. To 
estimate heritability, and to identify individual genetic variants and gene 
transcripts associated with response to psychological therapies, will require 
the recruitment of thousands of participants (Visscher, Hemani, Vinkhuyzen, 
et al, 2014). This is non-trivial in the study of psychological therapies. Using a 
prospective design in examining response to CBT is beneficial for studying 
genetics in the context of an environmental exposure, but it results in a 
considerable degree of attrition. Participants drop out of psychological 
therapy for a wide variety of reasons. Poor therapy response is a major cause 
of dropout, and this is of clear relevance to studying differential response 
(Loerinc, Meuret, Twohig, et al, 2015). Studies can be designed to allow the 
appropriate inclusion of participants who drop out (through intention-to-
treat analyses and last-observation-carried-forward), but this comes at an 
increased financial burden, which in turn limits the cohort size attainable.  
Alongside attrition, the power of therapygenetic cohorts is limited by 
heterogeneity. Psychological therapy is focussed on the needs of the 
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participant, meaning that the same therapy given to different participants 
will result in a different therapeutic experience, even when ostensibly the 
same program is delivered by the same therapist (Rice & Greenberg, 1984; 
Shirk & Saiz, 1992). Obtaining the necessary cohort size to conduct genetic 
studies is likely to require combining multiple smaller cohorts, with 
participants treated by different therapists, and experiencing a variety of 
different therapeutic regimens. Again, the studies described in Chapters 3 
and 4 are vulnerable to this limitation. However, this must be balanced 
against the generalisability of findings. The provision of psychological 
therapy is riven with heterogeneity; any predictor must be robust to that 
heterogeneity. As such, the brute force approach of overwhelming 
heterogeneity with sample size, while crude, may be the most appropriate 
approach in this instance.  
 Chapters 3 and 4 study the phenotype of “response to psychological 
therapy”. However, this is far from an objective phenotype. No gold-
standard approach to the definition of "therapy response" as a phenotype 
exists, and even the precise terms are not well-defined (Creswell & Waite, 
2016; Loerinc, Meuret, Twohig, et al, 2015). "Response" and "remission" are 
occasionally used interchangeably, but usually refer to distinct features. 
Response is often defined as a change in a given measure from baseline, but 
the exact size of the change required, and whether this is measured in 
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absolute units or as a percentage, varies (Loerinc, Meuret, Twohig, et al, 2015; 
Prien, Carpenter & Kupfer, 1991). In contrast, “remission” is usually a 
dichotomous variable meaning that the participant has passed some low 
threshold of severity. This distinction means that, depending on the 
definitions used in the study, it is often possible for an individual to respond 
but not remit or vice versa (Loerinc, Meuret, Twohig, et al, 2015). Remission 
often implies the individual no longer meet diagnostic criteria, although 
even this simple definition shows considerable heterogeneity in application, 
with the diagnosis in question ranging from the primary source of 
therapeutic concern to all possible inclusion criteria for the study (Creswell 
& Waite, 2016). Given the high comorbidity seen in individuals with anxiety 
disorders (particularly children), these different meanings of remission 
introduce heterogeneity when comparing between studies, and this is 
compounded yet further when comparing studies of response and remission 
(Creswell & Waite, 2016; Waite & Creswell, 2014). Furthermore, although 
CBT studies are based on a core framework, programs vary in length and 
may focus on different aspects of treatment (Barrett, Turner & Lowry-
Webster, 2000; Bögels, 2008; Kendall & Hedtke, 2006; Schneider, Blatter-
Meunier, Herren, et al, 2013). Again, the resulting heterogeneity hampers 
combined analysis across programs (Creswell & Waite, 2016; Haby, 
Donnelly, Corry, et al, 2006; Hudson, Keers, Roberts, et al, 2015; Loerinc, 
Meuret, Twohig, et al, 2015). 
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As a direct result of the way in which they are defined, response and 
remission are measure-dependent (Prien, Carpenter & Kupfer, 1991). Even 
within this thesis, however, the two empirical chapters studying 
psychological therapy response employ different measures of the phenotype, 
and this reflects the use of a variety of measures in studies more generally 
(Loerinc, Meuret, Twohig, et al, 2015). This variation has definable effects; 
those studies combining multiple measures of the same type report 
significantly lower response rates on average, as do intention-to-treat 
analyses compared to those limited to treatment completers only (Loerinc, 
Meuret, Twohig, et al, 2015). Combining measures using different reporters 
or measurement techniques (for example, a diagnostic scale and a 
behavioural marker) increases the validity of the outcome measure, as does 
the independent assessment of response (Loerinc, Meuret, Twohig, et al, 
2015).  
As such, convincing arguments have been made that the most 
powerful and robust method to study response is to combine multiple 
measures (preferably from different modalities) to create a single response 
variable (Loerinc, Meuret, Twohig, et al, 2015). It will be noted that this is not 
the approach taken within this thesis. Power is an important concern in 
studying psychological therapy response, and Chapters 3 and 4 used a 
continuous measure of response (rather than creating a dichotomy) for this 
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reason. However, response was encoded using a single measure in both 
cases. The combined measure of response suggested in the literature may be 
more valid as a measure of improvement following therapy. However, 
unless the set of measures that are combined to create this composite are 
used as standard across studies, the gain in power from this combination is 
arguably negated by the loss in interpretability and comparability between 
studies. If the outcome of therapygenetic studies is to be useful, it must be 
understandable outside of the context of a single study (Eley, 2014; Paulus, 
2015). This said, it is likely that the phenotype definition in Chapters 3 and 4 
is anti-conservative, resulting in better treatment outcomes than would be 
obtained using a combined measure of response or intention-to-treat 
analyses.  
 Individuals recruited to receive psychological therapy are usually 
severely unwell (hence their need for therapy). This generates a potential 
confound, namely regression to the mean (Barnett, van der Pols & Dobson, 
2005). Illness severity fluctuates over time, and individuals seeking therapy 
are more likely to be at the severe end of that fluctuation. As such, when they 
are assessed several weeks later (following the end of their therapy), they 
may be less severely ill simply because they have descended from the peak 
of their fluctuation, rather than due to the therapy. In studying the efficacy of 
therapy, this can be (and has been) countered using a matched waitlist 
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control group (Hofmann & Smits, 2008; James, James, Cowdrey, et al, 2013). 
The same approach could be taken to account for regression to the mean 
when investigating predictors of response to therapy. However, allocating 
individuals to a provably inferior treatment condition (such as a waitlist) 
would be ethically unsound, as scientific gains would come at the expense of 
prolonged distress to the participants (Emanuel & Miller, 2001). The studies 
contained in Chapters 3 and 4 are thus exposed-only studies, where all 
participants received treatment. The results must be interpreted carefully. 
The studies examined change in illness severity from the onset of a shared 
exposure to its completion (and beyond into follow-up), but this change is 
not necessarily a response to that exposure. However, a robust predictor of 
treatment response would have value regardless of its relevance to the 
underlying mechanisms. This reflects a general point concerning statistical 
modelling, namely that models are rarely “right”, but can be useful – a 
robust predictor of regression to the mean would be largely irrelevant to the 
mechanisms of therapy response, but would be of considerable value in 
clinical decision making (Box, 1976; Paulus, 2015). 
 A further consequence of the absence of a control group in Chapters 3 
and 4 is that all participants are exposed to the specific environment (CBT). 
Genetic variants (or differences in RNA transcript expression) might be 
associated with change in severity independently of the environmental 
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exposure (including variants associated with regression to the mean as 
discussed above). Accordingly, such case-only studies cannot truly 
investigate gene-environment interactions, as the environmental exposure 
does not vary between individuals (For much the same reason, such studies 
also do not examine gene-environment correlation.) A gene-environment 
interaction can be inferred by assuming that the change in severity results 
only from exposure to CBT – if this is true, then a genetic association with 
change in severity is an association with exposure, and as such represents an 
instance of gene-environment interplay. However, to demonstrate this 
robustly would require performing a parallel GWAS in an untreated control 
group and comparing the results, which has ethical impediments as 
discussed above. One possibility to address this would be to take a 
naturalistic approach. CBT is commonly over-subscribed, and so waitlists 
exist independently of the necessity for a control condition, and could be 
used for parallel genetic studies. However, there would be potential 
limitations of this approach, not least that there may be a negative "nocebo" 
effect of being placed on waitlist (Furukawa, Noma, Caldwell, et al, 2014).  
In general, genomics can overwhelm the subtlety of behavioural 
phenotypes by brute force. With enough power and robust statistical 
methods, genetic effects can be identified in spite of heterogeneity produced 
by confounders not included in the model (Manchia, Cullis, Turecki, et al, 
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2013). Response to cognitive behavioural therapy is an example of this: 
response results from factors relating not just to the recipient, but also to the 
therapist (and to the interaction between them; Ackerman & Hilsenroth, 
2003; Ilardi & Craighead, 1994; Martin, Garske & Davis, 2000). However, 
with enough power, it should be possible to identify genetic effects (which 
are recipient-based) regardless of the context of the therapist. 
 Chapter 4 studied RNA transcripts as a measure of the combined 
effect of genetic and environmental influences on response to therapy. It 
extended therapygenetic investigations a step closer to studying the 
multifactorial and highly interactive network of influences that is likely to 
underlie therapeutic response. However, there are a number of factors that 
make RNA transcripts less attractive than DNA variation as a source of 
biological predictors. Chief among these is the dynamic nature of RNA 
expression. Unlike genetic variation (which is stable across the lifespan, and 
effectively identical between tissues), RNA expression levels can show 
considerable temporal variability within an individual (Raj & van 
Oudenaarden, 2008). In addition to stochastic variability, variation in gene 
expression can result from confounds such as temperature or general health. 
Statistical noise thus has a greater effect on differences in gene expression 
than on differences in genetic variation between individuals. Gene 
expression is also spatially variable, and not all tissues will be of interest in 
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studying behavioural phenotypes. There remains controversy concerning 
which of blood, saliva and buccal cells represent the best proxy for variation 
in brain tissues (Davies, Volta, Pidsley, et al, 2012; Lowe, Gemma, Beyan, et 
al, 2013; Smith, Kilaru, Klengel, et al, 2015; Sullivan, Fan & Perou, 2006). Brain 
tissue would be preferable, but is inaccessible as a living tissue. Blood is 
inferior to brain tissue, but is feasible to use in living participants and shows 
more consistency in collection compared to buccal cells (Hansen, Simonsen, 
Nielsen, et al, 2007). Saliva provides a less invasive method of collection than 
blood and is also more consistent than buccal cells. When combined, the 
temporal and spatial variability of gene expression partly negates the 
increased power individual gene expression measures might be expected to 
show over individual genetic variants. The logistic and technical difficulties 
of collecting RNA samples are likely to limit the possible cohort size 
attainable, rendering expression studies inferior to genetic studies in this 
context.    
 The latter chapters of the thesis make use of polygenic risk scoring to 
explore genome-environment interactions. Specifically, the optimal risk score 
is used, as determined by high-resolution scoring across 10000 thresholds 
(Euesden, Lewis & O'Reilly, 2015). The use of the optimal score as a proxy 
for the genome is an analytical choice, and a range of risk scores could be 
used instead (at the cost of increasing the number of tests performed). Using 
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the optimal score is conceptually similar to the general two-stage strategy of 
only testing for interactions between variables whose main effects pass a 
given threshold for significance (Bourgon, Gentleman & Huber, 2010; Dai, 
Kooperberg, Leblanc, et al, 2012; Ege & Strachan, 2013; Kooperberg & 
Leblanc, 2008). Such filtering strategies increase power at the expense of 
neglecting potential interactions with variables that do not pass the filter 
(Domingue & Boardman, 2016). Testing for interactions using a genome-
wide risk score differs from testing for interactions using individual variants 
because all possible risk scores are correlated (as is addressed in the use of 
the empirically-derived family-wise error correction from Euesden, Lewis & 
O'Reilly, 2015). Therefore, using the optimal risk score explicitly tests the 
hypothesis that the overall genetic component of phenotypic variance 
interacts with an environmental effect, while controlling appropriately for 
multiple testing.   
 Optimisation maximises the phenotypic variance explained by the 
polygenic risk score as a main effect. Nonetheless, none of the scores used in 
this thesis captures a majority of the heritability of the relevant trait. Even 
scores generated from the GIANT BMI GWAS (over 300,000 individuals) into 
the UK Biobank (21039 individuals in Chapter 5) only captured around 5.6% 
of the variance (9-18% of the estimated 30-60% of variance accounted for by 
genetic influences; Polderman, Benyamin, de Leeuw, et al, 2015; Yang, 
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Bakshi, Zhu, et al, 2015). As such, polygenic risk scores can only be 
considered weak proxies for the effect of the genome at present. This is, to an 
extent, a temporary limitation that will be reduced by the use of larger base 
GWAS in polygenic scoring, as is demonstrated by the increase in variance 
explained by polygenic risk scores in more recent schizophrenia GWAS 
(Dudbridge, 2013; Schizophrenia Working Group of the Psychiatric 
Genomics, 2014). However, the construction of polygenic risk scores, 
particularly the accumulation of errors through summing the effects of many 
variants, may limit the amount of variance they can ever explain 
(Dudbridge, 2013; Wray, Yang, Hayes, et al, 2013). An alternative would be 
to use whole-genome regression to construct genetic best linear unbiased 
predictors (gBLUPS), which estimate the overall genomic influence on a trait 
as a random effect from a GRM (de los Campos, Vazquez, Fernando, et al, 
2013). However, this method requires individual-level genotype data for 
prediction (rather than summary statistics), which limits its generalisability 
and applicability between datasets (Moser, Lee, Hayes, et al, 2015; Speed & 
Balding, 2014).   
 The study of genetic effects in this thesis focusses on common variants 
present on (or imputable from) microarrays. Furthermore, the effect of these 
variants is modelled additively, both when considered individually in 
GWAS, and when combined in genome-environment interaction analyses. It 
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is assumed that the effects of the genome can be modelled as a single risk 
score, constructed from common variants. However, this assumption does 
not take into account the role of rare variation, nor of non-additive effects.  
There is a growing appreciation that variants across the allelic 
frequency spectrum contribute to the genetic component of variance 
(Gratten, Wray, Keller et al, 2014; Hoischen, Krumm & Eichler, 2014). Much 
of the genome-wide assessment of rare variants has come from whole exome 
sequencing studies, with the most in-depth studies in psychiatric genomics 
focussing on schizophrenia and autism (Hoischen, Krumm & Eichler, 2014). 
Current cohort sizes are not yet sufficient to make broad statements about 
the role of rare variation in behavioural disorders, but findings from these 
initial studies suggests they might contribute considerably to the genetic 
component of variance. In reference to depression specifically, it has 
required very large cohort sizes for common variant discovery to begin, and 
so it is likely that even larger cohorts will be needed to understand the 
genome-wide contribution of rare variation in this disorder. An analysis of 
the genetic component of variance in BMI suggested that rare (MAF < 0.01) 
variants able to be imputed from genome-wide microarrays capture around 
5% of variance in BMI (Yang, Bakshi, Zhu et al, 2015). Given that the same 
study estimated the heritability of BMI to be approximately 27%, and that 
around 32% of variation at rare variants couldn't be captured by imputation, 
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this rare component in BMI might capture as much as a third of the total 
heritability (Yang, Bakshi, Zhu et al, 2015). As such, it is reasonable to expect 
a sizable proportion of the genomic influence on the traits studied in this 
thesis will stem from rare variation inadequately assayed by the methods 
used herein.  
 Similarly, non-additive genetic effects may influence the traits 
examined in this thesis. For example, a meta-analysis of twin studies 
reported the average correlation between dizygotic twin pairs for recurrent 
depressive disorder was less than half that of monozygotic twin pairs, 
suggesting that the correlation between identical twins may be increased by 
non-additive genetic effects (Polderman, Benyamin, de Leeuw, et al, 2015). 
This finding is potentially confounded by the age of assessment in the 
constituent twin studies of this meta-analysis. Specifically, studies in 
children and adolescents were more likely to report dizygotic twin pair 
correlations indicative of shared environmental effects, whereas studies in 
adults were more likely to support non-additive genetic effects. All of data in 
the recurrent depressive analysis assessed by Polderman et al (2015) comes 
from adults, compared to 54% in the depressive episode analysis (the results 
of which are most consistent with a model of additive genetics alone), and 
14% in the "other anxiety disorders" analysis (which reported a pattern of 
twin correlations supporting shared environmental effects; Polderman, 
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Benyamin, de Leeuw, et al, 2015). One explanation for this may be that there 
is a stable non-additive genetic effect, which is masked in studies of children 
by the presence of shared environmental effects. As each member of a twin 
pair becomes exposed to different environments across adolescence, the 
shared effect of environment on a given trait may decline, allowing the non-
additive environmental effect to be observed. This hypothesis is difficult to 
test with the twin method, which lacks sufficient sources of variance to fit the 
full ACDE model (Neale & Cardon, 1992). However, studies of genome-wide 
gene-gene interactions are becoming increasing tractable thorough 
computational and analytical developments (Wei, Hemani & Haley, 2014). 
As such, exploring the role of non-additive genetic effects on depression 
from a genotype-level perspective may represent a valuable, if challenging, 
avenue for future research.  
 The interaction models used in chapters 5 and 6 assume that the 
interacting variables are independent. Gene-environment correlation violates 
this assumption, and could bias the results and interpretation of the 
interaction term (Dudbridge & Fletcher, 2014; Jaffee & Price, 2007; Purcell, 
2002). The effects of gene-environment interactions are likely to be small, and 
as such even correlations that do not meet significance may have an effect on 
the interaction term (Jaffee & Price, 2007). Given the relative novelty of 
polygenic-risk-by-environment interaction studies, it remains unclear to 
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what degree correlations will affect interaction terms when the genetic 
variable captures variation genome-wide. Furthermore, genetic effects from 
genome-wide association studies are heavily dependent on the estimation of 
the effect of causal variants via marker variants in linkage disequilibrium. 
This introduces a misclassification problem, whereby the true effect of a 
locus is estimated with a degree of error due to imperfect linkage 
disequilibrium between the causal variant and its markers (Dudbridge & 
Fletcher, 2014). This misclassification can lead to spurious marker-by-
environment interactions when the causal variant is associated with the 
environment of interest, even when no causal variant-by-environment 
interaction exists (Dudbridge & Fletcher, 2014). Polygenic scores are 
constructed from multiple markers, and so the misclassification problem is 
also likely to have an effect on polygenic-risk-by-environment interactions. 
As such, and despite the fact that the correlations between the interacting 
variables in both chapters were non-significant, it is possible that the effects 
of the interaction models in this thesis are confounded by gene-environment 
correlations. It would be valuable to define theoretically the underlying 
mathematics of this bias in polygenic-risk-by-environment interactions.  
 A motivating factor behind the studies presented in Chapters 5 and 6 
was the developing public health crisis caused by increasing rates of obesity. 
However, some of the negative consequences of obesity may result from 
208 
 
generally poor physical health, and the suitability of BMI as a measure of 
this phenotype is debatable. BMI is biassed by muscle mass (which is heavier 
than fat mass) and oversimplifies the complexities of human body shape 
(Nevill, Stewart, Olds, et al, 2006). Alternative phenotypes, such as waist 
circumference or fat mass may better reflect the health risk represented by 
obesity (Janssen, Katzmarzyk & Ross, 2004). Nonetheless, high BMI is 
associated with the negative health outcomes from obesity, and also with 
comorbidities such as depression (Luppino, de Wit, Bouvy, et al, 2010; 
Taylor, Ebrahim, Ben-Shlomo, et al, 2010). Given the relative ease of defining 
BMI, and the need for pragmatic measures to obtain the required cohort sizes 
for genomic studies, BMI remains a reasonable proxy for studying the 
genetics of obesity in the context of comorbidity and environmental 
influences (Taylor, Ebrahim, Ben-Shlomo, et al, 2010).   
7.3 The work in the context of the field, and future directions suggested  
Studying response to therapy represents a prospective, controllable 
approach to the exposed-only genomic method, which has been successful in 
the study of post-traumatic stress disorder (where the exposure is 
unpredictable and uncontrollable; Ashley-Koch, Garrett, Gibson, et al, 2015; 
Guffanti, Galea, Yan, et al, 2013; Logue, Baldwin, Guffanti, et al, 2013; 
Nievergelt, Maihofer, Mustapic, et al, 2015; Solovieff, Roberts, 
Ratanatharathorn, et al, 2014; Stein, Chen, Ursano, et al, 2016; Sumner, 
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Pietrzak, Aiello, et al, 2014; Wolf, Rasmusson, Mitchell, et al, 2014; Xie, 
Kranzler, Yang, et al, 2013). The use of robust statistical genetic methods in 
therapygenetics should improve the quality of evidence produced by such 
studies. This is not of abstract importance; anxiety is a considerable burden 
on the individual and society both financially and regarding quality of life, 
and can be a chronic issue from childhood into adulthood (Baxter, Vos, Scott, 
et al, 2014; Bittner, Egger, Erkanli, et al, 2007; Fineberg, Haddad, Carpenter, et 
al, 2013; Gregory, Caspi, Moffitt, et al, 2007; Remes, Brayne, van der Linde, et 
al, 2016). Improving the quality of treatment for anxiety, especially in 
childhood, would have broad and important societal and public health 
effects. 
 “Therapygenomic” studies can have practical utility in providing 
potential prognostic information for individuals undergoing psychological 
therapy, as well as value in demonstrating theoretical concepts. Perhaps the 
key example of this lies in determining the extent of the genetic component 
to response to CBT, including demonstrating that such a component exists. 
In behavioural genetics more broadly, this has been achieved using family-
based methods, particularly twin studies. However, in the case of 
psychological therapy response, such methods are limited by the availability 
of appropriate participants. Obtaining large cohorts from clinical therapy 
settings is difficult; limiting recruitment to parent-child triads or twin pairs 
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(to allow heritability to be estimated) would be sufficient to make any such 
study impractical. There would also be discordance between related 
individuals at the disorder level, as well as the treatment response level, and 
appropriately modelling this would be non-trivial (Plomin & Haworth, 2010; 
Tansey, Guipponi, Hu, et al, 2013). An alternative approach would be to give 
psychological therapy to twin pairs or family members without a target 
disorder, which could alleviate both of these limitations. However, it may 
prove difficult to demonstrate that these genetic effects generalise to therapy-
seeking individuals. Alternatively, an epidemiological approach might be 
undertaken, potentially with a genetic component. For example, electronic 
health records listing individuals receiving psychological therapy could be 
combined with either genetic data from biobanking efforts or with additional 
registers of family relationships to allow the assessment of heritability or 
familiality (which would be conflated with shared environment). However, 
there are likely to be few, if any, suitable datasets for such a study, 
controlling for confounding effects such as initial severity could be 
challenging, and the possible outcome measures would potentially be 
limited to overarching measures of quality of life such as employment status. 
Genomic data provides a potentially workable solution to identifying a 
heritable component to CBT response, via approaches such as GREML or LD 
score regression (Bulik-Sullivan, Loh, Finucane, et al, 2015; Yang, Lee, 
Goddard, et al, 2011). Although this will require cohort sizes in the 
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thousands to achieve sufficient power, it seems more achievable than the 
alternatives. 
Both investigations in Chapters 3 and 4 demonstrate that it is feasible 
to study therapygenetics using genomic methods, improving the standard of 
evidence for identifying predictors of treatment response. This is crucial to 
identifying associated variants robustly, as has been demonstrated by the 
general failure to replicate the findings of candidate gene studies in genomic 
studies, and the consistent direction of effect for associated variants across 
the component studies in large GWAS meta-analyses (Bosker, Hartman, 
Nolte, et al, 2011; Farrell, Werge, Sklar, et al, 2015; Schizophrenia Working 
Group of the Psychiatric Genomics, 2014). Adopting the genomic approach is 
not straightforward, but many earlier limitations (particularly cost) have 
been removed by technological developments across the last decade. The 
primary barriers to future genomic studies are cohort size and heterogeneity. 
The former could be addressed by the formation of an international 
collaboration of clinical studies, such as have yielded success in other areas 
of behavioural genomics. However, the heterogeneity involved in such an 
effort would be high. The development of large psychological therapy 
programs and the increasing popularity of internet-delivered therapies 
provide an interesting alternative. Such programs generally have fewer 
exclusion criteria than randomised control trials (RCTs; Clark, 2011; 
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Cromarty, Drummond, Francis, et al, 2016; Hepgul, King, Amarasinghe, et al, 
2016). Although individual studies of this type are likely to experience more 
heterogeneity than do RCTs, greater accessibility provides larger numbers, 
and as such there would be less need to combine multiple trials, resulting in 
potentially less heterogeneity overall. However, power is in part a trade-off 
between sample size and heterogeneity, and if sample sizes were sufficiently 
large, combining different types of programs could be worthwhile despite 
the increase in heterogeneity.  
The most appropriate biological substrate for studying treatment 
response remains up for debate. As argued above, gene transcripts are likely 
to be less useful than genetic variants; however, other alternatives exist. 
Epigenetic marks, particularly DNA methylation but also histone 
modifications, show some of the variability that limits the use of gene 
expression measures but are more stable over time. As such they may 
represent a useful intermediate between gene expression and genetic 
variants that is worthy of further exploration. However, the appropriate 
tissue in which to study epigenetic marks is not obvious, and would need to 
be taken into consideration when designing any future study. This is 
especially important given the relatively novelty of the field of epigenomics, 
and the likely need for thousands of samples to obtain adequate power to 
detect the effects of individual epigenetic marks.  
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Study design is the primary means to increase statistical power to 
identify real effects. However, this can also be achieved (arguably to a lesser 
extent) through analytical methods, as was attempted in Chapter 4. 
Dimensional reduction techniques aim to combine the variable-rich output of 
genomic studies in meaningful ways, and in doing so reduce the multiple 
testing load of such investigations. Data-driven or literature-driven 
clustering (such as are implemented in WGCNA or GOrilla respectively) can 
provide insight into the combined effects of high-dimensional data. 
Typically these methods are used on gene expression or DNA methylation 
data, but they could be extended to incorporate genetic variation, or even to 
incorporate both biological and environmental variables. This has clear 
implications in the context of gene-environment interplay – clusters 
featuring both environmental and biological factors may provide valuable 
targets for further study. Alternatively, dimensional reduction could be 
extended by identifying the main component of variance within clusters. For 
example, the first principal component of variance in a gene expression 
module from WGCNA could be used as an endophenotype in GWAS 
analyses. This might enable the identification of genetic influences on the 
action of a biological pathway in general, rather than focussing on the 
expression of a single gene. However, adopting any dimensional reduction 
methods requires an appreciation of the underlying statistical model. For 
example, while WGCNA has become a popular method for data-driven 
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clustering, it assumes that biological networks of interaction are best 
modelled with scale-free topology, which is disputed (Khanin & Wit, 2006; 
Stumpf, Wiuf & May, 2005).   
Attempts to increase power through dimensional reduction also 
underlie the use of polygenic risk scores in this thesis. Rather than examining 
thousands of independent variants, risk scoring allows a single proxy for the 
effect of the genome to be defined. Chapters 5 and 6 differ in the way they 
treat the environment. In Chapter 5, environmental effects are not explicitly 
modelled, but instead are reflected in the robustness of the relationship 
between BMI and depression, even when the effect of the polygenic risk 
score is taken into account. This has parallels with the manner in which 
environment is defined in quantitative genetic analyses. In contrast, Chapter 
6 explicitly defines environmental effects. Although only two environmental 
effects were defined in this study, multiple environments could be included 
in this approach, limited only by the increased burden of multiple testing. As 
such, the method used in Chapter 6 is equivalent to a GWIS with the genetic 
component collapsed into a single variable. 
The subject explored in Chapter 5 has considerable external relevance 
– both depression and being overweight contribute considerably and 
increasingly to the burden of ill health (Lim, Vos, Flaxman, et al, 2013; 
Murray, Vos, Lozano, et al, 2012; Ng, Fleming, Robinson, et al, 2014; 
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Whiteford, Degenhardt, Rehm, et al, 2013). Furthermore, understanding the 
relationship between these traits could inform treatment - there is evidence 
to suggest a differential effect of monoamine oxidase inhibitory 
antidepressants on depression depending on weight status (Liebowitz, 
Quitkin, Stewart, et al, 1988; Quitkin, Stewart, McGrath, et al, 1993). Equally, 
different approaches might be taken to manage weight in individuals with 
depression if there is a direct causal relationship between the traits than if 
they are both common outcomes from stem from an alternative cause (for 
example, both might result from a low-quality diet; Lopresti, Hood & 
Drummond, 2013; Penninx, 2016). However, Chapter 5 is far from the first 
study of this question. Aside from the decades of study of the phenotypic 
and clinical relationship between depression and BMI, there is a growing 
literature regarding the genetic component of this relationship. Chapter 5 
employs a similar method to a recent paper from the Generation Scotland 
study and includes attempts to cross-replicate findings from Generation 
Scotland and UK Biobank (Clarke, Hall, Fernandez-Pujals, et al, 2015). Chief 
among these was the presence of a significant interaction such that genetic 
influences on BMI were greater in individuals with depression than in 
controls, which was observed in Generation Scotland but not in UK Biobank. 
While this was in part due to an analytical artefact (the use of different 
polygenic risk scores), the fact that this disparity remained when the same 
approach was used in both studies suggests that the composition of the 
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depression case group differed between UK Biobank and Generation 
Scotland. The results from Chapter 5 in the context of the field thus suggest 
that studying the relationship between BMI and depression may first require 
dissection of the depression group into more homogeneous subsets. This is 
supported by other recent work, which suggested that genetic risk for 
metabolic phenotypes was associated with depression in individuals with 
atypical depression, but not in those with typical depression (Milaneschi, 
Lamers, Bot, et al, 2015; Milaneschi, Lamers, Peyrot, et al, 2016). Depression is 
far from being the only heterogeneous behavioural phenotype. The necessity 
to identify homogeneous subgroups is a major theme in behavioural 
genetics, and this extends to the study of gene-environment interplay.  
Chapter 6 demonstrates an important point concerning BMI 
development, which may be informative about behavioural development in 
general. Within the study, there are two related phenotypes, BMI at age 11 
and the slope of change between 11 and 16 (modelled linearly). The latter 
phenotype is dependent on the first, and so BMI at 11 was included as a 
covariate in the analysis of change across adolescence. As a result, the effects 
of variables of interest (in this instance, genetic risk and social environmental 
factors) before 11 years old are captured by the inclusion of BMI at 11 as a 
covariate, and so some insight into the stability of these effects can be 
gleaned from the results. In the instance of BMI, this suggested relatively 
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stable influences of parenting and SES, and a genetic influence with both 
stable and novel components (because a PRS derived from an adult sample 
shows an effect both at 11 and across adolescence, despite the inclusion of 
BMI at 11 as a variable in the latter analysis). This provides an interesting 
corroboration of traditional longitudinal modelling approaches, which also 
argue for both stable and time-specific effects of genetics on BMI (Haworth, 
Carnell, Meaburn, et al, 2008; Hjelmborg, Fagnani, Silventoinen, et al, 2008). 
7.4 Gene-environment interplay in the behavioural genomic era 
 Decades of behavioural genetic research strongly argues that both 
genetic and non-genetic influences have important roles in behaviour. 
Although specific, robust examples of gene-environment interaction are few, 
it seems unlikely that these different components act entirely independently. 
Genome-wide association studies have strengthened the study of genetic 
factors as main effects, providing multiple examples of common variants 
that influence behavioural traits. The field of gene-environment interplay is 
now beginning to catch up, and to adopt genome-wide methods. 
 Within this thesis, I have explored alternatives to genome-wide 
interaction studies (GWIS), which are the most direct way of using genomics 
to study gene-environment interplay. The potential to examine multiple 
environmental influences using GWIS is limited by power. However, it has 
become feasible to perform GWIS focussed on specific environmental 
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influences, and such studies may prove valuable in identifying interactions 
(Dunn, Wiste, Radmanesh, et al, 2016; Winkler, Justice, Graff, et al, 2015). 
Although focussing on a single environment violates the hypothesis-neutral 
ethos of genomic studies, there is a broader evidence basis for candidate 
environments than for candidate genetic variants, including the role of 
childhood maltreatment in depression and cannabis use in schizophrenia 
(Green, Young & Kavanagh, 2005; Nanni, Uher & Danese, 2012). 
 Genomic data is information-rich, and alternative approaches that use 
genomics complement the GWIS approach. Fundamentally, the aim of such 
research is to identify genetic variants or an overall genomic effect that is 
contingent on environmental context. Exposed-only GWAS achieve this aim 
directly, by using differential response to a shared environment as the 
phenotype. Cognitive behavioural therapy provides a theoretically attractive 
phenotype for pursuing such studies. The studies presented in Chapters 3 
and 4 demonstrate that genomic studies can be used to investigate genetic 
associations with response to cognitive behavioural therapy as an 
environmental exposure. The results provide an exclusionary upper 
threshold for proposed effect sizes; future studies must be designed with 
sufficient power to test the likely small effect sizes that can be inferred from 
behavioural genomic studies more generally. Much the same conclusions can 
be applied to the study of RNA transcripts in Chapter 4.  
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Using polygenic risk scores to dissect relationships between phenotypes 
allows environmental effects to be inferred by the removal of genetic effects, 
and as such gives insight into the broad effect of (additive) genetic and non-
genetic factors on that relationship. Chapter 5 demonstrated that this 
approach can be informative of the likely components of the relationship 
between depression and BMI. Such an approach will become more effective 
as polygenic risk scores capture a greater proportion of variance, and could 
be extended to incorporate alternative methods to use genotype data as a 
proxy for the overall effect of the genome (such as the summarised GBLUPs 
proposed by Speed & Balding (2014)).   
Finally, studying genetic risk-by-environment interactions allows a direct 
test of the effect of environmental context, while reducing the multiple 
testing inherent in the GWIS approach. Polygenic risk-by-environment 
interaction studies of this kind are becoming popular, and Chapter 6 adds to 
this literature. However, it also demonstrates the difficulties of combining 
the cohort sizes needed for genomic study with the precise environmental 
definitions needed to robustly assess gene-environment interplay.  
The concept of gene-environment interplay is intuitively attractive, and 
fits within the broader theory of systems biology - that is, that influences on 
biological phenotypes are not independent, but exist within a broad network 
of many interacting components. However, the evidence to date in support 
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of gene-environment interplay in behavioural phenotypes, including from 
the studies in this thesis, is underwhelming. There are few, if any, robust 
gene-by-environment interactions in the behavioural literature. The 
5HTTLPR-by-stressful life event interaction associated with depression may 
be an exception, but the variability in the environments studied, the different 
genotypic models used in such analyses, and the amount of analytical 
variability in meta-analysis of this association is sufficient to prevent a strong 
conclusion on the veracity of that association (Sharpley, Palanisamy, Glyde et 
al, 2014; Taylor & Munafo, 2016). In part, this lack of evidence reflects the 
slow movement of the field as a whole away from the candidate gene 
method, the limitations of which (focus on a small number of genes, 
tendency to use small sample sizes, vulnerability to winner's curse) have 
already been discussed in this thesis (Dick, Agrawal, Keller et al 2015). This is 
compounded further by the general difficulties that large-scale 
environmental research presents - adopting a gold-standard measure of a 
specific environment and obtaining this on sufficient participants to capture 
small genetic influences has proved a considerable challenge.  
However, some of the issues that have impaired gene-environment 
research in the past can be addressed by adopting a genome-wide approach. 
The polygenic risk score-by-environment approach, although it did not yield 
conclusive results when used in this thesis, removes the necessity to select a 
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genetic variant of interest. As the base datasets used to develop risk scores 
become larger, and risk scores begin to capture more variance, risk score-by-
environment interactions may become more meaningful. A caveat to this is 
that the current approach effectively assumes genetic homogeneity of the 
trait under study (at least in within-trait analyses), which may not be the case 
- the risk score as a whole may not interact with a given environment even if 
a subset of variants truly do. However, the growing general interest in the 
partitioning of variance components is likely to spread to PRS, and this may 
provide opportunities for extending the PRS-by-environment interaction 
paradigm to account for genetic heterogeneity in traits under study. 
A further issue that has limited candidate gene-environment interaction 
studies has been a limited appreciation of multiple testing and the low prior 
probability that a given interaction is truly associated with the outcome. 
Although it was not the focus of this thesis, the GWIS approach is now 
becoming tractable, and yielding findings (Dunn, Wiste, Radmanesh et al, 
2016). Too few GWIS studies have been done to date to know whether such 
findings will prove robust, but the general replicability of findings from 
main effects GWAS gives reason to be hopeful that single-variant genome-
wide approaches, in concert with variant-grouping methods like PRS, may 
identify gene-environment interactions (Vinkhuyzen & Wray, 2015).    
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By incorporating environmental measurements into genetic studies (and 
vice versa), it might be possible to gain important insights into the 
fundamental, and highly complex, nature of behaviour. It is unlikely that a 
single investigation will ever serve to answer a question of biological interest 
because no method is a perfect model of the underlying system, but applying 
multiple approaches can provide a richer evidence base than using a single 
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Data supplement to Coleman et al. Genome-wide association study of response to 






Unless otherwise specified, clinical trials included all primary anxiety disorder diagnoses. All 
sites made secondary anxiety disorder diagnoses where appropriate.  
 
Sydney, Australia  
Participants aged 6-18 were recruited from the Centre for Emotional Health, Macquarie 
University, Sydney. All participants completed the Cool Kids program(1), with 10-12 family 
sessions involving the parents (the majority of which were conducted in groups;  8% of the 
sample’s DNA were collected retrospectively). Variations on this treatment program include 
a subgroup from previous randomized trials who received group, individual or phone-based 
CBT sessions(2, 3); participants from a guided self-help trial with phone support for children 
in rural Australia(4); a group from a trial with additional parental anxiety management (5); 
and those recruited from an ongoing randomized trial of progressive allocation to treatment 
(Stepped Care).  
 
Reading and Oxford, UK  
Participants aged 5-18 were recruited jointly from Reading and Oxford from eight trials at 
the Berkshire Child Anxiety Clinic (University of Reading) and the Oxfordshire Primary Child 
and Adolescent Mental Health Service. Participants received treatment in three main 
themes; one focusing on children with anxious mothers; a set of trials using a parent-guided 
self-help CBT program; and an online CBT program for adolescents.  
 
The Mother and Child (MaCh) project(6). Children whose mother also had a current anxiety 
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program(7). The mothers of these children also received extra sessions focusing on their 
own anxiety and on mother-child interactions.  
Overcoming. Children were treated with a parent-guided self-help CBT program, comprised 
of the same primary components as the Cool Kids program (7, 8). This consisted of 2-4 in-
person sessions and 2-4 telephone sessions. A sub-set of this group with a primary anxiety 
disorder diagnosis of Social Phobia also received targeted Cognitive Bias Modification 
Training (CBM-I,(9)). Additionally, participants with highly anxious parents (screened using 
DASS or by meeting ADIS criteria) were randomized to groups in a trial including additional 
sessions for the parents which focused on strategies for tolerating children’s negative 
emotions. In Oxford, treatment was based on the same basic program, and delivered by 
primary health workers as part of a feasibility trial(10). 
 
BRAVE. The final treatment group completed a therapist-supported online CBT program for 
adolescents (BRAVE), consisting of 10 sessions, half with 5 additional parent sessions and 
half without parent sessions.  
 
Aarhus, Denmark  
Participants aged 7-17 years were recruited from the Department of Psychology and 
Behavioural Sciences, Aarhus University, and all anxiety disorder diagnoses were included. 
Participants received CBT using the Cool Kids manual (including the adolescent version 
where appropriate (7, 11)). Participants came from two groups; one aged 7-17, from a trial 
including treatment and waitlist conditions; and another group aged 7-12 from a trial 
comparing efficacy of traditional group-based treatment with Cool Kids versus a guided self-
help version with clinician support (bibliotherapy). In both trials only participants that 
received in-person CBT were included. 
 
Bergen, Norway  
Participants aged 5-13 were recruited from the child part of the “Assessment and Treatment 
– Anxiety in Children and Adults” study, Haukeland University Hospital, Bergen. Patients 
referred to outpatient mental health clinics in Western Norway, with a primary diagnosis of 
separation anxiety, social phobia, or generalized anxiety, received group or individual 
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treatment with the FRIENDS program (4th edition(12, 13)) in a randomized control trial 
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Bochum, Germany  
Participants aged 5-18 were recruited from the Research and Treatment Centre for Mental 
Health, Ruhr-Universität Bochum. Participants received either exposure-based CBT (8-25 
sessions, with sessions occurring at least every 2 weeks), the Coping Cat program (15), or a 
family-based  version of CBT specifically designed to target separation anxiety disorder 
(TAFF (16, 17)). Diagnoses were provided separately for parent- and child-report. The 
primary diagnosis was selected as being the most severe from either reporter. If the most 
severe disorder reported by each was of equal severity but was a different diagnosis, the 
parent-reported diagnosis was selected.  
 
Basel, Switzerland  
Participants aged 5-13 (all with a primary diagnosis of Separation Anxiety Disorder) were 
recruited from the Faculty of Psychology, University of Basel. All participants took part in a 
randomized control trial comparing a family-based version of CBT specifically designed to 
target separation anxiety disorder (TAFF (16, 17)with Coping Cat(15)). All participants 
received 16 sessions over 12 weeks.  
 
Groningen, The Netherlands  
Participants aged 8 to 17 were recruited from the Department of Child and Adolescent 
Psychiatry, University of Groningen. All participants were treated within  a randomized 
control trial of Coping Cat (Dutch version (18)) including 12 individual child sessions and 2 
parent sessions. 
 
Florida, USA  
Participants aged 7 to 16 (including all primary anxiety disorder diagnoses except PTSD) 
were recruited from the Child Anxiety and Phobia Program, Florida International University, 
Miami. All participants received 12 to 14 hour-long sessions of individual manualized CBT. 
Additionally, two conditions included parental involvement focusing on different parent 
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Cambridge, UK  
Participants aged 8-17 were recruited from the MRC Cognition and Brain Sciences Unit, 
Cambridge, UK. Participants were taking part in the ASPECTS trial, which recruited 
individuals exposed to a recent (i.e. in the previous six months) traumatic stressor (i.e. any 
event that involve the threat of death, severe injury, or threat to bodily integrity, or 
witnessing such an event). Those that developed PTSD were randomized to a 10-week 
waitlist or individual PTSD-specific CBT(19), which consisted of up to 10 sessions over a 10 
week period. Only participants that received treatment were included. 
 
Amsterdam, The Netherlands  
 Participants aged 10-14 were recruited from the Academic Treatment Centre for Parent and 
Child, University of Amsterdam UvA Minds and received either 12 weeks of CBT in individual 
sessions or 8 weeks of CBT in group sessions, according to the Dutch protocol Discussing + 
Doing = Daring(20). Diagnoses were provided separately for parent- and child-report with 
the primary diagnosis selected from these data by the trial manager. 
 
Assessment of treatment response 
At all sites, an experienced diagnostician trained the independent assessors using 
observation, feedback and supervision, and clearly specified guidelines for allocating 
diagnoses and CSRs were used. Inter-site consistency between the two largest sites, Sydney 
and Reading/Oxford (hereafter referred to as Reading), was established through initial 
training of assessors at Reading using video-recorded assessments from Sydney. In addition, 
detailed guidance provided by the Sydney site was used in assessments at Reading 
throughout the study. The principal investigator at the Aarhus site (Mikael Thastum) was 
trained in Sydney, and assessors in Aarhus received additional training from the principal 
investigator at the Florida site (Wendy Silverman). As such, treatment response for 
participants at these four sites, which comprise 85% of the sample, was assessed with a 
consistent methodology. Within-site inter-rater reliability for the primary anxiety diagnosis 
ranged from 0.72-1.00, demonstrating that inter-rater agreement was high. 
 Clinical Severity Ratings across time (and number of participants assessed) by site are 
shown in Supplementary Table 1c. Overall, mean severity decreased from pre-treatment to 
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However, the results at each follow-up assessment are dependent on which sites performed 
the assessment; therefore, this should not be considered a general trajectory of treatment 
response. Similarly, although the mean CSR at each assessment varies between sites, the 
95% confidence intervals of each mean overlap, suggesting mean CSRs do not vary 
significantly. The follow-up phenotype presented in this paper is imputed from this 
information, as described in the main text.  
 
Non-genetic influences on treatment outcome 
A diagnosis of specific phobia was associated with poorer response (percentage change in 
CSR score over time) and non-remission (CSR>4) at post-treatment, and a diagnosis of social 
phobia was associated with poorer outcome on both measures at post-treatment and at 
follow-up (both compared to a diagnosis of generalized anxiety disorder). Comorbid mood 
and externalizing disorders predicted poorer outcomes at both time-points, and parental 
psychopathology (self-reported anxious and depressive symptoms) interacted with time 
since treatment, showing little effect post-treatment but associated with poorer response at 
follow-up. For further information, see (21). 
 
Sample preparation 
DNA concentration was quantified before genotyping by fluorometry using PicoGreen 
(Invitrogen). Samples below 50ng/ul were concentrated using ultrafiltration and re-
suspension. 3600ng of each sample (usually as 300ul at 12ng/ul, although this was adjusted 
as sample characteristics dictated) was dispensed using a customized Beckman FX robot, 
and then pipetted via a manual multichannel pipette into a 96-well filtration plate, which 
captured DNA fragments above 500bp (Multiwell 96-well PCR clean-up plate, Millipore). 
Samples were filtered under 750mBar of pressure until wells were dry. Following filtration, 
samples were re-suspended in 40ul of Tris-EDTA buffer with vigorous shaking, and DNA 
concentration re-quantified using spectroscopy (Nanodrop). Samples with concentration 
above 50ng/ul continued to genotyping on the Illumina Human Core Exome-12v1.0 
microarray, which assays approximately 250 000 common SNPs and 250 000 exomic SNPs 
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Quality control 
In addition to recalling of rare variants with ZCall, recalling was also performed in Opticall 
(22). The two methods were concordant for 99.78% of cases.  
 
Quality control post-recalling was performed in PLINK (23) and PLINK2 (24), with reference 
to previously published protocols (25, 26). SNPs were excluded if the frequency of the minor 
allele was <5%, or if the frequencies of both alleles were out of Hardy-Weinberg 
equilibrium, with a threshold of p<10-5. Samples and SNPs were excluded if call rate was 
<99%. Samples were excluded if phenotypic gender was inconsistent with X-chromosome 
homozygosity (F-statistic), if genome-wide heterozygosity was >3 standard deviations from 
the sample mean, if more than 18.75% of variants were shared by descent (pi-hat) between 
two samples, or if the average pi-hat of the sample differed from the mean by >6 standard 
deviations (Supplementary Figure 1). Reported sample gender was compared with X 
chromosome heterozygosity calculated from genotypes. Male samples are expected to be 
homozygous for X chromosome SNPs, while females are expected to be heterozygous – the 
standard PLINK thresholds of >0.8 and <0.2 respectively were used as guidance. Two 
samples were just outside these thresholds, but were retained as their phenotypic gender 
matched that suggested by the genotypes. 
 
Principal component analysis (PCA) was performed in EIGENSTRAT (27, 28) on the dataset, 
pruned for linkage disequilibrium (25). Specifically, SNPs were compared pairwise in 
windows of 1500 SNPs, and one of each pair removed if R2 > 0.2, and the procedure 
repeated after a shift of 150 SNPs (23). Initially, PCA was performed with the intention of 
using principal components to control for population stratification within the dataset. 
However, the use of quantitative phenotypes from which site differences had been 
regressed, combined with the fact that participants were recruited from across the globe, 
prevented the use of principal components for this purpose. The top 100 principal 
components were not associated with either phenotype beyond a level expected by chance. 
However, the principal components capture the different ethnicities in the sample, 
confirming participant self-reported ancestry. The majority (92.4%) of the sample are of 
White Western European descent (Supplementary Figure 2a, 2b; Supplementary Table 1). 
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genome-wide data provided a better alternative to control for background genetic similarity 
between individuals (29).  
 
Association analyses were performed on phenotypes indicative of sample quality (sample 
concentration at entry into genotyping, and whether the sample was collected as a buccal 
swab or as saliva) as a quality control step. QQ plots were generated using R (script adapted 
from M. Weale, available at http://sites.google.com/site/mikeweale) and lambda-median 
values calculated to assess inflation. SNPs showing a lower p-value than expected under the 
null (those below thresholds p<0.01 and p<0.001, respectively) for either sample quality 
phenotype were excluded from the final analysis. 
 
Statistical analysis 
GWAS was performed using mixed linear model association analysis (MLMA), which derives 
a genomic relationship matrix (GRM) from genome-wide genotype data, and uses it to 
model the overall genetic contribution to phenotypic correlation between participants as a 
random effect. The mlma-loco option in GCTA was used to perform a leave-one-
chromosome-out marker-excluded analysis on the autosomes, in which the GRM was 
produced excluding variants on the same chromosome at the SNP being tested. This 
prevents any effect of the variant of interest being partly captured by the GRM (which 
would reduce the measured effect of the variant). X-chromosome SNPs were assessed using 
the mlma option and a GRM produced from all autosomes. The X chromosome results were 
then merged with the autosomal data. 
 
The ability of the GWAS to replicate previous findings was explored. Variants previously 
implicated in CBT response in mood disorders were examined, as well as further variants in 
HTR2A that have been linked to anxiety disorders more generally (see Table 2). Fourteen 
SNPs were identified, of which nine passed quality control in the GWAS, none of which was 
nominally associated with either phenotype (all p>0.05). Other variants, such as VNTRs in 
SLC6A4 (STin2) and MAOA cannot be captured by GWAS. This is also true of the SLC6A4 
5HTTLPR, which was explored elsewhere (30). In addition to individual assessment, the 
effect of the SNPs as a set in a linear regression in PLINK was examined. This regression used 
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for further confounds. The effect of the set was not significant (p=1). However, population 
stratification was not controlled for in this analysis, as it is not currently possible to include a 
set-based test in the MLMA-GWAS, so it is possible the results of the set-based test were 
population-confounded. 
 
The GRM produced in the main analysis from all autosomes was used to perform univariate 
genomic-relatedness-matrix restricted maximum likelihood (GREML) estimation. GREML 
estimates the heritability captured by the SNPs investigated within the study; this is a 
fraction of the total heritability in the phenotype, as genotyping will not capture the full 
effect of variants in imperfect linkage disequilibrium with genotyped SNPs (31). GREML was 
performed with iterative inclusion of zero to twenty principal components. 
 
Polygenic risk score profiling (implemented in PRSice (32)) was used to investigate the 
predictive power of the dataset. For each dataset, SNP positions were converted to hg19 
where necessary and SNPs not present in the GxT GWAS discarded. The remaining SNPs 
were clumped by the top p-value using PLINK, such that no SNP that remained was in 
linkage disequilibrium (r2>0.1, distance <250kb) with a more significant SNP (33). Risk 
profiles were created in PLINK, using SNPs with external GWAS p ranging from 0.0001 to 0.5, 
in increments of 0.00005. Risk was weighted by multiplying risk allele number by beta or 
log(OR), depending on the dataset. The proportion of variance (adjusted R2) was calculated 
from a linear regression of score on outcome for each p-value threshold. 
 
Leave-one-out polygenic risk score profile analyses was performed to test prediction within 
the dataset. In separate analyses, participants with GAD, separation anxiety disorder, social 
phobia and specific phobias were secondarily excluded from the data, and MLMA analysis 
performed on the remaining participants. Profile scores were calculated using the method 
described above, and the resulting profiles used to predict response in the excluded 
individuals. The same technique was also used to predict response in participants from 
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Table DS1(a) Demographic details for the 980 participants included in the follow-up GWAS  
 
Site N % Female 
Mean Age  
(95% CI) 
White Western European ancestry (N, 
%) 
Reading 229 55.02 9.57 (6.02-13.12) 208 (91%) 
Sydney 467 53.10 9.42 (5.56-13.28) 435 (93%) 
Oxford 14 57.14 9.21 (6.37-12.06) 14 (100%) 
Florida 25 48.00 9.24 (4.95-13.53) 13 (52%) 
Aarhus 96 59.38 11.12 (5.98-16.27) 93 (97%) 
Amsterdam 3 0.00 12.67 (9.61-15.72) 3 (100%) 
Groningen 25 56.00 11.64 (5.62-17.66) 24 (96%) 
Bochum 37 56.76 11.22 (5.72-16.72) 34 (92%) 
Basel 38 52.63 8.42 (4.19-12.65) 38 (100%) 
Bergen 36 61.11 11.44 (7.38-15.51) 35 (97%) 
Cambridge 10 70.00 13.4 (8.79-18.01) 10 (100%) 
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Treatment Primary Anxiety Diagnosis 
Individual CBT Group CBT Guided Self-Help SAD Social Phobia Specific Phobia GAD Other Anxiety Disorder 
Reading 103 0 126 57 48 40 67 17 
Sydney 24 382 61 64 92 31 247 33 
Oxford 0 0 14 5 6 1 1 1 
Florida 25 0 0 9 5 3 6 2 
Aarhus 1 95 0 25 13 16 27 15 
Amsterdam 1 2 0 1 1 1 0 0 
Groningen 25 0 0 5 11 3 4 2 
Bochum 37 0 0 9 11 13 3 0 
Basel 38 0 0 38 0 0 0 1 
Bergen 20 16 0 11 16 0 9 0 
Cambridge 10 0 0 0 0 0 0 10 
Total 284 495 201 224 203 108 364 81 
266 
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Severity by assessment 
Pre Post 3 months Six months 12 months 
Mean N Mean N Mean N Mean N Mean N 
Reading 5.64 (4.07-7.21) 229 2.69 (-2.05-7.44) 227 - - 1.90 (-2.65-6.45) 143 2.11 (-2.70-6.91) 76 
Sydney 6.33 (4.57-8.09) 467 3.21 (-0.33-6.75) 432 2.85 (-1.54-7.25) 41 2.78 (-0.63-6.19) 324 2.76 (-1.29-6.81) 46 
Oxford 5.64 (3.79-7.50) 14 2.36 (-2.64-7.36) 14 - - 0.00 (0.00-0.00) 2 - - 
Florida 6.84 (4.34-9.34) 25 2.72 (-0.84-6.27) 25 - - - - 5.50 (2.04-8.96) 4 
Aarhus 6.45 (3.97-8.93) 96 2.71 (-2.64-8.06) 96 1.97 (-3.19-7.14) 92 - - 1.40 (1.07-1.72) 7 
Amsterdam 5.00 (3.00-7.00) 3 5.00 (-3.72-13.72) 3 - - - - - - 
Groningen 6.24 (4.48-8.00) 25 2.75 (-0.37-5.87) 25 0.43 (-2.51-3.38) 23 - - - - 
Bochum 6.86 (4.65-9.08) 37 2.00 (-2.40-6.40) 34 1.63 (1.33-1.93) 17 1.57 (-2.63-5.78) 14 1.52 (1.23-1.81) 21 
Basel 5.92 (4.42-7.42) 38 2.18 (-0.37-4.73) 38 - - - - 4.67 (2.36-6.98) 3 
Bergen 6.81 (4.42-9.19) 36 4.80 (0.25-9.35) 35 - - - - 3.58 (-1.50-8.65) 33 
Cambridge 6.40 (4.05-8.75) 10 2.24 (-0.41-4.89) 10 - - - - - - 
Total 6.20 (4.20-8.20) 980 2.96 (-1.28-7.20) 939 1.94 (-2.72-6.61) 173 2.47 (-1.43-6.37) 483 2.54 (-1.98-7.07) 190 
 267 
 
Addendum: Discussion of inter-site variability in response to CBT 
As can be seen in Table DS1(c), although a general pattern of response to 
CBT can be observed (decreasing across treatment, and then roughly plateauing 
across follow-up, as described under "Assessment of treatment response" 
above), there is considerable inter-site variability. There are multiple potential 
reasons why this variability may exist, as there are a number of differences 
between sites. The type of treatment delivered, and the specific anxiety disorder 
of the participants varied between sites (Table DS1(b)). Although all sites used 
manualised forms of CBT, therapy was delivered by site-specific therapists, 
confounding therapist-specific influences with site. The number of participants 
varied considerably between sites, and as such the average severity at smaller 
sites is likely to be more affected by participants who responded particularly 
well or poorly (Table DS1(c)). Within the GWAS analysis contained in Chapter 
3, variables for treatment type, disorder, and trial (which is nested within site) 
were included as covariates in order to mitigate against this variability in 
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Table DS2 Clumps with association p-value < 1x10-4 in the GWAS, extending Tables 1 and 2 
 
a)    Independent clumps associated with CBT response post-treatment with p<1x10-4 
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b)    Independent clumps associated with CBT response at six-month follow-up with p<1x10-4 































































































































3.44x10-5 0.426 Genotyped MSX2 
rs9472259 6 44291641- 3.50x10-5 0.327 0.989 SLC29A1, 
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4.83x10-5 0.278 0.994 - 












5.27x10-5 0.439 Genotyped SGCG, SACS 












6.03x10-5 0.00980 0.828 ENPP1, CTGF 
rs7784698 7 98253847- 6.17x10-5 0.0608 0.993 NPTX2 
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Table DS3 Clumps with association p-value < 1x10-4 in the GWAS limited to 
White Western European individuals 
a) Independent clumps associated with CBT response at post-treatment  with p <10-4 
Sentinel SNP CHR Clump BP 
Sentinel SNP Genes +/- 


















6.40x10-6 0.122 0.936 - 
rs16823934 3 115335684 8.38x10-6 0.24 Genotyped GAP43 

























2.16x10-5 0.0519 Genotyped CRADD 











































































5.90x10-5 0.289 0.943 - 












7.14x10-5 0.0202 0.930 - 
rs4939881 18 47161733 7.56x10-5 0.413 0.985 LIPG 







7.81x10-5 0.386 0.993 - 






rs4591151 16 72354029 8.54x10-5 0.0112 0.858 - 




8.72x10-5 0.00730 0.855 - 
rs141980060 2 128737920 8.86x10-5 0.0118 0.834 
AMMECR1L  
SAP130 




9.61x10-5 0.119 0.964 - 
rs727675 14 31733642 9.65x10-5 0.424 Genotyped 
HECTD1 
HEATR5A 
rs9882669 3 127578497 9.75x10-5 0.174 0.982 
MGLL 
KBTBD12 





b) Independent clumps associated with CBT response at follow-up  with p <10-4 
Sentinel 
SNP 
CHR Clump BP 
Sentinel SNP 
Genes +/- 100kb 

































































































3.51x10-5 0.0587 0.971 - 












4.96x10-5 0.0828 Genotyped 
TMEM131 
VWA3B 
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Fig. DS2(b) Samples projected on the first two principal components derived from the 
HapMap3 samples, showing that the majority cluster in a White Western European group 
(red box), with admixed samples descending down to East Asian ancestry (right), and to 






Appendix III: Supplementary information from Chapter 4: Separate and 
combined effects of genetic variants and pre-treatment whole blood gene 
expression on response to exposure-based cognitive behavioural therapy for 
anxiety disorders. 
III.I Supplementary Methods 
III.I.I. Construction of the co-expression matrix in WGCNA 
Data-driven clustering of co-expressed probes was performed using an 
automatically-constructed signed network from the blockwiseModules function in 
WGCNA. An unsigned topological overlap matrix and a signed network were 
specified to obtain expression modules with a shared direction of effect within 
the modules. The adjacency function for the network used a soft thresholding 
power of 13, obtained from the network topology analysis function 
(pickSoftThreshold), which identifies the lowest power at which the fit of the 
network to scale-free topology has R2>0.9. A dendrogram of probe relationships 
was constructed using average linkage hierarchical clustering, and modules 
defined via a dynamic hybrid tree cutting approach (Langfelder and Horvath 
2008). The cutting threshold for module definition was set to 0.25 and a 
minimum module size of 30 was specified. Genes were assigned to modules 
according to the significance of their correlation with the module eigengene 
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(that is, pamRespectsDendro=FALSE and reassignThreshold=0). All other 
arguments to the blockwiseModules function were set as default (Langfelder and 
Horvath 2008). 
III.I.II. Enrichment analysis in GOrilla 
GOrilla identifies enrichment in ranked lists of genes by calculating a minimum 
hypergeometric score. The ranked list is split into a target set (the first x genes) 
and the background set (the entire list). This is performed iteratively, adding 
each gene into the target set until all genes are included. The enrichment score is 
calculated from the optimal target set, using a hypergeometric distribution, 
correcting for the multiple thresholding involved in the method (Eden et al 
2009). GOrilla reports false discovery rate q-values; however, the distribution of 
p-values resulting from these analyses was skewed and could not be controlled 
appropriately using false discovery rate. Accordingly, significance was set as 
the Bonferroni correction for the 8746 GO terms tested (p=5.72x10-6). 
Addendum to III.I.II Up-regulated and down-regulated genes 
Following the publication of chapter 4, it was suggested that ranking by signed 
effect size (in this case, Pearson's r) may be more powerful for assessing gene-set 
enrichment than ranking by p-value. Although I am unconvinced of the 
evidence for increased power from this method (at least in the case of 
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continuous data), it does allow for additional exploration of gene set 
enrichment. Accordingly, the GOrilla analyses in Chapter 4 were re-run, 
ranking by Pearson's r, and calculating scores from the top of the list to the 
bottom (capturing up-regulated genes; Supplementary Table 5b) and bottom-to-
top (capturing down-regulated genes; Supplementary Table 5c). As the Gene 
Ontology database had been updated since the original analyses, GOrilla 
analyses ranking by p-value were also re-run (Supplementary Table 5a, which 
differs from the published Supplementary Table 5).  
Performing these analyses allows dissection of the reported gene set findings - 
for example, the enrichment of genes involved in apoptosis signalling in the 
post-treatment analyses appears to be driven more specifically by the up-
regulation of cysteine-type endopeptidase activity. New gene sets are also 
implicated, including a trend towards the down-regulation of histone 
acetylation in post-treatment. However, it should be noted that (with one 
exception), the findings of the up-regulated and down-regulated gene set 
enrichment analyses are only nominally significant (as were the original 
analyses), and that the increased number of enriched gene sets is partly a 
function of the increased number of tests performed. The most striking 
difference between the two methods of assessing gene set enrichment is that the 
up-regulation of immune system process genes was significantly associated 
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with response at follow-up, even taking into account the number of tests 
performed. This gene set was originally nominally associated with response at 
follow-up, although this effect was diminished when the analyses ranking by p-
value were re-run. Although this is interesting, conclusions concerning this 
association should be cautious, particularly given the extensive roles played by 
the immune system, and the broad, exploratory nature of the analyses in 
Chapter 4.  
III.I.III. GWAS and polygenic risk scoring analyses 
No individual genetic variants were identified with genome-wide significance 
(Supplementary Table 3). This was expected, and is in line with a previous 
GWAS of CBT response (Coleman et al 2016). This cohort was too small to 
provide the necessary power to detect the anticipated small effect sizes of 
individual genetic variants underlying treatment response to psychiatric 
disorders. Associations of potential biological interest were identified near 
ADCY2 and GDNF. The rs17826816 variant in adenylate cyclase 2 (ADCY2) has 
previously been implicated in a large GWAS of bipolar disorder (Muhleisen et al 
2014). Glial cell-line derived neurotrophic factor (GDNF) is a signalling 
molecule, expressed in the cerebellum and involved in the promotion of 
dopamine uptake (Lin et al 1993).  Although both of these regions are plausibly 
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involved in psychiatric phenotypes, the small sample size and lack of genome-
wide significance means these associations with treatment response could be 
the result of chance alone. More broadly, this is supported by the lack of 
concordance between these results and those from our previous GWAS of CBT 
response (see below). 
The purpose of including genetic data in this analysis was twofold: to enrich 
expression analyses (as discussed in the main text), and to enable polygenic risk 
score analysis between this cohort and our previous study of CBT response in 
children (Supplementary Table 4a; Coleman et al 2016). However, results from 
our previous study did not significantly predict variance in treatment response 
in this analysis. There are a number of potential explanations for this. Power 
estimation in polygenic risk scoring relies on a large number of variables, and 
accordingly power estimates in this analysis should be treated with caution. 
Assuming an underlying true heritability of response to CBT of 30%, perfect 
genetic correlation between the two samples, a highly polygenic model in which 
95% of variants have an effect, and an alpha threshold of 0.001, estimates using 
polygenescore in R suggests the follow-up results from the child study have 
~5% power to predict response at follow-up in the adult study (the most 
predictive estimate in this analysis; Dudbridge 2013; Palla and Dudbridge 2015). 
Therefore, we can conclude that this analysis was underpowered in general. In 
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addition, the two analyses are dissimilar. The participants in this paper were 
adults, recruited from Germany, entirely of White Western European ancestry, 
and undergoing treatment for panic disorder and specific phobias. The 
treatment featured a considerable element of exposure, and the treatment 
response phenotype was derived from the Clinical Global Impressions severity 
scale. In comparison, the children in the previous analysis were recruited from 
across the globe, mostly not German (although predominantly were of White 
Western European ancestry), and were undergoing treatment for a range of 
anxiety disorders, very few of which were panic disorder (and it is likely that 
the specific phobias the children were treated for differed considerably from 
those for which the adults were treated). Treatments were not primarily 
exposure-based, and the response phenotype was derived from the Anxiety 
Disorders Interview Schedule (Silverman and Albano 1996). Consequently, 
there are a variety of differences between the two groups which may explain the 
lack of prediction. We cannot exclude the possibility that no genetic component 
to CBT response exists; however, there are sufficient alternative reasons for the 
observed lack of concordance (and the absence of a genetic component would 




To reduce the difference between the two groups compared using polygenic 
risk scoring, a within-cohort analysis was undertaken, using the results from the 
dental treatment group to predict response in all other groups (Supplementary 
Table 4b). The results here, while non-significant, are superficially more 
promising, explaining a higher proportion of variance and being less likely to 
have occurred by chance. However, it would be wrong to conclude anything 
substantial from these results – the analysis is very likely to be underpowered 
due to the small sample sizes, and the optimisation provided by the PRSice 
method results in the best prediction being reported. This combination is likely 
to result in false positives, despite the rigorous correction for multiple testing 
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III.III. Supplementary Tables 
III.III.I Supplementary Table 1 
Comorbidity WC DA SP PD-CBT PD-EXP 
N 72 46 8 9 9 
Panic disorder with agoraphobia 7 6 1 0 0 
Panic disorder without agoraphobia 5 4 1 0 0 
Agoraphobia without panic disorder 5 5 0 0 0 
Specific phobia 30 13 7 5 5 
Social anxiety disorder 13 6 0 3 4 
Generalised anxiety disorder 1 1 0 0 0 
Major depressive disorder 13 6 1 1 5 
Post-traumatic stress disorder 3 3 0 0 0 
Substance abuse 7 7 0 0 0 
Hypochondriasis 5 2 0 2 1 
Personality disorder NOS 3 3 0 0 0 
Bulimia nervosa 2 2 0 0 0 
Somatisation disorder 1 1 0 0 0 
Mild intellectual disability 1 1 0 0 0 
Insomnia 1 0 0 1 0 
 
Supplementary Table 1: Comorbidities in the whole cohort, and by treatment 
group. Some individuals had multiple mental comorbidities, so individual 




III.III.II. Supplementary Table 2 
Response post-treatment Improved No Change Deteriorated Test Stat p 
N 165 16 4 - - - 
Age in years (Mean [SD]) 38.9 [11.5] 38.9 [9.65] 43.3 [13.6] ANOVA 0.284 0.753 
Gender (N male [%]) 61 [37.0] 4 [25.0] 1 [25.0] Fisher's exact test 0.646 
Baseline CGI severity (Mean [SD]) 4.74 [1.11] 4.50 [1.37] 3.75 [0.500] ANOVA 1.78 0.172 
Treatment duration in days (Mean [SD]) 198 [181] 157 [190] 284 [229] ANOVA 0.836 0.435 
Follow-up duration in days (Mean [SD]) 213 [57.5] 235 [65.4] 262 [173] ANOVA 1.62 0.202 
Psychoactive medication at baseline (N taking [%]) 15 [9.09] 4 [25.0] 1 [25.0] Fisher's exact test 0.0742 
Mental disorder comorbidities (N [%]) 61 [37.0] 8 [50.0] 2 [50.0] Fisher's exact test 0.547 
Response at follow-up Improved No Change Deteriorated Test Stat P 
N 101 11 10 - - - 
Age in years (Mean [SD]) 39.1 [12.1] 39.3 [12.7] 39.7 [13.2] ANOVA 0.00977 0.990 
Gender (N male [%]) 35 [34.7] 4 [36.4] 2 [20.0] Fisher's exact test 0.748 
Baseline CGI severity (Mean [SD]) 4.69 [1.00] 4.36 [1.29] 3.80 [0.422] ANOVA 3.99 0.0211 * 
Treatment duration in days (Mean [SD]) 225 [186] 273 [244] 141 [130] ANOVA 1.34 0.265 
Follow-up duration in days (Mean [SD]) 212 [50.6] 204 [57.1] 232 [115] ANOVA 0.681 0.508 
Psychoactive medication at baseline (N taking [%]) 7 [6.93] 1 [9.09] 3 [30.0] Fisher's exact test 0.0446 
Mental disorder comorbidities (N [%]) 34 [33.7] 3 [27.3] 8 [80.0] Fisher's exact test 0.0144 † 
Supplementary Table 2: Demographic information on the whole cohort, split by response to treatment group.  
Post-hoc t-tests (variances assumed unequal; Bonferroni-corrected threshold p = 0.0125; significant differences in bold): 
* Deteriorated lower: vs improved: t=-5.37, p=2.44x10-5, vs no change: t=-1.37, p=0.194  




III.III.III. Supplementary Table 3 
a) Independent clumps associated with CBT response at post-treatment with p<5x10-6 
Sentinel 
SNP 
A1 CHR Clump BP 
Sentinel SNP   Genes +/- 
100kb Z p MAF Info 





 0.0225 0.927 POM121L12 
rs17826816 G 5 




 0.262 0.996 ADCY2 

















b) Independent clumps associated with CBT response at six-month follow-up with p<5x10-6 
Sentinel 
SNP 
A1 CHR Clump BP 
Sentinel SNP   Genes +/- 
100kb Z p MAF Info 





 0.103 0.973 - 





 0.164 Gen. GDNF 





 0.374 0.992 THBS2 












Supplementary Table 3: Variants with p<5x10-6 in the GWAS from pre-
treatment to a) post-treatment and b) follow-up. Variants in linkage 
disequilibrium (r2 > 0.25) with a more associated variant are not shown. 
Negative Z scores indicate worse response with each effect allele (A1).  
Gen. = Genotyped SNP  
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III.III.IV. Supplementary Tables 4a and 4b 
a) Polygenic risk scores child GWAS -> Whole cohort 
Base: Child CBT Target: Adult CBT Best threshold p-value  Variance explained (R
2
) 
Baseline – Post-treatment Baseline – Post-treatment 0.10445 0.329 0.00536 
Baseline – Follow-up Baseline – Post-treatment 0.0021 0.221 0.00848 
Baseline – Post-treatment Baseline – Follow-up 0.0315 0.123 0.0199 
Baseline – Follow-up Baseline – Follow-up 0.0012 0.0372 0.0364 
Supplementary Table 4a: Variance explained by the most predictive polygenic risk scores from a GWAS of CBT response in 
children predicting response in the whole cohort (Chapter 3). No threshold passes the recommended α  =  0.001 for a single test 
(Euesden et al 2015). 
b) Polygenic risk scores DA <-> other treatment groups 
Base: SP + PD-CBT + PD-EXP Target: DA Best threshold p-value  Variance explained (R
2
) 
Baseline – Post-treatment Baseline – Post-treatment 9x10-4 0.0458 0.0427 
Baseline – Post-treatment Baseline – Follow-up 0.06545 0.263 0.0240 
Baseline – Follow-up Baseline – Post-treatment 0.01155 0.0408 0.0447 
Baseline – Follow-up Baseline – Follow-up 1.5x10-4 0.258 0.0246 
Base: DA Target: SP + PD-CBT + PD-EXP Best threshold p-value  Variance explained (R
2
) 
Baseline – Post-treatment Baseline – Post-treatment 0.18425 0.0523 0.0436 
Baseline – Post-treatment Baseline – Follow-up 0.01475 0.0219 0.0770 
Baseline – Follow-up Baseline – Post-treatment 0.01425 0.0266 0.0565 
Baseline – Follow-up Baseline – Follow-up 0.0196 0.0764 0.0468 
Supplementary Table 4b: Variance explained by the most predictive polygenic risk scores between the DA group and all others. No 
threshold passes the recommended α  =  0.001 for a single test (Euesden et al 2015).
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III.III.V. Supplementary Table 5a 
GO Term Description p Enrichment # Genes 
GO Process terms nominally associated with treatment response baseline-post-
treatment 
GO:2001233 




 6.69 9/34 
GO:0009966 










 2652 1/1 
GO:0072044 collecting duct development 4.22x10
-4
 68 2/39 
GO:1903902 




 11.84 5/35 







 2652 1/1 
GO Process terms nominally associated with treatment response baseline-follow-up 
GO:0010715 




 156 2/17 
GO:0043966 histone H3 acetylation 7.93x10
-5
 25.38 4/38 
GO:0002376 immune system process 8.13x10
-5
 1.26 215/743 
GO:0050920 regulation of chemotaxis 8.54x10
-5 
2.37 19/851 
GO:0048678 response to axon injury 1.17x10
-4
 52 3/17 
GO:0006915 
apoptotic process involved in 
patterning of blood vessels 
1.71x10
-4
 106.08 2/25 
GO:0006955 immune response 2.49x10
-4
 1.77 48/312 
GO:0050921 response to wounding 2.51x10
-4
 21.83 4/18 
GO:0007166 










 15.98 3/166 
GO Function terms nominally associated with treatment response baseline-follow-up 
GO:0045295 gamma-catenin binding 1.71x10
-4 
106.08 2/25 
GO:0019899 enzyme binding 3.76x10
-4






 1.90 37/523 
Supplementary Table 5a: Gene ontology terms with p<5x10-4 in either 
analysis. Final column (b/n) shows the optimal number of top genes from the 
ranking (n) to maximise the enrichment of genes from the pathway (b). * A 
single gene (FDFT1) gene set - all GO terms referring to this gene set are 




Supplementary Table 5b 
GO Term Description p Enrichment # Genes 
GO Process terms nominally associated with treatment response baseline-post-
treatment considering up-regulated genes 
GO:2001267 
regulation of cysteine-type 
endopeptidase activity 




 44.33 3/30 
GO:1903306 
negative regulation of 
regulated secretory pathway  
4.51x10
-4
 21.45 3/93 
GO:0033003 




 10.44 5/91 
GO Process terms nominally associated with treatment response baseline-post-
treatment considering down-regulated genes 
GO:0035065 




 3.32 10/729 
GO:0036498 
IRE1-mediated unfolded 
protein response  
1.79x10
-4






 2660 1/1 
GO Function terms nominally associated with treatment response baseline-












 2660 1/1 
GO Component terms nominally associated with treatment response baseline-





Supplementary Table 5b: Gene ontology terms with p<5x10-4 in the post-
treatment analysis, assessing up-regulated and down-regulated genes 
separately. * A single gene (FDFT1) gene set - all GO terms referring to this 
gene set are collapsed into these exemplars.   
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Supplementary Table 5c 
GO Term Description p Enrichment # Genes 
GO Process terms nominally associated with treatment response baseline-
follow-up considering up-regulated genes 
GO:0002376 immune system process 1.47x10
-7
 1.47 153/456 
GO:0002252 immune effector process 1.39x10
-5
 1.57 90/456 
GO:0048583 




 1.21 298/908 
GO:0006887 exocytosis 2.34x10
-5






 2.92 19/481 
GO:0048678 response to axon injury 3.54x10
-5
 73.89 3/12 
GO:0006818 hydrogen transport 4.69x10
-5
 2.70 21/481 
GO:0009966 




 1.24 226/908 
GO:0006952 defence response 9.35x10
-5
 1.65 65/435 
GO:0051258 protein polymerisation 1.02x10
-4
 3.32 12/601 
GO:0044763 




 1.16 298/457 
GO:0051340 




 66.5 2/40 
GO:0006935 chemotaxis 4.88x10
-4






 4.47 8/397 
GO Function terms nominally associated with treatment response baseline-
follow-up considering up-regulated genes 
GO:0005507 copper ion binding 2.90x10
-4







 2.69 17/481 
GO Component terms nominally associated with treatment response baseline-













 2.33 22/545 
GO:0044425 membrane part 3.49x10
-4




GO Process terms nominally associated with treatment response baseline-
follow-up considering down-regulated genes 
GO:0090304 










 32.44 3/82 
GO:1901360 










 152 2/5 
GO:0006396 RNA processing 3.38x10
-4
 1.46 86/737 
GO:0008543 





 18.67 4/30 
GO:0006413 translational initiation 4.59x10
-4
 1.90 32/711 
GO Function terms nominally associated with treatment response baseline-
follow-up considering down-regulated genes 
GO:0003676 nucleic acid binding 5.71x10
-5
 1.24 243/711 
GO:0003723 RNA binding 8.19x10
-5
 1.32 163/711 
 
Supplementary Table 5c: Gene ontology terms with p<5x10-4 in the follow-up 
analysis, assessing up-regulated and down-regulated genes separately.   
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III.III.VI. Supplementary Table 6 
 
Removed for space concerns – available at 
http://www.tandfonline.com/doi/suppl/10.1080/15622975.2016.1208841?scroll=top  
 
Supplementary Table 6: Linkage-independent blood eQTLs with q<0.05.  
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III.IV. Supplementary Figures 
III.IV.I. Supplementary Figure 1 (Post-treatment) 
 
Supplementary Figure 1a: Manhattan plot of associations between treatment 
response baseline to post-treatment and genetic variants. X-axis shows 
position of genetic variants by chromosome. Y-axis is –log p-value, with top 
line showing the threshold for genome-wide significance (p = 5x10-8), and 







Supplementary Figure 1b: Quantile-quantile plot of associations between 
treatment response baseline to post-treatment and genetic variants. X-axis 
shows log p-value distribution expected under the null hypothesis. Y-axis 
shows observed log p-values. Lambda median is a measure of genomic 
inflation. Lambda ≈ 1, indicating minimal inflation due to confounds. 
Observed p-values do not deviate from the distribution expected under the 
null hypothesis.  
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III.IV.II. Supplementary Figure 2 (Follow-up) 
 
Supplementary Figure 2a: Manhattan plot of associations between treatment 















Supplementary Figure 2b: Quantile-quantile plot of associations between 
treatment response baseline to follow-up and genetic variants.  
Note that this plot includes all assayed variants (that is, variants in high 
linkage disequilibrium are retained), in order to assess the distribution of the 
observed results. 106 variants on chromosome 4 are in very high linkage 
disequilibrium and have an association p-value of 5.37x10-6. Accordingly, 
they appear as a single point in the Manhattan plot (Supplementary Figure 
2a), but form a kink in this QQ plot.  
Compare Supplementary Figure 2c below, which removes variants in high 








Supplementary Figure 2c: Supplementary Figure 2b replotted after removing 
all variants in very high linkage disequilibrium with a more strongly 






Appendix IV: Supplementary information from Chapter 5: The 
relationship between depression and body mass index in the UK Biobank, 
and the contribution of polygenic risk 
IV.I Supplementary Notes 
IV.I.I. Antidepressant use 
Medication was classified into weight-increasing (amitriptyline, paroxetine, 
mirtazapine, clomipramine, nortriptyline and imipramine; N = 409), weight-
decreasing (fluoxetine and venlafaxine; N = 348), weight-modulating 
(citalopram, sertraline, trazodone, duloxetine and fluvoxamine; N = 489) and 
weight-neutral (dosulepin/dothiepin, escitalopram, lofepramine, 
trimipramine, reboxetine, flupentixol/flupenthixol, doxepin, 
tranylcypromine, tryptophan, hypericum, buspirone, chlordiazepoxide, 
diazepam, lorazepam and nitrazepam; N=229). Drugs were assigned a 
weight effect if such was reported as frequent (or more common) in the 
SIDER drug side-effects database (with confirmation by searching the 
associated warning literature; Kuhn, Letunic, Jensen, et al, 2016). If a drug 
was not present in the database, assessment was made by a PubMed 
literature search for "drug AND (weight AND (gain OR loss))" and 




IV.I.II. BMI PRS 
The BMI PRS in this study was derived from the all ancestries analyses from 
the GIANT BMI consortium (Locke, Kahali, Berndt, et al, 2015). This 
consortium also published analyses in a European-only cohort (Locke, 
Kahali, Berndt, et al, 2015). The analyses in this paper were repeated using 
this European-only PRS, with no effect on the conclusions drawn.  
 
IV.II. Supplementary References 
Kuhn, M., Letunic, I., Jensen, L. J., et al (2016) The SIDER database of drugs and side 
effects. Nucleic Acids Res, 44, D1075-1079. 
Locke, A. E., Kahali, B., Berndt, S. I., et al (2015) Genetic studies of body mass index yield 






IV.III. Supplementary Tables 
IV.III.I. Supplementary Table 1 
Coefficient B SE p 
Male gender -0.364 0.0152 <10-50 
Age (years) -0.158 0.0151 8.55x10-26 
Townsend Index 0.189 0.0152 1.73x10-35 
Centre * 1.86 1.25 0.137 
Birth Cluster * 0.386 0.112 5.53x10-4 
Batch * 0.279 0.122 0.0221 
PC1 0.00121 0.0156 0.938 
PC2 0.0127 0.0152 0.403 
PC3 0.00308 0.0157 0.845 
PC4 0.00266 0.0208 0.898 
PC5 -0.00806 0.0211 0.702 
PC6 -0.0279 0.0157 0.0746 
PC7 0.0158 0.0161 0.326 
PC8 -0.0283 0.0177 0.110 
 
Supplementary Table 1: Effects of covariates in the null model predicting 




IV.III.II. Supplementary Table 2 
Coefficient B SE p 
Male gender 0.106 0.00682 <10-50 
Age (years) 0.0477 0.00686 3.73x10-12 
Townsend Index 0.0954 0.00700 3.70x10-42 
Centre * 0.634 0.212 0.00283 
Birth Cluster * 0.144 0.0515 0.00525 
Batch * 0.206 0.0557 2.13x10-4 
PC1 -0.00426 0.00706 0.546 
PC2 1.52x10-4 0.00687 0.982 
PC3 0.00869 0.00712 0.222 
PC4 0.00814 0.00940 0.387 
PC5 -0.0197 0.00953 0.0385 
PC6 -0.00540 0.00706 0.444 
PC7 -0.00585 0.00726 0.326 
PC8 -0.00312 0.00793 0.110 
 
Supplementary Table 2: Effects of covariates in the null model predicting 





IV.III.III. Supplementary Table 3 
Coefficient B SE p 
Male gender 0.0711 0.0119 2.38x10-9 
Age (years) 0.0395 0.0120 9.83x10-4 
Townsend Index 0.0919 0.0122 6.46x10-14 
Centre * 0.775 0.339 0.0222 
Birth Cluster * 0.155 0.0948 0.103 
Batch * 0.320 0.0983 0.00113 
PC1 -0.0159 0.0123 0.196 
PC2 -0.00850 0.0120 0.479 
PC3 0.00656 0.0125 0.599 
PC4 0.0119 0.0165 0.471 
PC5 -0.0273 0.0167 0.103 
PC6 -6.66x10-5 0.0123 0.996 
PC7 -0.0146 0.0126 0.246 
PC8 0.00182 0.0139 0.896 
 
Supplementary Table 3: Effects of covariates in the null model predicting 





IV.III.IV. Supplementary Table 4 
Coefficient B SE p 
Male gender 0.141 0.00833 <10-50 
Age (years) 0.0596 0.00835 9.81x10-13 
Townsend Index 0.0868 0.00853 3.21x10-24 
Centre * 0.618 0.258 0.0164 
Birth Cluster * 0.123 0.0593 0.0381 
Batch * 0.151 0.0684 0.0271 
PC1 0.00263 0.00861 0.760 
PC2 0.00464 0.00838 0.580 
PC3 0.00978 0.00866 0.259 
PC4 0.00449 0.0115 0.695 
PC5 -0.0153 0.0116 0.189 
PC6 -0.00688 0.00862 0.425 
PC7 -0.00212 0.00889 0.811 
PC8 -0.00411 0.00968 0.671 
 
Supplementary Table 4: Effects of covariates in the null model predicting 





IV.III.V. Supplementary Table 5 
Coefficient B SE p 
Null model See Supplementary Table 1 
… + depression PRS 0.108 0.0165 5.32x10-11 
… + BMI PRS 0.0137 0.0162 0.395 
… + log-BMI 0.104 0.0161 9.28x10-11 
… + depression PRS  







… + depression PRS x log-BMI (Multiplicative) -0.0202 0.0167 0.227 
… + depression PRS x log-BMI (Additive) -0.00349 0.00331 0.292 
… + BMI PRS 







… + BMI PRS x log-BMI (Multiplicative) 9.82x10-4 0.0160 0.951 
… + BMI PRS x log-BMI (Additive) 5.44x10-4 0.00318 0.864 
… + depression PRS 







… + depression PRS x BMI PRS (Multiplicative) -0.0155 0.0170 0.362 
… + depression PRS x BMI PRS (Additive) 0.00271 0.00330 0.412 
… + depression PRS 
… + BMI PRS  










… + depression PRS x BMI PRS (Multiplicative) 
… + depression PRS x log-BMI (Multiplicative) 










… + depression PRS x BMI PRS (Additive) 
… + depression PRS x log-BMI (Additive) 










… + depression PRS x BMI PRS x log-BMI 
(Multiplicative) 
0.00628 0.0157 0.689 
… + depression PRS x BMI PRS x log-BMI 
(Additive) 
0.00101 0.00310 0.746 
Supplementary Table 5: Effects of adding variables and interactions to the 
null model predicting variance in depression status, excluding individuals 
on medication. Significant (p < 0.0125) terms are in bold. Interactions include 
all main effects, covariates and covariate interaction terms. 
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IV.III.VI. Supplementary Table 6 
Coefficient B SE p 
Null model See Supplementary Table 2 
… + BMI PRS 0.232 0.00684 < 10-50 
… + depression PRS 0.0115 0.00715 0.107 
… + depression 0.105 0.0158 3.41x10-11 
… + BMI PRS  







… + BMI PRS x depression 0.00147 0.0154 0.339 
… + depression PRS 







… + depression PRS x depression -0.0200 0.0161 0.215 
… + BMI PRS 







… + BMI PRS x depression PRS -3.09x10-4 0.00710 0.965 
… + BMI PRS 
… + depression PRS  










… + depression PRS x BMI PRS 
… + BMI PRS x depression 










… + depression PRS x BMI PRS x depression 0.00907 0.0151 0.548 
Cases 
Null model See Supplementary Table 3 
… + BMI PRS 0.238 0.0129 < 10-50 
… + depression PRS -0.00830 0.0135 0.538 
… + BMI PRS 







… + BMI PRS x depression PRS -3.41x10-4 0.0133 0.979 
Supplementary Table 6: Effects of adding variables and interactions to the 
null model predicting variance in log-BMI (in the whole sample and 
depression cases only), excluding individuals on medication. Significant (p < 
0.0125) terms are in bold. Interactions include all main effects, covariates and 
covariate interaction terms. 
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IV.III.VII. Supplementary Table 7 
Coefficient B SE p 
Null model See Supplementary Table 2 
…+ weight increaser 
… + weight decreaser 
… + weight modulator 













… + BMI PRS 0.232 0.00660 < 10-50 
… + depression PRS 0.00659 0.00690 0.340 
… + depression 0.105 0.0157 1.75x10-11 
… + BMI PRS  







… + BMI PRS x depression 0.0153 0.0153 0.317 
… + depression PRS 







… + depression PRS x depression -0.0218 0.0160 0.171 
… + BMI PRS 







… + BMI PRS x depression PRS -2.43x10-4 0.00684 0.972 
… + BMI PRS 
… + depression PRS  










… + depression PRS x BMI PRS 
… + BMI PRS x depression 














(Supplementary Table 7 continued) 
 
Supplementary Table 7: Effects of adding variables and interactions to the 
null model predicting variance in log-BMI (in the whole sample and 
stratified by depression status), adding covariates for medication status. 
Significant (p < 0.0125) terms are in bold. Interactions include all main 




Null model See Supplementary Table 3 
…+ weight increaser 
… + weight decreaser 
… + weight modulator 













… + BMI PRS 0.238 0.0115 < 10-50 
… + depression PRS -0.0169 0.0120 0.159 
… + BMI PRS 







… + BMI PRS x depression PRS 0.00273 0.0118 0.817 
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IV.III.VIII. Supplementary Table 8 
 
Supplementary Table 8: Effects of adding variables and interactions to the 
null model (effects shown in Supplementary Table 2) predicting variance in 
depression status, with the BMI PRS from Speliotes et al (2010). Significant (p 
< 0.05) terms are in bold. Interactions include all main effects, covariates and 
covariate interaction terms. 
Coefficient B SE p 
Null model See Supplementary Table 1 
… + BMI PRS (Speliotes) 0.00642 0.0151 0.670 
… + BMI PRS (Speliotes) 







… + BMI PRS (Speliotes) x log-BMI 
(Multiplicative) 
0.0141 0.0153 0.357 
… + BMI PRS (Speliotes) x log-BMI (Additive) 0.00316 0.00324 0.330 
… + depression PRS  







… + depression PRS x BMI PRS (Speliotes) 
(Multiplicative) 
-0.00596 0.0155 0.700 
… + depression PRS x BMI PRS (Speliotes) 
(Additive) 
-0.00142 0.00323 0.661 
… + depression PRS  
… + BMI PRS (Speliotes) 










… + depression PRS x BMI PRS (Speliotes) 
(Multiplicative) 
… + depression PRS x log-BMI (Multiplicative) 











… + depression PRS x BMI PRS (Speliotes) 
(Additive) 
…+ depression PRS x log-BMI (Additive) 










… + depression PRS x BMI PRS (Speliotes) x log-
BMI (Multiplicative) 
-0.00556 0.0152 0.714 
… + depression PRS x BMI PRS (Speliotes) x log-
BMI (Additive) 
-0.00118 0.00320 0.712 
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IV.III.IX. Supplementary Table 9 
Supplementary Table 9: Effects of adding variables and interactions to the null 
model predicting variance in log-BMI, with the BMI PRS from Speliotes et al (2010), 
and stratifying by depression case status. Significant (p < 0.0125) terms are in bold. 
Interactions include all main effects, covariates and covariate interaction terms. 
Coefficient B SE p 
Null model See Supplementary Table 2 
… + BMI PRS (Speliotes) 0.188 0.00668 < 10-50 
… + BMI PRS (Speliotes) 







… + BMI PRS x depression 0.0280 0.0145 0.0542 
… + BMI PRS (Speliotes) 







… + BMI PRS x depression PRS -0.00762 0.00678 0.261 
… + BMI PRS (Speliotes) 
… + depression PRS  










… + depression PRS x BMI PRS (Speliotes) 
… + BMI PRS (Speliotes)x depression 










… + depression PRS x BMI PRS (Speliotes) x 
depression 
-0.00628 0.0141 0.657 
Cases 
Null model See Supplementary Table 3 
… + BMI PRS (Speliotes) 0.200 0.0116 < 10-50 
… + BMI PRS (Speliotes) 







… + BMI PRS x depression PRS -0.0101 0.0117 0.389 
Controls 
Null model See Supplementary Table 4 
… + BMI PRS (Speliotes) 0.182 0.00816 < 10-50 
… + BMI PRS (Speliotes) 







… + BMI PRS (Speliotes) x depression PRS -0.0613 0.00841 0.466 
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IV.III.X. Supplementary Table 10 
Coefficient B SE p 
Depression 
BMI PRS 0.005 0.003 0.062 
Depression PRS 0.01 0.003 1.01 x 10-5 
log-BMI 
BMI PRS 0.26 0.007 < 10-50 
Depression PRS 0.01 0.008 0.072 
BMI PRS x depression 0.046 0.019 0.016 
log-BMI in depression cases 
BMI PRS 0.31 0.02 1.84 x 10-49 
log-BMI in depression controls 
BMI PRS 0.25 0.008 < 10-50 
 
Supplementary Table 10: Analyses from the Generation Scotland cohort, 
using the BMI PRS derived from Locke et al (2015). For the BMI PRS x 
depression interaction, MDD and covariate-by-PRS and covariate-by-
depression interactions were included (not shown).
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IV.IV. Supplementary Figures 
IV.IV.I. Supplementary Figure 1 
 
Supplementary Figure 1: Sample exclusions during quality control 
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Appendix V: Supplementary information from Chapter 6: Interactions 
between social environment and polygenic risk scores for body mass 
index predicting variance in adolescent body mass index 
V.I Supplementary Methods 
V.I.I Genotyping protocol and quality control (as described in Selzam, 
Krapohl, von Stumm, et al, 2016) 
Genome-wide genotype data was obtained in two waves of collection. In the 
first wave, DNA from 3,665 samples was extracted from buccal cheek swabs 
and genotyped at Affymetrix, Santa Clara, California, USA. Samples were 
successfully hybridised to Affymetrix Gene Chip 6.0 SNP genotyping arrays 
using experimental protocols recommended by the manufacturer 
(Affymetrix Inc., Santa Clara, CA). The raw image data from the arrays were 
normalised and preprocessed at the Wellcome Trust Sanger Institute, 
Hinxton, UK for genotyping as part of the Wellcome Trust Case Control 
Consortium 2 (https://www.wtccc.org.uk/ccc2/) according to the 
manufacturer’s guidelines 
(http://www.affymetrix.com/support/downloads/manuals/genomewidesnp6




In the second wave, DNA for 4,649 individuals was extracted from saliva 
samples and hybridised to HumanOmniExpressExome-8v1.2 genotyping 
arrays at the Institute of Psychiatry, Psychology and Neuroscience Genomics 
& Biomarker Core Facility. The raw image data from the array were 
normalised, preprocessed, and filtered in GenomeStudio following internal 
protocols 
(http://confluence.brc.iop.kcl.ac.uk:8090/display/PUB/Production+Version%3
A+Illumina+Exome+Chip+SOP+v1.4). Prior to genotype calling, 869 multi-
mapping SNPs and 353 samples with call rate <.95 were removed. ZCall was 
used to augment the genotype calling for samples and SNPs that passed the 
initial QC (Goldstein, Crenshaw, Carey, et al, 2012).  
After initial quality control and genotype calling, the same quality control 
was separately performed on samples from both waves using PLINK, R and 
vcftools (Chang, Chow, Tellier, et al, 2015; Danecek, Auton, Abecasis, et al, 
2011; Purcell, Neale, Todd-Brown, et al, 2007; Team, 2014).  
Samples were removed from subsequent analyses on the basis of call rate 
(<0.99), suspected non-European ancestry, heterozygosity, array signal 
intensity, and relatedness. SNPs were excluded if the minor allele frequency 
was <.05%, if more than 1% of genotype data were missing, or if the Hardy 
Weinberg p-value was lower than 10-5. Non-autosomal markers and 
insertion-deletions were removed. Association between the SNP and the 
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array, batch, or plate on which samples were genotyped was calculated; 
SNPs with an effect p-value < 10-3 were excluded. A total sample of 6,710 
samples, with 3,617 individuals and 600,034 SNPs genotyped on Illumina 
and 3,093 individuals and 525,859 SNPs genotyped on Affymetrix remained 
after quality control. 
Genotypes from the two arrays were separately imputed using the 
Haplotype Reference Consortium (McCarthy, Das, Kretzschmar, et al, 2016) 
and Minimac3 1.0.13 (Fuchsberger, Abecasis & Hinds, 2014; Howie, 
Fuchsberger, Stephens, et al, 2012) available on the Michigan Imputation 
Server as reference data. A series of quality checks was performed before 
data from the two waves were merged (e.g. array effects, allele frequencies 
by imputation quality). For the present analyses we limited our analyses to 
variants genotyped or imputed at info > 0.95 on both arrays, allele frequency 
difference between arrays smaller than 5%, and Hardy Weinberg  
p-value was greater than 10-5. Using these criteria, 5,147,884 genotyped and 
well-imputed SNPs were retained for the analyses. 
Principal component analysis was performed on a subset of 42,859 common 
(MAF>5%) autosomal SNPs found on the HapMap3 data (Consortium, 2010), 
after stringent pruning to remove markers in high linkage disequilibrium (r2 
> 0.1) and excluding high linkage disequilibrium genomic regions so as to 
ensure that only genome-wide effects were detected.  
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V.II Supplementary Notes 
V.II.I Sensitivity analyses using alternative PRS 
The main analyses used a PRS derived from the all-ancestries analysis of the 
GIANT adult BMI GWAS meta-analysis (Locke, Kahali, Berndt, et al, 2015). 
There are good justifications to consider the European-only analyses from 
the adult GWAS (as the TEDS sample is predominantly of White Western 
European ancestry) and a recent child BMI GWAS meta-analysis as 
alternative base GWAS for generating PRS (Felix, Bradfield, Monnereau, et 
al, 2016; Locke, Kahali, Berndt, et al, 2015; Trzaskowski, Eley, Davis, et al, 
2013). Analyses were repeated using these PRS. Conclusions from the 
replication with the European subset PRS differed in that the main effect of 
socioeconomic status on change in BMI across adolescence in males was not 
significant when PRS was in the model (p = 0.00451). Using the child BMI 
PRS from Felix et al (2016) did not alter the conclusions from the main 
analyses. 
V.II.II. Interaction analyses with FTO rs1558902 
To enable comparison to this previous literature, analyses were re-run using 
the number of A alleles of rs1558902 (and rs9939609) in place of the 
polygenic risk score. Conclusions from the analysis of rs1558902 and 
rs9939609 did not differ, as these variants are in strong linkage 
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disequilibrium (r2 > 0.9), and so only results from rs9939609 are shown. 
Results were similar to those obtained with the full polygenic risk score, but 
showed smaller effects (Supplementary Tables 4 and 5).  
V.III Supplementary References 
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V.IV. Supplementary Tables  

















-43 0.93 0.60 0.90 0.63 0.36 0.46 0.44 0.035 0.88 
BMI 
Change 
-0.52 - 0.26 0.054 0.0016 0.77 0.0089 1.9x10
-5
 0.22 0.024 0.56 0.83 0.0051 0.79 0.63 0.042 0.80 
BMI 
PRS 
0.22 -0.026 - 0.43 0.13 0.54 0.35 0.078 0.81 0.037 0.80 0.45 0.77 0.77 0.81 0.80 0.48 




 0.0025 0.63 0.97 0.91 0.61 0.93 0.71 0.14 0.45 0.37 0.86 




 0.14 0.18 0.19 1.4 x10
-5
 0.91 0.42 0.10 0.78 0.33 
Sex -0.051 -0.0067 0.010 0.091 0.0030 - 0.55 9.2x10
-72
 0.12 0.071 0.32 0.24 0.98 0.75 0.25 0.13 0.76 
Age 0.15 -0.059 -0.016 -0.052 -0.073 -0.01 - 3.7x10
-77 0.31 0.14 0.60 0.58 0.28 0.92 0.77 0.86 0.32 
Puberty 0.24 -0.097 0.030 -0.0083 -0.063 -0.30 0.31 - 0.57 0.58 0.88 0.25 0.47 0.50 0.43 0.45 0.98 
Wave1 -0.0016 0.028 -0.0042 -6.0 x10
-4




0.00032 0.22 0.95 0.10 0.31 0.28 
PC1 -0.0090 0.051 -0.036 0.0020 0.023 -0.031 0.025 0.0096 0.72 - 0.79 0.18 0.56 0.26 0.22 0.79 0.23 
PC2 0.0022 -0.013 0.0044 0.0088 -0.022 -0.017 0.0091 -0.0027 0.34 -0.0045 - 0.63 0.70 0.40 0.29 0.28 0.12 
PC3 0.0083 0.0049 -0.013 -0.0016 0.074 0.020 -0.0096 -0.020 0.061 -0.023 0.0081 - 0.19 0.42 0.10 0.70 0.68 
PC4 0.016 -0.064 0.0050 -0.0064 -0.0019 -4.6x10
-4
 -0.018 -0.012 -0.021 -0.0099 -0.0066 0.023 - 0.25 0.86 0.92 0.87 
PC5 -0.013 0.0059 0.0051 0.025 -0.014 -0.0054 0.0018 -0.012 0.001 0.019 -0.015 -0.014 -0.020 - 0.94 0.68 0.60 
PC6 0.013 0.011 -0.0041 -0.013 0.028 0.020 0.0051 -0.014 -0.028 -0.021 -0.018 0.028 -0.0031 0.0012 - 0.84 0.28 
PC7 -0.036 -0.046 0.0044 0.015 0.0047 0.026 -0.0030 -0.013 -0.017 -0.0046 -0.018 -0.0066 -0.0018 0.0071 -0.0034 - 0.13 
PC8 0.0026 0.0058 -0.012 0.0030 0.017 -0.0052 -0.017 -4.0x10
-4
 0.018 0.021 -0.026 -0.0072 0.0030 -0.0089 0.019 0.026 - 
Supplementary Table 1: Correlations between phenotypes and variables in the analyses (Pearson pairwise product-moment 
correlation; lower triangle) and associated p-values (upper triangle). Nominally significant correlations are marked in bold  
(p < 0.05). 
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V.IV.II Supplementary Table 2a 
BMI at 11 years old, with parenting 
 Full cohort (N = 3414) Females (N = 1750) Males (N = 1664) 















































































































































Null model + parental style  0.0378 0.0167 0.0239 0.0413 0.0230 0.0730 0.0364 0.0242 0.133 
Null model + BMI PRS 0.210 0.0162 1.59x10-37 0.192 0.0224 3.04x10-17 0.231 0.0234 2.68x10-22 
Null model + Parental style  



















Null model + Parental style x BMI PRS 0.00642 0.0172 0.709 -0.00627 0.0240 0.794 0.0296 0.0252 0.241 
Supplementary Table 2a: Effects of adding variables and interactions to the null model (uppermost line) predicting variance in BMI 
at 11 years old, with parenting as the environment of interest. Significant (p<0.00417) terms are in bold. Interactions include all 
main effects, covariates and covariate interaction terms (Keller, 2014).   
 328 
 
Supplementary Table 2b 
BMI at 11 years old, with socioeconomic status 
 Full cohort (N = 3414) Females (N = 1750) Males (N = 1664) 













































































































































Null model + SES  -0.0729 0.0167 1.33x10-5 -0.0694 0.0231 0.00274 -0.0766 0.0243 0.00167 
Null model + BMI PRS 0.211 0.0162 7.95x10-38 0.192 0.0225 2.38x10-17 0.232 0.0235 1.75x10-22 
Null model + SES 



















Null model + SES  x BMI PRS -0.0336 0.0165 0.0413 -0.0230 0.0233 0.324 -0.0382 0.0239 0.111 
Supplementary Table 2b: Effects of adding variables and interactions to the null model (uppermost line) predicting variance in BMI 
at 11 years old, with socioeconomic status as the environment of interest. Significant (p<0.00417) terms are in bold. Interactions 
include all main effects, covariates and covariate interaction terms (Keller, 2014).  
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V.IV.III Supplementary Table 3a 
BMI change across adolescence, with parenting 
 Full cohort (N = 1943) Females (N = 1043) Males (N = 900) 
Coefficient B SE p B SE p B SE p 
Null 
Model 















































































































































Null model + parental style  -0.00848 0.0196 0.666 -0.0147 0.0265 0.580 -9.79x10-5 0.0291 0.997 
Null model + BMI PRS 0.0902 0.0197 4.96x10-6 0.105 0.0266 8.12x10-5 0.0738 0.0295 0.0124 
Null model + parental style 



















Null model + Parental style x BMI PRS 0.000551 0.0207 0.979 0.0209 0.0285 0.463 -0.0416 0.0309 0.179 
Supplementary Table 3a: Effects of adding variables and interactions to the null model (uppermost line) predicting change in BMI 
across adolescence, with parenting as the environment of interest. Significant (p<0.00417) terms are in bold. Interactions include all 
main effects, covariates and covariate interaction terms (Keller, 2014). 
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Supplementary Table 3b 
BMI change across adolescence, with socioeconomic status 
 Full cohort (N = 1943) Females (N = 1043) Males (N = 900) 
Coefficient B SE p B SE P B SE p 
Null 
Model 

















































































































































Null model + SES 0.0106 0.0196 0.591 -0.0135 0.0265 0.612 0.0407 0.0295 0.168 
Null model + BMI PRS 0.0904 0.0197 4.70x10-6 0.105 0.0266 8.19x10-5 0.0739 0.0295 0.0124 
Null model + SES 



















Null model + SES x BMI PRS -0.0494 0.0205 0.0159 -0.0724 0.0282 0.0103 -0.0152 0.0311 0.626 
Supplementary Table 3b: Effects of adding variables and interactions to the null model (uppermost line) predicting change in BMI 
across adolescence, with socioeconomic status as the environment of interest. Significant (p<0.00417) terms are in bold. Interactions 
include all main effects, covariates and covariate interaction terms (Keller, 2014).  
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V.IV.IV. Supplementary Table 4 
Coefficient B SE p Adjusted R2 
BMI at 11 years old, with parenting 
Null model Supplementary Table 2a 0.0667 
(Null model) + Parental style 0.0378 0.0167 0.0239 0.0678 
(Null model) + rs9939609 0.150 0.0239 4.64x10-10 0.0770 









(Null model) + Parental style x 
rs9939609 
-0.0208 0.0245 0.395 0.0800 
BMI at 11 years old, with SES 
Null model Supplementary Table 2b 0.0628 
Null model + SES -0.0729 0.0167 1.33x10-5 0.0678 
Null model + rs9939609 0.149 0.0240 6.08x10-10 0.0734 









Null model + SES x rs9939609 -0.0237 0.0242 0.328 0.0794 
Supplementary Table 4: Effects of adding variables and interactions to the null model predicting variance in BMI at 11 years old, 
with parenting as the environment of interest and FTO variant rs9939609 as the genotype of interest. Significant (p<0.00417) terms 
are in bold. Interactions include all main effects, covariates and covariate interaction terms (Keller, 2014). 
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V.IV.V. Supplementary Table 5 
Coefficient B SE p Adjusted R2 
BMI change, with parenting 
Null model Supplementary Table 3a 0.277 
(Null model) + Parental style -0.00848 0.0196 0.666 0.277 
(Null model) + rs9939609 0.0450 0.0285 0.114 0.277 









(Null model) + Parental style x 
rs9939609 
0.00651 0.0289 0.821 0.274 
BMI change, with SES 
Null model Supplementary Table 3b 0.277 
Null model + SES 0.0106 0.0196 0.591 0.277 
Null model + rs9939609 0.0454 0.0285 0.111 0.277 









Null model + SES x rs9939609 0.0180 0.0293 0.541 0.279 
Supplementary Table 5: Effects of adding variables and interactions to the null model predicting variance in BMI at 11 years old, 
with SES as the environment of interest and FTO variant rs9939609 as the genotype of interest. Significant (p<0.00417) terms are in 
bold. Interactions include all main effects, covariates and covariate interaction terms (Keller, 2014). 
